Index to Management's Discussion and Analysis of Financial Condition and Results


                                 of Operations
                                                                Page
  Forward-Looking Statements and Other Financial Information     52
  Executive Summary                                              52
  Industry Trends                                                55
  Summary of Critical Accounting Estimates                       61
  Economic Capital                                               68
  Acquisitions and Dispositions                                  68
  Results of Operations                                          69
  Effects of Inflation                                           84
  Investments                                                    85
  Derivatives                                                    101
  Off-Balance Sheet Arrangements                                 103
  Insolvency Assessments                                         104
  Policyholder Liabilities                                       104
  Liquidity and Capital Resources                                112
  Adoption of New Accounting Pronouncements                      129
  Future Adoption of New Accounting Pronouncements               129
  Non-GAAP and Other Financial Disclosures                       129
  Subsequent Events                                              133



                                       51

--------------------------------------------------------------------------------

Table of Contents



Forward-Looking Statements and Other Financial Information
For purposes of this discussion, "MetLife," the "Company," "we," "our" and "us"
refer to MetLife, Inc., a Delaware corporation incorporated in 1999, its
subsidiaries and affiliates. This discussion should be read in conjunction with
"Note Regarding Forward-Looking Statements," "Risk Factors," "Selected Financial
Data," "Quantitative and Qualitative Disclosures About Market Risk" and the
Company's consolidated financial statements included elsewhere herein.
This Management's Discussion and Analysis of Financial Condition and Results of
Operations may contain or incorporate by reference information that includes or
is based upon forward-looking statements within the meaning of the Private
Securities Litigation Reform Act of 1995. See "Note Regarding Forward-Looking
Statements" for cautionary language regarding forward-looking statements.
This Management's Discussion and Analysis of Financial Condition and Results of
Operations includes references to our performance measures, adjusted earnings
and adjusted earnings available to common shareholders, that are not based on
GAAP. See "- Non-GAAP and Other Financial Disclosures" for definitions and a
discussion of these and other financial measures, and "- Results of Operations"
for reconciliations of historical non-GAAP financial measures to the most
directly comparable GAAP measures.
For information relating to the Company's financial condition and results of
operations as of and for the year ended December 31, 2017, as well as for the
year ended December 31, 2018 compared with the year ended December 31, 2017, see
"Management's Discussion and Analysis of Financial Condition and Results of
Operations" in MetLife, Inc.'s Annual Report on Form 10-K for the year ended
December 31, 2018.
Executive Summary
Overview
MetLife is one of the world's leading financial services companies, providing
insurance, annuities, employee benefits and asset management. MetLife is
organized into five segments: U.S.; Asia; Latin America; EMEA; and MetLife
Holdings. In addition, the Company reports certain of its results of operations
in Corporate & Other. See "Business - Segments and Corporate & Other" and Note 2
of the Notes to the Consolidated Financial Statements for further information on
the Company's segments and Corporate & Other. Management continues to evaluate
the Company's segment performance and allocated resources and may adjust related
measurements in the future to better reflect segment profitability.
Current Year Highlights
During 2019, overall sales increased compared to 2018 as improved sales in our
U.S. Group Benefits business, as well as in Latin America and EMEA, more than
offset lower sales in Japan. Positive net flows drove an increase in our
investment portfolio; however, investment yields declined and interest credited
rates were higher. Underwriting experience was unfavorable compared to 2018 and
results in both 2019 and 2018 included a charge due to the impact of our annual
actuarial assumption review. In addition, our 2019 results benefited from
certain tax settlements. A favorable change in net investment gains (losses)
primarily reflects 2018 losses on the fair value option ("FVO") Brighthouse
Financial, Inc. common stock ("FVO Brighthouse Common Stock") and higher gains
on sales of fixed maturity securities. An unfavorable change in net derivative
gains (losses) was primarily the result of changes in key equity index levels,
partially offset by a decline in interest rates.
The following represents segment level results and percentage contributions to
total segment level adjusted earnings available to common shareholders for the
year ended December 31, 2019:

                                       52

--------------------------------------------------------------------------------


  Table of Contents

                                       [[Image Removed: segmentbarcharta01.jpg]]
_______________
(1) Excludes Corporate & Other adjusted loss available to common shareholders of
$401 million.
(2) Consistent with GAAP guidance for segment reporting, adjusted earnings is
our GAAP measure of segment performance. For additional information, see Note 2
of the Notes to the Consolidated Financial Statements.

                                       53

--------------------------------------------------------------------------------

Table of Contents

Year Ended December 31, 2019 Compared with the Year Ended December 31, 2018


                                                                                                 Consolidated Results - Highlights
                                                                                                 Net income (loss) available to
                                                                                                 MetLife, Inc.'s common
                                                                                                 shareholders up $739 million:

                                                                                                 • Favorable change in net
                                                                                                   investment gains (losses) of
                                                                                                   $742 million ($586 million, net
                                                                                                   of income tax)

                                                                                                 • Unfavorable change in net
                         [[Image Removed: a2019vs2018barcharta02.jpg]]                             derivative gains (losses) of
                                                                                                   $223 million ($176 million, net
                                                                                                   of income tax)

                                                                                                 • Adjusted earnings available to
                                                                                                   common shareholders up $306
                                                                                                   million




(1) See "- Results of Operations - Consolidated Results" and "- Non-GAAP and Other Financial Disclosures" for reconciliations and definitions of non-GAAP financial measures.


                                        Consolidated Results - Adjusted 

Earnings Highlights Adjusted earnings available to common shareholders up $306 million: •

                           The primary drivers of the increase in 

adjusted earnings were benefits from certain tax settlements and


                            higher net investment income due to growth in 

the investment portfolio, partially offset by higher


                            interest credited expense, unfavorable 

underwriting and the impact of our annual actuarial assumption


                            review.
•                           Our results for 2019 included the following:
                            •                       unfavorable impact 

from our annual actuarial assumption review of $143 million,


                                                    net of income tax
                            •                       a $17 million, net of 

income tax, charge due to an increase in our incurred but


                                                    not reported ("IBNR") 

long-term care reserves, reflecting enhancements to our


                                                    methodology related to 

potential claims


                            •                       expenses associated 

with our previously announced unit cost initiative of $332


                                                    million, net of income 

tax


                            •                       a $317 million tax 

benefit related to the resolution of an uncertainty


                                                    regarding the deemed 

repatriation transition tax enacted as a part of U.S. Tax


                                                    Reform
                            •                       a $222 million

benefit from the IRS audit settlement related to the tax


                                                    treatment of a 

wholly-owned U.K. investment subsidiary of MLIC, which was


                                                    comprised of a $158

million tax benefit and a $64 million interest benefit •

                           Our results for 2018 included the following:
                            •                       a $349 million

benefit from the IRS audit settlement related to the tax


                                                    treatment of a 

wholly-owned U.K. investment subsidiary of MLIC, which was


                                                    comprised of a $168

million tax benefit and a $181 million interest benefit


                            •                       favorable reserve 

adjustment of $62 million, net of income tax, relating to


                                                    certain variable 

annuity guarantees assumed from a former joint venture in

Japan
                            •                       a $37 million, net of 

income tax, favorable net insurance adjustment resulting


                                                    from reserve and DAC 

modeling improvements in our individual disability


                                                    insurance business
                            •                       expenses associated 

with our previously announced unit cost initiative of $284


                                                    million, net of income 

tax


                            •                       a $63 million, net of 

income tax, charge due to an increase in our IBNR life


                                                    reserves, reflecting 

enhancements to our processes related to potential claims


                            •                       a $60 million, net of 

income tax, increase in litigation reserves


                            •                       unfavorable impact 

from our annual actuarial assumption review of $42 million,


                                                    net of income tax



                                       54

--------------------------------------------------------------------------------

Table of Contents



For a more in-depth discussion of our consolidated results, see "- Results of
Operations - Consolidated Results," "- Results of Operations - Consolidated
Results - Adjusted Earnings" and "- Results of Operations - Segment Results and
Corporate & Other."
Consolidated Company Outlook
At the December 2019 Investor Day, we introduced our Next Horizon Strategy which
is founded on three pillars: (i) "Focus" - generate strong free cash flow by
deploying capital and resources to the highest value opportunities, (ii)
"Simplify" - simplify our business to deliver operational efficiency and an
outstanding customer experience, and (iii) "Differentiate" - drive competitive
advantage through our brand, scale, talent, and innovation. The pillars of our
Next Horizon Strategy are the basis of our ability to create and deliver optimal
shareholder value.
We continue to shift our business mix to protection-oriented and fee-based
businesses. As a result, we expect our results to be less sensitive to interest
rates. Assuming interest rates follow the observable forward yield curves, as of
the year ended December 31, 2019, we expect the ratio of free cash flow to
adjusted earnings over the two-year period of 2020 and 2021 to be 65% to 75%,
assuming a 10-year U.S. Treasury rate between 1.5% and 4.5%. We believe that
free cash flow is a key determinant of common stock dividends and common stock
repurchases. We have returned approximately $16.0 billion to shareholders from
2016 through 2019 and we expect to generate approximately $20.0 billion in free
cash flow over the next five years, while maintaining a $3.0 billion to $4.0
billion buffer of liquid assets at the holding companies.
Despite the prolonged low interest rate environment, we continue to project
adjusted return on equity, excluding accumulated other comprehensive income
("AOCI") other than foreign currency translation adjustments ("FCTA"), of 12% to
14% over the near-term. This target reflects the completion of restructuring
charges related to our unit cost improvement program in 2019 which we project
will result in approximately $900 million of pre-tax expense margin expansion in
2020. We expect to maintain this margin by holding to a 12.3% direct expense
ratio in 2020, excluding total notable items related to direct expenses and
pension risk transfers, while creating additional capacity to fund over $1.0
billion in incremental technology and innovation investments to accelerate our
growth over the next five years.
When making these and other projections, we must rely on the accuracy of our
assumptions about future economic and business conditions, which can be affected
by known and unknown risks and other uncertainties. Additional guidance from the
U.S. Treasury, SEC or the FASB may require us to revise these projections in
future periods.
Other Key Information
Argentina Highly Inflationary
The inflation levels in Argentina have been elevated for several years. In the
first half of 2018, Argentina's reported inflation rates began to increase
dramatically and the Argentine central bank significantly increased interest
rates in an effort to combat inflation. Based on Argentina's reported inflation
rates and trends, as of July 1, 2018, we designated Argentina as a highly
inflationary economy for accounting purposes. The application of highly
inflationary accounting did not have a material impact on the Company's
consolidated financial statements for the years ended December 31, 2019 and
2018.
Industry Trends
We continue to be impacted by the changing global financial and economic
environment that has been affecting the industry.
Financial and Economic Environment
Our business and results of operations are materially affected by conditions in
the global capital markets and the economy generally. Stressed conditions,
volatility and disruptions in global capital markets, particular markets, or
financial asset classes can have an adverse effect on us, in part because we
have a large investment portfolio and our insurance liabilities and derivatives
are sensitive to changing market factors. See "Risk Factors - Economic
Environment and Capital Markets Risks - Difficult Economic Conditions May Harm
Our Businesses, Results of Operations or Financial Condition."
We have market presence in numerous countries and, therefore, our business
operations are exposed to risks posed by local and regional economic conditions.
For example, MetLife is the largest provider of benefits to Mexican federal
government personnel and public officials, however, the administration of
President López Obrador of Mexico is implementing an austerity plan which, among
other measures, has eliminated benefits such as major medical insurance and
contributions to additional savings benefit insurance for such individuals. See
"Business - Regulation - Fiscal Measures" and "Risk Factors - Economic
Environment and Capital Markets Risks - Difficult Economic Conditions May Harm
Our Businesses, Results of Operations or Financial Condition - Currency Exchange
Rate Risk."

                                       55

--------------------------------------------------------------------------------

Table of Contents



We are closely monitoring political and economic conditions that might
contribute to global market volatility and impact our business operations,
investment portfolio and derivatives. For example, events following the U.K.
referendum on June 23, 2016 and the uncertainties, including foreign currency
exchange risks, associated with its withdrawal from the EU have contributed to
global market volatility. These factors could contribute to weakening Gross
Domestic Product growth, primarily in the U.K. and, to a lesser degree, in
continental Europe and beyond. The magnitude and longevity of the potential
negative economic impacts would depend on the detailed agreements reached by the
U.K. and the EU as a result of the negotiations regarding future trade and other
arrangements. See "- Investments - Current Environment - Selected Country and
Sector Investments." We are also monitoring the imposition of tariffs or other
barriers to international trade, changes to international trade agreements, and
their potential impacts on our business, results of operations and financial
condition. In addition, the possibility of government shutdowns or a failure to
raise the debt ceiling, due to a policy impasse or otherwise, could adversely
impact our business and liquidity. See "Business - Regulation - Cross-Border
Trade" and "Business - Regulation - Fiscal Measures." See also "Risk Factors -
Economic Environment and Capital Markets Risks - Difficult Economic Conditions
May Harm Our Businesses, Results of Operations or Financial Condition" and "Risk
Factors - Business Risks - The Global Nature of Our Operations Exposes Us to a
Variety of Political, Legal, Operational, Economic and Other Risks."
Central banks around the world are using monetary policy to address regional
economic conditions. In the United States, the Federal Reserve Board which had
been tightening monetary policy by raising the federal funds rate and shrinking
the balance sheet, now has lowered rates to sustain the economic expansion and
has begun to expand its balance sheet once again to reduce liquidity issues in
financing markets. The European Central Bank has resumed quantitative easing for
as long as necessary and left its deposit interest rate unchanged at its
historic low. In Japan, the Japanese government and the Bank of Japan are
maintaining stimulus measures in order to boost inflation expectations and
achieve sustainable economic growth in Japan. Such measures include the
imposition of a negative rate on commercial bank deposits, continued government
bond purchases and tax reform, including the lowering of the Japanese corporate
tax rate. Going forward, Japan's structural and demographic challenges may
continue to limit its potential growth unless reforms that boost productivity
are put into place. Japan's high public sector debt levels are mitigated by low
refinancing risks. Further actions by central banks in the future may affect
interest rates and risk markets in the U.S., Europe, Japan and other developed
and emerging economies, and may ultimately result in market volatility. We
cannot predict with certainty the effect of these actions or the impact on our
business operations, investment portfolio or derivatives. See "- Investments -
Current Environment."
Impact of a Sustained Low Interest Rate Environment
Market interest rates are a key driver of our results. Sustained periods of low
U.S. interest rates, may cause us to:
•      Reduce the difference between interest credited to policyholders and
       interest earned on supporting assets ("gross margin");

• Reinvest investment proceeds in lower yielding assets and experience

higher frequency prepayment or redemption of assets in our portfolio;

• Increase our reserves or trigger loss recognition events related to policy

liabilities, accelerate amortization of DAC and VOBA, and potentially

impair intangible assets;

• Reduce interest expense, change pension and other post-retirement benefit


       calculations, and change derivative cash flows and market values;


•      Change our product offerings, design features, crediting rates and sales
       mix; and


•      Experience changing policyholder behavior, including surrender or
       withdrawal activity.


For additional discussion on gross margin and interest rate assumptions, as well
as the potential impact of low interest rates, see "Risk Factors - Economic
Environment and Capital Markets Risks - Difficult Economic Conditions May Harm
Our Businesses, Results of Operations or Financial Condition - Interest Rate
Risk;" "Risk Factors - Business Risks - We May Be Required to Accelerate the
Amortization of or Impair DAC, DSI or VOBA;" "Risk Factors - Business Risks - We
May Be Required to Recognize an Impairment of Our Goodwill or Other Long-Lived
Assets or to Establish a Valuation Allowance Against Our Deferred Income Tax
Assets;" "Risk Factors - Business Risks - Guarantees Within Certain Products May
Decrease Our Earnings, Increase the Volatility of Our Results, Result in Higher
Risk Management Costs and Expose Us to Increased Counterparty Risk;" and "-
Results of Operations - Consolidated Results - Year Ended December 31, 2019
Compared with the Year Ended December 31, 2018 - Actuarial Assumption Review and
Certain Other Insurance Adjustments."

                                       56

--------------------------------------------------------------------------------

Table of Contents



Mitigating Actions
To mitigate unfavorable impacts of a low U.S. interest rate environment, we
maintain diversification across products, distribution channels, and geographies
while proactively evaluating interest rate and product strategies. In addition,
we apply disciplined asset/liability management ("ALM") strategies, including
the use of derivatives, and may take management actions such as:
• Lowering interest crediting rates or adjusting the dividend scale on products;


• Limiting or closing certain products to new sales to manage exposures; and

• Shifting sales focus to less interest rate sensitive products.




Our ability to take such actions may be limited by competition, regulatory
approval requirements, or minimum crediting rate guarantees and may not match
the timing or magnitude of interest rate changes.
In addition to proactive mitigation strategies, businesses within our Latin
America, EMEA, and Asia (exclusive of our Japan business) segments help mitigate
unfavorable impacts to our consolidated results given their limited U.S.
interest rate sensitivity.
As a result of the foregoing, we expect adjusted earnings will continue to
increase over the near term despite the sustained low U.S. interest rate
environment.
For additional discussion on interest rate risk management and our ability to
change interest crediting rates or dividend scales, see "Risk Factors - Economic
Environment and Capital Markets Risks - Difficult Economic Conditions May Harm
Our Businesses, Results of Operations or Financial Condition - Interest Rate
Risk;" "Management's Discussion and Analysis of Financial Condition and Results
of Operations - Policyholder Liabilities;" and "Quantitative and Qualitative
Disclosures About Market Risk - Management of Market Risk Exposures."
Low Interest Rate Scenario
To illustrate our sensitivity to lower U.S. interest rates, we compared the
outcome of a hypothetical low interest rate environment (the "Low Interest Rate
Scenario") relative to the economic assumptions used for our insurance contracts
(the "Base Scenario") through 2022.
The Low Interest Rate Scenario assumes an immediate decline of U.S. interest
rates for all maturities to 1.00% on January 1, 2020 and subsequent 10 basis
point increases for maturities one year and longer on January 1, 2021 and
January 1, 2022. Other than changing U.S. interest rates through 2022, all other
economic assumptions are equivalent in the Low Interest Rate Scenario and Base
Scenario.
The following table compares the most relevant short-term and long-term interest
rate assumptions for the dates indicated:
                                            Years Ended December 31,
                         2020                         2021                         2022
                 Low                          Low                          Low
               Interest                     Interest                     Interest
                 Rate                         Rate                         Rate
               Scenario    Base Scenario    Scenario    Base Scenario   

Scenario    Base Scenario
Three-month
LIBOR           1.00%          1.61%         1.00%          1.65%         1.00%          1.72%
10-year U.S.
Treasury        1.00%          2.04%         1.10%          2.15%         1.20%          2.25%


Hypothetical Impact to Net Derivative Gains (Losses) and Adjusted Earnings
We estimate a net favorable impact to net derivative gains (losses) from non-VA
program derivatives through 2022. We hold significant positions in long-duration
receive-fixed U.S. interest rate swaps, which are most sensitive to the 10-year
and 30-year swap rates, to hedge reinvestment risk. For purposes of the Low
Interest Rate Scenario, we have excluded all VA program derivatives. For
information regarding our VA and non-VA program derivatives, see "- Results of
Operations - Consolidated Results."
We estimate a net unfavorable impact to consolidated adjusted earnings through
2022. The negative impact of reinvesting cash flows in lower yielding assets is
partially offset by lowering interest crediting rates and dividend scales on
products, and additional derivative income.

                                       57

--------------------------------------------------------------------------------

Table of Contents



The following table summarizes the hypothetical impact on net derivative gains
(losses) and the adjusted earnings for certain segments, as well as Corporate &
Other for the dates indicated:
                                     Years Ended December 31,
                                     2020         2021      2022
                                          (In millions)
Net Derivative Gains (Losses):
Non-VA Program Derivatives      $   2,620      $ (170 )   $ (125 )

Adjusted Earnings:
U.S.                            $       -      $  (15 )   $  (50 )
Group Benefits                          -           -        (15 )

Retirement and Income Solutions - (10 ) (25 ) Property & Casualty

                     -          (5 )      (10 )
Asia (Japan only)                       -         (15 )      (40 )
MetLife Holdings                        -         (65 )     (110 )
Corporate & Other                     (15 )        35          -

Total Adjusted Earnings Impact $ (15 ) $ (60 ) $ (200 )




Segments and Corporate & Other
The primary drivers of the Low Interest Rate Scenario impacting our segments, as
well as Corporate & Other, are summarized below. Our Latin America, EMEA, and
Asia (exclusive of our Japan business) segments are excluded given their limited
U.S. interest rate sensitivity.
For additional information regarding account values subject to minimum crediting
rate guarantees, the maturity profile of fixed maturity securities
available-for-sale ("AFS"), and the yield on invested assets, see "-
Investments;" "- Policyholder Liabilities - Policyholder Account Balances;" and
Note 8 of the Notes to the Consolidated Financial Statements.
U.S.
Group Benefits
Our group life insurance products are primarily renewable term policies. This
provides repricing flexibility to mitigate the negative impact of reinvesting in
lower yielding assets.
Our retained asset accounts experience gross margin compression due to minimum
crediting rate guarantees. Less than half of these accounts are at their minimum
crediting rates. Additionally, we experience gross margin compression from our
disability policy claim reserves for which crediting rates cannot be reduced. We
use interest rate derivatives to mitigate risk for both products.
Gross margin compression is limited for our group disability products, which are
generally renewable term policies allowing for crediting rate adjustments at
renewal based on the retrospective experience rating and current interest rate
assumptions.
Retirement and Income Solutions
This business contains both short and long-duration products consisting of
capital market products, pension risk transfers, structured settlements, and
other benefit funding products. Based on our investment portfolios and expected
cash flows, only a small portion of invested assets are subject to reinvestment
risk through 2022.
A significant portion of short-duration products are managed on a floating rate
basis, which mitigates gross margin compression. The Low Interest Rate Scenario
does not assume any additional ALM actions we may take in our capital markets
business.

                                       58

--------------------------------------------------------------------------------

Table of Contents



Our long-duration products have very predictable cash flows and we use both
interest rate derivatives and asset/liability duration matching to mitigate
gross margin compression. These mitigating strategies partially offset the
negative impact of reinvesting in lower yielding assets.
Property & Casualty
Our products primarily consist of six-month and annual term renewable policies
and do not have policyholder benefits linked to interest rates. This provides
significant re-pricing flexibility to mitigate the negative impact of
reinvesting in lower yielding assets.
Asia
Our Japan business offers traditional life insurance and accident & health
products, many of which are U.S. dollar denominated. We experience gross margin
compression to the extent our investment portfolios are U.S. interest rate
sensitive and we are unable to offset the impact by lowering interest crediting
rates. Additionally, we manage interest rate risk on our life products through a
combination of product design features and ALM strategies.
Our Japan business also offers U.S. dollar denominated annuities which are
predominantly single premium products with crediting rates set upon issuance.
This allows for tightly managing product ALM, cash flows and net spreads, which
mitigates interest rate risk.
For purposes of the Low Interest Rate Scenario, we have excluded businesses
outside of Japan given their insignificant U.S. interest rate sensitivity.
MetLife Holdings
Our interest rate sensitive life products include traditional and universal life
products. Since most of our traditional life insurance is participating, we can
mitigate gross margin compression by adjusting the applicable dividend scale.
For our universal life products, we manage interest rate risk through a
combination of product design features and ALM strategies, including the use of
interest rate derivatives. Although we are able mitigate gross margin
compression by lowering interest crediting rates on certain in-force universal
life policies, these actions may be partially offset by increased liabilities
for policies with secondary guarantees.
Our annuity products experience gross margin compression primarily from deferred
annuities with minimum crediting rate guarantees. Most of these contracts are at
their minimum crediting rate, and, therefore we use interest rate derivatives to
partially mitigate gross margin compression.
Our long-term care business experiences gross margin compression as we cannot
reduce interest crediting rates for established claim reserves. Long-term care
policies are guaranteed renewable, and rates may be adjusted on a class basis
with regulatory approval to reflect emerging experience. We review the discount
rate assumptions and other assumptions associated with our long-term care claim
reserves no less frequently than annually and, with respect to interest rates,
set the discount rate based on the prevailing interest rate environment.
Our retained asset accounts experience gross margin compression due to minimum
crediting rate guarantees. Most of these accounts are at their minimum crediting
rates and therefore we use interest rate derivatives to mitigate gross margin
compression.
Based on our investment portfolios and cash flow estimates, approximately 7% of
our invested assets each year are subject to reinvestment risk through 2022.
Corporate & Other
Corporate & Other contains the surplus investment portfolios used to fund
capital and liquidity needs, certain reinsurance agreements, collateral
financing arrangements, and our outstanding debt and preferred securities. Under
the Low Interest Rate Scenario, the negative impact of reinvesting in lower
yielding assets is partially offset by the positive impact of lower interest
expense on collateral financing and variable rate debt.
For purposes of the Low Interest Rate Scenario, the preferred stock dividend
impact is excluded and the impact on pension and postretirement plan expenses is
included within Corporate & Other and not allocated across segments. Under the
Low Interest Rate Scenario, the pension and other postretirement benefit
liabilities increase, however, the impact is offset by corresponding returns on
the fixed income plan assets resulting in lower expenses.

                                       59

--------------------------------------------------------------------------------

Table of Contents



Competitive Pressures
The life insurance industry remains highly competitive. See "Business -
Competition." Product development is focused on differentiation leading to more
intense competition with respect to product features and services. Several of
the industry's products can be quite homogeneous and subject to intense price
competition. Cost reduction efforts are a priority for industry players, with
benefits resulting in price adjustments to favor customers and reinvestment
capacity. Larger companies have the ability to invest in brand equity, product
development, technology optimization, risk management, and innovation, which are
among the fundamentals for sustained profitable growth in the life insurance
industry. Insurers are focused on their core businesses, specifically in markets
where they can achieve scale. Insurers are increasingly seeking alternative
sources of revenue; there is a focus on monetization of assets, fee-based
services, and opportunities to offer comprehensive solutions, which include
providing value-added services along with traditional products. Financial
strength and flexibility and technology modernization are prerequisites for
sustainable growth in the life insurance industry. Larger market participants
tend to have the capacity to invest in analytics, distribution, and information
technology and have the capability to engage with the new digital entrants.
There is a shift in distribution from proprietary to third party models in
mature markets, due to the lower cost structure. Evolving customer expectations
are having a significant impact on the competitive environment as insurers
strive to offer the superior customer service demanded by an increasingly
sophisticated industry client base. We believe that the continued volatility of
the financial markets and its impact on the capital position of many competitors
will continue to strain the competitive environment. Legislative and other
changes affecting the regulatory environment can also affect the competitive
environment within the life insurance industry and within the broader financial
services industry. See "Business - Regulation." We believe that the
aforementioned factors have highlighted financial strength, technology
efficiency, and organizational agility as the most significant differentiators
and, as a result, we believe the Company is well positioned to compete in this
environment.
Regulatory Developments
In the United States, our life insurance companies are regulated primarily at
the state level, with some products and services also subject to federal
regulation. As life insurers introduce new and often more complex products,
regulators refine capital requirements and introduce new reserving standards for
the life insurance industry. Regulations recently adopted or currently under
review can potentially impact the statutory reserve and capital requirements of
the industry. See "Risk Factors - Regulatory and Legal Risks - Our Businesses
Are Highly Regulated, and Changes in Laws, Regulation and in Supervisory and
Enforcement Policies May Reduce Our Profitability, Limit Our Growth, or
Otherwise Adversely Affect Our Business, Results of Operations and Financial
Condition." Regulators have also undertaken market and sales practices reviews
of several markets or products, including equity-indexed annuities, variable
annuities and group products and, in some states, instituted a moratorium on new
reserve financing transactions. See "Business - Regulation," "Risk Factors -
Economic Environment and Capital Markets Risks - Our Statutory Life Insurance
Reserve Financings May Be Subject to Cost Increases, and New Financings May Be
Subject to Limited Market Capacity," "Risk Factors - Regulatory and Legal Risks
- Our Businesses Are Highly Regulated, and Changes in Laws, Regulation and in
Supervisory and Enforcement Policies May Reduce Our Profitability, Limit Our
Growth, or Otherwise Adversely Affect Our Business, Results of Operations and
Financial Condition" and "- Liquidity and Capital Resources - The Company -
Capital - Affiliated Captive Reinsurance Transactions."

                                       60

--------------------------------------------------------------------------------

Table of Contents



Summary of Critical Accounting Estimates
The preparation of financial statements in conformity with GAAP requires
management to adopt accounting policies and make estimates and assumptions that
affect amounts reported on the Consolidated Financial Statements. For a
discussion of our significant accounting policies, see Note 1 of the Notes to
the Consolidated Financial Statements. The most critical estimates include those
used in determining:

(i) liabilities for future policy benefits and the accounting for reinsurance;

(ii) capitalization and amortization of DAC and the establishment and

amortization of VOBA;

(iii) estimated fair values of investments in the absence of quoted market values;

(iv) investment impairments;

(v) estimated fair values of freestanding derivatives and the recognition and

estimated fair value of embedded derivatives requiring bifurcation;

(vi) measurement of goodwill and related impairment;

(vii) measurement of employee benefit plan liabilities; (viii) measurement of income taxes and the valuation of deferred tax assets; and

(ix) liabilities for litigation and regulatory matters.




In addition, the application of acquisition accounting requires the use of
estimation techniques in determining the estimated fair values of assets
acquired and liabilities assumed - the most significant of which relate to the
aforementioned critical accounting estimates. In applying these policies and
estimates, management makes subjective and complex judgments that frequently
require assumptions about matters that are inherently uncertain. Many of these
policies, estimates and related judgments are common in the insurance and
financial services industries; others are specific to our business and
operations. Actual results could differ from these estimates.
Liability for Future Policy Benefits
Generally, future policy benefits are payable over an extended period of time
and related liabilities are calculated as the present value of future expected
benefits to be paid, reduced by the present value of future expected premiums.
Such liabilities are established based on methods and underlying assumptions in
accordance with GAAP and applicable actuarial standards. Principal assumptions
used in the establishment of liabilities for future policy benefits are
mortality, morbidity, policy lapse, renewal, retirement, disability incidence,
disability terminations, investment returns, inflation, expenses and other
contingent events as appropriate to the respective product type and geographical
area. These assumptions are established at the time the policy is issued and are
intended to estimate the experience for the period the policy benefits are
payable. Utilizing these assumptions, liabilities are established on a block of
business basis. If experience is less favorable than assumed, additional
liabilities may be established, resulting in a charge to policyholder benefits
and claims.
Future policy benefit liabilities for disabled lives are estimated using the
present value of benefits method and experience assumptions as to claim
terminations, expenses and interest.
Liabilities for unpaid claims are estimated based upon our historical experience
and other actuarial assumptions that consider the effects of current
developments, anticipated trends and risk management programs, reduced for
anticipated salvage and subrogation.
Future policy benefit liabilities for minimum death and income benefit
guarantees relating to certain annuity contracts are based on estimates of the
expected value of benefits in excess of the projected account balance,
recognizing the excess ratably over the accumulation period based on total
expected assessments. Liabilities for ULSG and paid-up guarantees are determined
by estimating the expected value of death benefits payable when the account
balance is projected to be zero and recognizing those benefits ratably over the
accumulation period based on total expected assessments. The assumptions used in
estimating the secondary and paid-up guarantee liabilities are consistent with
those used for amortizing DAC, and are thus subject to the same variability and
risk. The assumptions of investment performance and volatility for variable
products are consistent with historical experience of the appropriate underlying
equity index, such as the S&P 500 Index.
We regularly review our estimates of liabilities for future policy benefits and
compare them with our actual experience. Differences between actual experience
and the assumptions used in pricing these policies and guarantees, as well as in
the establishment of the related liabilities, result in variances in profit and
could result in losses.

                                       61

--------------------------------------------------------------------------------

Table of Contents



See Note 4 of the Notes to the Consolidated Financial Statements for additional
information on our liability for future policy benefits.
Reinsurance
Accounting for reinsurance requires extensive use of assumptions and estimates,
particularly related to the future performance of the underlying business and
the potential impact of counterparty credit risks. We periodically review actual
and anticipated experience compared to the aforementioned assumptions used to
establish assets and liabilities relating to ceded and assumed reinsurance and
evaluate the financial strength of counterparties to our reinsurance agreements
using criteria similar to that evaluated in our security impairment process. See
"- Investment Impairments." Additionally, for each of our reinsurance
agreements, we determine whether the agreement provides indemnification against
loss or liability relating to insurance risk, in accordance with applicable
accounting standards. We review all contractual features, including those that
may limit the amount of insurance risk to which the reinsurer is subject or
features that delay the timely reimbursement of claims. If we determine that a
reinsurance agreement does not expose the reinsurer to a reasonable possibility
of a significant loss from insurance risk, we record the agreement using the
deposit method of accounting.
See Note 6 of the Notes to the Consolidated Financial Statements for additional
information on our reinsurance programs.
Deferred Policy Acquisition Costs and Value of Business Acquired
We incur significant costs in connection with acquiring new and renewal
insurance business. Costs that relate directly to the successful acquisition or
renewal of insurance contracts are capitalized as DAC. In addition to
commissions, certain direct-response advertising expenses and other direct
costs, deferrable costs include the portion of an employee's total compensation
and benefits related to time spent selling, underwriting or processing the
issuance of new and renewal insurance business only with respect to actual
policies acquired or renewed. We utilize various techniques to estimate the
portion of an employee's time spent on qualifying acquisition activities that
result in actual sales, including surveys, interviews, representative time
studies and other methods. These estimates include assumptions that are reviewed
and updated on a periodic basis to reflect significant changes in processes or
distribution methods.
VOBA represents the excess of book value over the estimated fair value of
acquired insurance, annuity, and investment-type contracts in force at the
acquisition date. For certain acquired blocks of business, the estimated fair
value of the in-force contract obligations exceeded the book value of assumed
in-force insurance policy liabilities, resulting in negative VOBA, which is
presented separately from VOBA as an additional insurance liability included in
other policy-related balances. The estimated fair value of the acquired
obligations is based on projections, by each block of business, of future policy
and contract charges, premiums, mortality and morbidity, separate account
performance, surrenders, expenses, investment returns, nonperformance risk
adjustment and other factors. Actual experience on the purchased business may
vary from these projections. The recovery of DAC and VOBA is dependent upon the
future profitability of the related business.
Separate account rates of return on variable universal life contracts and
variable deferred annuity contracts affect in-force account balances on such
contracts each reporting period, which can result in significant fluctuations in
amortization of DAC and VOBA. Our practice to determine the impact of gross
profits resulting from returns on separate accounts assumes that long-term
appreciation in equity markets is not changed by short-term market fluctuations,
but is only changed when sustained interim deviations are expected. We monitor
these events and only change the assumption when our long-term expectation
changes. The effect of an increase (decrease) by 100 basis points in the assumed
future rate of return is reasonably likely to result in a decrease (increase) in
the DAC and VOBA amortization with an offset to our unearned revenue liability
which nets to approximately $30 million. We use a mean reversion approach to
separate account returns where the mean reversion period is five years with a
long-term separate account return after the five-year reversion period is over.
The current long-term rate of return assumption for the variable universal life
contracts and variable deferred annuity contracts is 6.75%.
We periodically review long-term assumptions underlying the projections of
estimated gross margins and profits. These assumptions primarily relate to
investment returns, policyholder dividend scales, interest crediting rates,
mortality, persistency, and expenses to administer business. Assumptions used in
the calculation of estimated gross margins and profits which may have
significantly changed are updated annually. If the update of assumptions causes
expected future gross margins and profits to increase, DAC and VOBA amortization
will decrease, resulting in a current period increase to earnings. The opposite
result occurs when the assumption update causes expected future gross margins
and profits to decrease.
Our most significant assumption updates resulting in a change to expected future
gross margins and profits and the amortization of DAC and VOBA are due to
revisions to expected future investment returns, expenses, in-force or
persistency assumptions and policyholder dividends on participating traditional
life contracts, variable and universal life contracts and annuity contracts. We
expect these assumptions to be the ones most reasonably likely to cause
significant changes in the future. Changes in these assumptions can be
offsetting and we are unable to predict their movement or offsetting impact over
time.

                                       62

--------------------------------------------------------------------------------

Table of Contents



At December 31, 2019 and 2018, DAC and VOBA for the Company was $17.8 billion
and $18.9 billion, respectively. Amortization of DAC and VOBA associated with
the variable and universal life and annuity contracts was significantly impacted
by movements in equity markets. The following illustrates the effect on DAC and
VOBA of changing each of the respective assumptions, as well as updating
estimated gross margins or profits with actual gross margins or profits during
the years ended December 31, 2019 and 2018. Increases (decreases) in DAC and
VOBA balances, as presented below, resulted in a corresponding decrease
(increase) in amortization.
                                                         Years Ended December 31,
                                                          2019             2018
                                                               (In millions)
General account investment return                     $     (116 )     $    

22


Separate account investment return                            31              (42 )
Net investment/Net derivative gains (losses) and GMIB       (106 )           (215 )
In-force/Persistency                                          39            

26


Policyholder dividends, expense and other                    (81 )              -
Total                                                 $     (233 )     $     (209 )


Significant items contributing to the changes to DAC and VOBA amortization in
2019 consisted of the following:
•      Net increase in amortization of $106 million associated with net

investment/net derivative gains (losses) and GMIB, primarily driven by the

following:

- An increase in amortization of $25 million from net derivative gains

from freestanding derivatives hedging the variable annuity guarantees,


          partially offset by a decrease in amortization of approximately $10
          million from net derivative losses resulting from the increases in
          variable annuity guarantee obligations.

- A decrease in amortization of approximately $10 million associated with


          gains from GMIB hedges and the decreases in GMIB obligations.


-         Net increase in amortization of approximately $100 million from other
          investment activities.


•      Net increase in general account investment return mostly due to net
       investment income assumption unlocking and an update to the yield curve
       for market value adjustment.


Significant items contributing to the changes to DAC and VOBA amortization in
2018 consisted of the following:
•      Net increase in amortization of $215 million associated with net

investment/net derivative gains (losses) and GMIB, primarily driven by the

following:

- An increase in amortization of $90 million from net derivative gains

from freestanding derivatives hedging the variable annuity guarantees,


          partially offset by a decrease in amortization of approximately $30
          million from net derivative losses resulting from the increases in
          variable annuity guarantee obligations.

- An increase in amortization of approximately $35 million associated

with gains from GMIB hedges and the decreases in GMIB obligations.

- Net increase in amortization of approximately $100 million from the

annual actuarial assumption review and other investment activities.




Our DAC and VOBA balance is also impacted by unrealized investment gains
(losses) and the amount of amortization which would have been recognized if such
gains and losses had been realized. The increase in unrealized investment gains
(losses) decreased the DAC and VOBA balance by $1.5 billion in 2019. The
decrease in unrealized investment gains (losses) increased the DAC and VOBA
balance by $521 million in 2018. See Notes 5 and 8 of the Notes to the
Consolidated Financial Statements for information regarding the DAC and VOBA
offset to unrealized investment gains (losses).

                                       63

--------------------------------------------------------------------------------

Table of Contents



Estimated Fair Value of Investments
In determining the estimated fair value of our investments, fair values are
based on unadjusted quoted prices for identical investments in active markets
that are readily and regularly obtainable. When such unadjusted quoted prices
are not available, estimated fair values are based on quoted prices in markets
that are not active, quoted prices for similar but not identical investments, or
other observable inputs. If these inputs are not available, or observable inputs
are not determinable, unobservable inputs and/or adjustments to observable
inputs requiring management judgment are used to determine the estimated fair
value of investments.
The methodologies, assumptions and inputs utilized are described in Note 10 of
the Notes to the Consolidated Financial Statements.
Financial markets are susceptible to severe events evidenced by rapid
depreciation in asset values accompanied by a reduction in asset liquidity. Our
ability to sell investments, or the price ultimately realized for investments,
depends upon the demand and liquidity in the market and increases the use of
judgment in determining the estimated fair value of certain investments.
Investment Impairments
One of the significant estimates related to fixed maturity securities AFS is our
impairment evaluation. The assessment of whether an other-than-temporary
impairment ("OTTI") occurred is based on our case-by-case evaluation of the
underlying reasons for the decline in estimated fair value on a
security-by-security basis. Our review of each security for OTTI includes an
analysis of gross unrealized losses by three categories of severity and/or age
of gross unrealized loss. An extended and severe unrealized loss position on a
security may not have any impact on the ability of the issuer to service all
scheduled interest and principal payments. Accordingly, such an unrealized loss
position may not impact our evaluation of recoverability of all contractual cash
flows or the ability to recover an amount at least equal to its amortized cost
based on the present value of the expected future cash flows to be collected.
Additionally, we consider a wide range of factors about the security issuer and
use our best judgment in evaluating the cause of the decline in the estimated
fair value of the security and in assessing the prospects for near-term
recovery. Inherent in our evaluation of the security are assumptions and
estimates about the operations of the issuer and its future earnings potential.
Factors we consider in the OTTI evaluation process are described in Note 8 of
the Notes to the Consolidated Financial Statements.
The determination of the amount of allowances and impairments on the remaining
invested asset classes is highly subjective and is based upon our periodic
evaluation and assessment of known and inherent risks associated with the
respective asset class. Such evaluations and assessments are revised as
conditions change and new information becomes available.
See Notes 1 and 8 of the Notes to the Consolidated Financial Statements for
additional information relating to our determination of the amount of allowances
and impairments.
Derivatives
The determination of the estimated fair value of freestanding derivatives, when
quoted market values are not available, is based on market standard valuation
methodologies and inputs that management believes are consistent with what other
market participants would use when pricing the instruments. Derivative
valuations can be affected by changes in interest rates, foreign currency
exchange rates, financial indices, credit spreads, default risk, nonperformance
risk, volatility, liquidity and changes in estimates and assumptions used in the
pricing models. See Note 10 of the Notes to the Consolidated Financial
Statements for additional details on significant inputs into the OTC derivative
pricing models and credit risk adjustment.

                                       64

--------------------------------------------------------------------------------

Table of Contents



We issue variable annuity products with guaranteed minimum benefits, some of
which are embedded derivatives measured at estimated fair value separately from
the host variable annuity product, with changes in estimated fair value reported
in net derivative gains (losses). The estimated fair values of these embedded
derivatives are determined based on the present value of projected future
benefits minus the present value of projected future fees. The projections of
future benefits and future fees require capital market and actuarial
assumptions, including expectations concerning policyholder behavior. A risk
neutral valuation methodology is used under which the cash flows from the
guarantees are projected under multiple capital market scenarios using
observable risk-free rates. The valuation of these embedded derivatives also
includes an adjustment for our nonperformance risk and risk margins for
non-capital market inputs. The nonperformance risk adjustment, which is captured
as a spread over the risk-free rate in determining the discount rate to discount
the cash flows of the liability, is determined by taking into consideration
publicly available information relating to spreads in the secondary market for
MetLife, Inc.'s debt, including related credit default swaps. These observable
spreads are then adjusted, as necessary, to reflect the priority of these
liabilities and the claims paying ability of the issuing insurance subsidiaries
compared to MetLife, Inc. Risk margins are established to capture the
non-capital market risks of the instrument which represent the additional
compensation a market participant would require to assume the risks related to
the uncertainties in certain actuarial assumptions. The establishment of risk
margins requires the use of significant management judgment, including
assumptions of the amount and cost of capital needed to cover the guarantees.
The table below illustrates the impact that a range of reasonably likely
variances in credit spreads would have on our consolidated balance sheet,
excluding the effect of income tax, related to the embedded derivative valuation
on certain variable annuity products measured at estimated fair value. In
determining the ranges, we have considered current market conditions, as well as
the market level of spreads that can reasonably be anticipated over the near
term. The ranges do not reflect extreme market conditions such as those
experienced during the 2008-2009 financial crisis, as we do not consider those
to be reasonably likely events in the near future.
The impact of the range of reasonably likely variances in credit spreads
decreased as compared to prior periods. However, these estimated effects do not
take into account potential changes in other variables, such as equity price
levels and market volatility, which can also contribute significantly to changes
in carrying values. Therefore, the table does not necessarily reflect the
ultimate impact on the consolidated financial statements under the credit spread
variance scenarios presented below.
                                                           Changes in 

Balance Sheet Carrying Value At


                                                                        December 31, 2019
                                                       Policyholder Account Balances       DAC and VOBA
                                                                          (In millions)
100% increase in our credit spread                     $               488              $             46
As reported                                            $               624              $             73
50% decrease in our credit spread                      $               705              $             90


The accounting for derivatives is complex and interpretations of accounting
standards continue to evolve in practice. If it is determined that hedge
accounting designations were not appropriately applied, reported net income
could be materially affected. Assessments of the effectiveness of hedging
relationships are also subject to interpretations and estimations and different
interpretations or estimates may have a material effect on the amount reported
in net income.
Variable annuities with guaranteed minimum benefits may be more costly than
expected in volatile or declining equity markets. Market conditions including,
but not limited to, changes in interest rates, equity indices, market volatility
and foreign currency exchange rates, changes in our nonperformance risk,
variations in actuarial assumptions regarding policyholder behavior, mortality
and risk margins related to non-capital market inputs, may result in significant
fluctuations in the estimated fair value of the guarantees that could materially
affect net income. If interpretations change, there is a risk that features
previously not bifurcated may require bifurcation and reporting at estimated
fair value on the consolidated financial statements and respective changes in
estimated fair value could materially affect net income.

                                       65

--------------------------------------------------------------------------------

Table of Contents



Additionally, we ceded the risk associated with certain of the variable
annuities with guaranteed minimum benefits described in the preceding
paragraphs. The value of the embedded derivatives on the ceded risk is
determined using a methodology consistent with that described previously for the
guarantees directly written by us with the exception of the input for
nonperformance risk that reflects the credit of the reinsurer. Because certain
of the direct guarantees do not meet the definition of an embedded derivative
and, thus are not accounted for at fair value, significant fluctuations in net
income may occur since the change in fair value of the embedded derivative on
the ceded risk is being recorded in net income without a corresponding and
offsetting change in fair value of the direct guarantee.
See Note 9 of the Notes to the Consolidated Financial Statements for additional
information on our derivatives and hedging programs.
Goodwill
Goodwill is tested for impairment at least annually or more frequently if events
or circumstances, such as adverse changes in the business climate, indicate that
there may be justification for conducting an interim test.
For purposes of goodwill impairment testing, if the carrying value of a
reporting unit exceeds its estimated fair value, the implied fair value of the
reporting unit goodwill is compared to the carrying value of that goodwill to
measure the amount of impairment loss, if any. In such instances, the implied
fair value of the goodwill is determined in the same manner as the amount of
goodwill that would be determined in a business acquisition. The key inputs,
judgments and assumptions necessary in determining estimated fair value of the
reporting units include projected adjusted earnings, current book value, the
level of economic capital required to support the mix of business, long-term
growth rates, comparative market multiples, the account value of in-force
business, projections of new and renewed business, as well as margins on such
business, interest rate levels, credit spreads, equity market levels, and the
discount rate that we believe is appropriate for the respective reporting unit.
In the third quarter of 2019, we tested the MetLife Holdings life insurance
reporting unit for impairment using the actuarial based embedded value fair
valuation approach. The estimated fair value of the reporting unit exceeded the
carrying value by approximately 43% and, therefore, the reporting unit was not
impaired. If we had assumed that the discount rate was 100 basis points higher
than the discount rate used, the estimated fair value of the MetLife Holdings
life insurance reporting unit would have been higher than the carrying value by
approximately 22%. This reporting unit consists of operations relating to
products and businesses we no longer actively market. As of December 31, 2019,
the amount of goodwill allocated to this reporting unit was $887 million.
We also performed our annual goodwill impairment tests of all other reporting
units during the third quarter of 2019 using a qualitative assessment and/or
quantitative assessments under the market multiple and discounted cash flow
valuation approaches based on best available data as of June 30, 2019. We
concluded that the estimated fair values of all such reporting units were
substantially in excess of their carrying values and, therefore, goodwill was
not impaired.
We apply significant judgment when determining the estimated fair value of our
reporting units and when assessing the relationship of market capitalization to
the aggregate estimated fair value of our reporting units. The valuation
methodologies utilized are subject to key judgments and assumptions that are
sensitive to change. Estimates of fair value are inherently uncertain and
represent only management's reasonable expectation regarding future
developments. These estimates and the judgments and assumptions upon which the
estimates are based will, in all likelihood, differ in some respects from actual
future results. Declines in the estimated fair value of our reporting units
could result in goodwill impairments in future periods which could materially
adversely affect our results of operations or financial position.
See Note 12 of the Notes to the Consolidated Financial Statements for additional
information on our goodwill.
Employee Benefit Plans
Certain subsidiaries of MetLife, Inc. sponsor defined benefit pension plans and
other postretirement benefit plans covering eligible employees. See Note 18 of
the Notes to the Consolidated Financial Statements for information on amendments
to our U.S. benefit plans. The calculation of the obligations and expenses
associated with these plans requires an extensive use of assumptions such as the
discount rate, expected rate of return on plan assets, rate of future
compensation increases and healthcare cost trend rates, as well as assumptions
regarding participant demographics such as rate and age of retirement,
withdrawal rates and mortality. In consultation with external actuarial firms,
we determine these assumptions based upon a variety of factors such as
historical experience of the plan and its assets, currently available market and
industry data, and expected benefit payout streams.

                                       66

--------------------------------------------------------------------------------

Table of Contents



We determine the expected rate of return on plan assets based upon an approach
that considers inflation, real return, term premium, credit spreads, equity risk
premium and capital appreciation, as well as expenses, expected asset manager
performance, asset weights and the effect of rebalancing. Given the amount of
plan assets as of December 31, 2018, the beginning of the measurement year, if
we had assumed an expected rate of return for both our pension and other
postretirement benefit plans that was 100 basis points higher or 100 basis
points lower than the rates we assumed, the change in our net periodic benefit
costs would have been a decrease of $100 million and an increase of
$100 million, respectively, in 2019. This considers only changes in our assumed
long-term rate of return given the level and mix of invested assets at the
beginning of the year, without consideration of possible changes in any of the
other assumptions described above that could ultimately accompany any changes in
our assumed long-term rate of return.
We determine the discount rates used to value the Company's pension and
postretirement obligations, based upon rates commensurate with current yields on
high quality corporate bonds. Given our pension and postretirement obligations
as of December 31, 2018, the beginning of the measurement year, if we had
assumed a discount rate for both our pension and postretirement benefit plans
that was 100 basis points higher or 100 basis points lower than the rates we
assumed, the change in our net periodic benefit costs would have been a decrease
of $97 million and an increase of $94 million, respectively, in 2019. This
considers only changes in our assumed discount rates without consideration of
possible changes in any of the other assumptions described above that could
ultimately accompany any changes in our assumed discount rate. The assumptions
used may differ materially from actual results due to, among other factors,
changing market and economic conditions and changes in participant demographics.
These differences may have a significant impact on the Company's consolidated
financial statements and liquidity.
See Note 18 of the Notes to the Consolidated Financial Statements for additional
discussion of assumptions used in measuring liabilities relating to our employee
benefit plans.
Income Taxes
We provide for federal, state and foreign income taxes currently payable, as
well as those deferred due to temporary differences between the financial
reporting and tax bases of assets and liabilities. Our accounting for income
taxes represents our best estimate of various events and transactions. Tax laws
are often complex and may be subject to differing interpretations by the
taxpayer and the relevant governmental taxing authorities. In establishing a
provision for income tax expense, we must make judgments and interpretations
about the application of inherently complex tax laws. We must also make
estimates about when in the future certain items will affect taxable income in
the various tax jurisdictions in which we conduct business.
In establishing a liability for unrecognized tax benefits, assumptions may be
made in determining whether, and to what extent, a tax position may be
sustained. Once established, unrecognized tax benefits are adjusted when there
is more information available or when events occur requiring a change.
Valuation allowances are established against deferred tax assets when management
determines, based on available information, that it is more likely than not that
deferred income tax assets will not be realized. Significant judgment is
required in determining whether valuation allowances should be established, as
well as the amount of such allowances. See Note 1 of the Notes to the
Consolidated Financial Statements for additional information relating to our
determination of such valuation allowances.
We may be required to change our provision for income taxes when estimates used
in determining valuation allowances on deferred tax assets significantly change,
or when receipt of new information indicates the need for adjustment in
valuation allowances. Additionally, future events, such as changes in tax laws,
tax regulations, or interpretations of such laws or regulations, could have an
impact on the provision for income tax and the effective tax rate. Any such
changes could significantly affect the amounts reported on the consolidated
financial statements in the year these changes occur.
See also Notes 1 and 19 of the Notes to the Consolidated Financial Statements
for additional information on our income taxes.

                                       67

--------------------------------------------------------------------------------

Table of Contents



Litigation Contingencies
We are a defendant in a large number of litigation matters and are involved in a
number of regulatory investigations. Given the large and/or indeterminate
amounts sought in certain of these matters and the inherent unpredictability of
litigation, it is possible that an adverse outcome in certain matters could,
from time to time, have a material effect on the Company's consolidated net
income or cash flows in particular quarterly or annual periods. Liabilities are
established when it is probable that a loss has been incurred and the amount of
the loss can be reasonably estimated. Liabilities related to certain lawsuits,
including our asbestos-related liability, are especially difficult to estimate
due to the limitation of reliable data and uncertainty regarding numerous
variables that can affect liability estimates. On a quarterly and annual basis,
we review relevant information with respect to liabilities for litigation,
regulatory investigations and litigation-related contingencies to be reflected
in our consolidated financial statements. It is possible that an adverse outcome
in certain of our litigation and regulatory investigations, including
asbestos-related cases, or the use of different assumptions in the determination
of amounts recorded could have a material effect upon our consolidated net
income or cash flows in particular quarterly or annual periods.
See Note 21 of the Notes to the Consolidated Financial Statements for additional
information regarding our assessment of litigation contingencies.
Economic Capital
Economic capital is an internally developed risk capital model, the purpose of
which is to measure the risk in the business and to provide a basis upon which
capital is deployed. The economic capital model accounts for the unique and
specific nature of the risks inherent in our business. Our economic capital
model, coupled with considerations of local capital requirements, aligns segment
allocated equity with emerging standards and consistent risk principles.
Economic capital-based risk estimation is an evolving science and industry best
practices have emerged and continue to evolve. Areas of evolving industry best
practices include stochastic liability valuation techniques, alternative
methodologies for the calculation of diversification benefits, and the
quantification of appropriate shock levels. MetLife's management is responsible
for the ongoing production and enhancement of the economic capital model and
reviews its approach periodically to ensure that it remains consistent with
emerging industry practice standards. For further information, see "Financial
Measures and Segment Accounting Policies" in Note 2 of the Notes to the
Consolidated Financial Statements.
Acquisitions and Dispositions
Acquisition of PetFirst
In December 2019, the Company and PetFirst Healthcare, LLC ("PetFirst"), a
fast-growing pet health insurance administrator, entered into a definitive
agreement under which MetLife will acquire PetFirst. The transaction closed in
January 2020.
Acquisition of Willing
In November 2019, the Company completed the acquisition of Bequest, Inc.
("Willing"), a leading digital estate planning service. This transaction brings
new digital capabilities to the Company and reinforces its commitment to
providing simple and easy-to-use benefits that respond to consumer needs.
Pending Disposition of MetLife Hong Kong
For information regarding the Company's definitive agreement to sell, MetLife
Hong Kong, see Note 3 of the Notes to the Consolidated Financial Statements.
Disposition of MetLife Afore
For information regarding the Company's 2018 disposition of MetLife Afore, S.A.
de C.V. ("MetLife Afore"), its pension fund management business in Mexico, see
Note 3 of the Notes to the Consolidated Financial Statements.
Separation of Brighthouse
In 2017, MetLife, Inc. completed the separation of Brighthouse Financial, Inc.
and its subsidiaries ("Brighthouse") through a distribution of 96,776,670 shares
of Brighthouse Financial, Inc. common stock to the MetLife, Inc. common
shareholders (the "Separation"). For information regarding the Separation, the
Company's 2018 sale of the FVO Brighthouse Common Stock, and ongoing
transactions between MetLife and Brighthouse, see Notes 3 and 13 of the Notes to
the Consolidated Financial Statements.

                                       68

--------------------------------------------------------------------------------

Table of Contents



Results of Operations
Consolidated Results
Business Overview. Overall sales for 2019 increased over 2018 levels reflecting
higher sales in the majority of our businesses. In our U.S. segment, sales
increased in our Group Benefits business as a result of strong sales in both our
core and voluntary products. In our RIS business, sales were slightly lower, as
higher funding agreement issuances and structured settlement sales were more
than offset by lower sales of pension risk transfers and stable value products.
Sales in our Asia segment decreased as a result of lower sales in Japan, a large
group case in Australia in 2018, and the pending disposition of MetLife Hong
Kong, partially offset by higher sales in Korea. Sales in our Latin America
segment improved as a result of higher sales in Mexico, Brazil and Chile. In our
EMEA segment, sales improved as a result of increases in Turkey, the U.K. and
Egypt.
                                                               Years Ended December 31,
                                                                2019              2018
                                                                    (In millions)
Revenues
Premiums                                                   $     42,235       $    43,840
Universal life and investment-type product policy fees            5,603             5,502
Net investment income                                            18,868            16,166
Other revenues                                                    1,842             1,880
Net investment gains (losses)                                       444              (298 )
Net derivative gains (losses)                                       628               851
Total revenues                                                   69,620            67,941
Expenses
Policyholder benefits and claims and policyholder
dividends                                                        42,672     

43,907


Interest credited to policyholder account balances                6,464     

4,013


Capitalization of DAC                                            (3,358 )          (3,254 )
Amortization of DAC and VOBA                                      2,896     

2,975


Amortization of negative VOBA                                       (33 )             (56 )
Interest expense on debt                                            955             1,122
Other expenses                                                   13,229            12,927
Total expenses                                                   62,825            61,634
Income (loss) before provision for income tax                     6,795     

6,307


Provision for income tax expense (benefit)                          886     

1,179


Net income (loss)                                                 5,909     

5,128

Less: Net income (loss) attributable to noncontrolling interests

                                                            10                 5
Net income (loss) attributable to MetLife, Inc.                   5,899     

5,123


Less: Preferred stock dividends                                     178     

141

Net income (loss) available to MetLife, Inc.'s common shareholders

$      5,721

$ 4,982

Year Ended December 31, 2019 Compared with the Year Ended December 31, 2018 During 2019, net income (loss) increased $781 million from 2018, primarily driven by a favorable change in net investment gains (losses) and an increase in adjusted earnings, which includes benefits from certain tax settlements, partially offset by an unfavorable change in net derivative gains (losses).


                                       69

--------------------------------------------------------------------------------

Table of Contents



Management of Investment Portfolio and Hedging Market Risks with Derivatives. We
manage our investment portfolio using disciplined ALM principles, focusing on
cash flow and duration to support our current and future liabilities. Our intent
is to match the timing and amount of liability cash outflows with invested
assets that have cash inflows of comparable timing and amount, while optimizing
risk-adjusted net investment income and risk-adjusted total return. Our
investment portfolio is heavily weighted toward fixed income investments, with
over 80% of our portfolio invested in fixed maturity securities AFS and mortgage
loans. These securities and loans have varying maturities and other
characteristics which cause them to be generally well suited for matching the
cash flow and duration of insurance liabilities. In addition, our general
account investment portfolio includes, within contractholder-directed equity
securities and fair value option securities ("FVO Securities") (collectively,
"Unit-linked and FVO Securities"), contractholder-directed equity securities
supporting unit-linked variable annuity type liabilities ("Unit-linked
investments"), which do not qualify as separate account assets. Returns on these
Unit-linked investments, which can vary significantly from period to period,
include changes in estimated fair value subsequent to purchase, inure to
contractholders and are offset in earnings by a corresponding change in
policyholder account balances through interest credited to policyholder account
balances.
We purchase investments to support our insurance liabilities and not to generate
net investment gains and losses. However, net investment gains and losses are
incurred and can change significantly from period to period due to changes in
external influences, including changes in market factors such as interest rates,
foreign currency exchange rates, credit spreads and equity markets; counterparty
specific factors such as financial performance, credit rating and collateral
valuation; and internal factors such as portfolio rebalancing. Changes in these
factors from period to period can significantly impact the levels of both
impairments and realized gains and losses on investments sold.
We also use derivatives as an integral part of our management of the investment
portfolio and insurance liabilities to hedge certain risks, including changes in
interest rates, foreign currency exchange rates, credit spreads and equity
market levels. We use freestanding interest rate, equity, credit and currency
derivatives to hedge certain invested assets and insurance liabilities. A
portion of these hedges are designated and qualify as accounting hedges, which
reduce volatility in earnings. For those hedges not designated as accounting
hedges, changes in market factors lead to the recognition of fair value changes
in net derivative gains (losses) generally without an offsetting gain or loss
recognized in earnings for the item being hedged, which creates volatility in
earnings. We actively evaluate market risk hedging needs and strategies to
ensure our free cash flow and capital objectives are met under a range of market
conditions.
Certain variable annuity products with guaranteed minimum benefits contain
embedded derivatives that are measured at estimated fair value separately from
the host variable annuity contract, with changes in estimated fair value
recorded in net derivative gains (losses). We use freestanding derivatives to
hedge the market risks inherent in these variable annuity guarantees. We
continuously review and refine our strategy and ongoing refinement of the
strategy may be required to take advantage of NAIC rules related to a statutory
accounting election for derivatives that mitigate interest rate sensitivity
related to variable annuity guarantees. The restructured hedge strategy is
classified as a macro hedge program, included in the non-VA program derivatives
section of the table below, to protect our overall statutory capital from
significant adverse economic conditions. The valuation of these embedded
derivatives includes a nonperformance risk adjustment, which is unhedged, and
can be a significant driver of net derivative gains (losses) and volatility in
earnings, but does not have an economic impact on us.

                                       70

--------------------------------------------------------------------------------

Table of Contents



Net Derivative Gains (Losses). The variable annuity embedded derivatives and
associated freestanding derivative hedges are collectively referred to as "VA
program derivatives." All other derivatives that are economic hedges of certain
invested assets and insurance liabilities are referred to as "non-VA program
derivatives." The table below presents the impact on net derivative gains
(losses) from non-VA program derivatives and VA program derivatives:
                                                          Years Ended December 31,
                                                             2019             2018
                                                                (In millions)
Non-VA program derivatives
Interest rate                                          $       1,384       $     177
Foreign currency exchange rate                                   (67 )           464
Credit                                                           282             (52 )
Equity                                                          (403 )           115
Non-VA embedded derivatives                                     (162 )            78
Total non-VA program derivatives                               1,034        

782

VA program derivatives
Market risks in embedded derivatives                             851             (51 )
Nonperformance risk adjustment on embedded derivatives          (116 )      

133


Other risks in embedded derivatives                             (301 )          (310 )
Total embedded derivatives                                       434            (228 )
Freestanding derivatives hedging embedded derivatives           (840 )           297
Total VA program derivatives                                    (406 )            69
Net derivative gains (losses)                          $         628       $     851


The favorable change in net derivative gains (losses) on non-VA program
derivatives was $252 million ($199 million, net of income tax). This was
primarily due to a favorable change in interest rate impact due to long-term
U.S. interest rates decreasing in 2019 and increasing in 2018, favorably
impacting receive fixed interest rate swaps, options and total rate of return
swaps. In addition, credit spreads narrowed in 2019 and widened in 2018,
favorably impacting written credit default swaps used in replications. These
favorable impacts were partially offset by the weakening of the U.S. dollar
relative to certain foreign currencies in 2019 versus 2018, unfavorably
impacting foreign currency forwards and swaps that primarily hedge foreign
currency-denominated bonds. In addition, key equity markets increasing in 2019
versus decreasing in 2018 unfavorably impacted equity options acquired primarily
as part of our macro hedge program. There was also a change in the value of the
underlying assets, unfavorably impacting non-VA embedded derivatives related to
funds withheld on a certain reinsurance agreement. Because certain of these
hedging strategies are not designated or do not qualify as accounting hedges,
the changes in the estimated fair value of these freestanding derivatives are
recognized in net derivative gains (losses) without an offsetting gain or loss
recognized in earnings for the items being hedged.
The unfavorable change in net derivative gains (losses) on VA program
derivatives was $475 million ($375 million, net of income tax). This was due to
an unfavorable change of $249 million ($197 million, net of income tax) in the
nonperformance risk adjustment on embedded derivatives and an unfavorable change
of $235 million ($186 million, net of income tax) in freestanding derivatives
hedging market risks in embedded derivatives, net of market risks in embedded
derivatives, partially offset by a favorable change of $9 million, ($7 million,
net of income tax) in other risks in embedded derivatives. Other risks relate
primarily to the impact of policyholder behavior and other non-market risks that
generally cannot be hedged.
The aforementioned $235 million ($186 million, net of income tax) unfavorable
change reflects a $1.1 billion ($898 million, net of income tax) unfavorable
change in freestanding derivatives hedging market risks in embedded derivatives,
partially offset by a $902 million ($713 million, net of income tax) favorable
change in market risks in embedded derivatives.

                                       71

--------------------------------------------------------------------------------

Table of Contents

The primary changes in market factors are summarized as follows: • Long-term U.S. interest rates decreased in 2019 and increased in 2018,

contributing to a favorable change in our freestanding derivatives and an

unfavorable change in our embedded derivatives. For example, the 30-year

U.S. swap rate decreased 75 basis points in 2019 and increased 30 basis
       points in 2018.


•      Key equity index levels increased in 2019 and decreased in 2018,

contributing to an unfavorable change in our freestanding derivatives and


       a favorable change in our embedded derivatives. For example, the S&P 500
       Index increased 29% in 2019 and decreased 6% in 2018.


The aforementioned $9 million ($7 million, net of income tax) favorable change
in other risks in embedded derivatives reflects actuarial assumption updates and
a combination of factors, which include fees deducted from accounts, changes in
the benefit base, premiums, lapses, withdrawals and deaths.
The aforementioned $249 million ($197 million, net of income tax) unfavorable
change in the nonperformance risk adjustment on embedded derivatives resulted
from an unfavorable change of $137 million, before income tax, related to model
changes and changes in capital market inputs, such as long-term interest rates
and key equity index levels, on variable annuity guarantees in addition to an
unfavorable change of $112 million, before income tax, related to changes in our
own credit spread.
When equity index levels decrease in isolation, the variable annuity guarantees
become more valuable to policyholders, which results in an increase in the
undiscounted embedded derivative liability. Discounting this unfavorable change
by the risk adjusted rate yields a smaller loss than by discounting at the
risk-free rate, thus creating a gain from including an adjustment for
nonperformance risk.
When the risk-free interest rate decreases in isolation, discounting the
embedded derivative liability produces a higher valuation of the liability than
if the risk-free interest rate had remained constant. Discounting this
unfavorable change by the risk adjusted rate yields a smaller loss than by
discounting at the risk-free interest rate, thus creating a gain from including
an adjustment for nonperformance risk.
When our own credit spread increases in isolation, discounting the embedded
derivative liability produces a lower valuation of the liability than if our own
credit spread had remained constant. As a result, a gain is created from
including an adjustment for nonperformance risk. For each of these primary
market drivers, the opposite effect occurs when the driver moves in the opposite
direction.
Net Investment Gains (Losses). The favorable change in net investment gains
(losses) of $742 million ($586 million, net of income tax) primarily reflects
2018 losses on FVO Brighthouse Common Stock comprised of a change in fair value
through date of disposal and loss on disposal, as well as mark-to-market losses
on equity securities in 2018, both of which are measured at fair value through
net income. Additionally, there were higher gains on sales of fixed maturity
securities AFS in 2019 versus 2018. These favorable changes were partially
offset by higher foreign currency transaction losses.
Divested Businesses. Income (loss) before provision for income tax related to
the divested businesses, excluding net investment gains (losses) and net
derivative gains (losses), increased $18 million ($6 million, net of income tax)
to a loss of $104 million ($84 million, net of income tax) in 2019 from a loss
of $122 million ($90 million, net of income tax) in 2018. Included in this
increase was an increase in total revenues of $115 million, before income tax,
and an increase in total expenses of $97 million, before income tax. Divested
businesses primarily include activity related to the Separation and the pending
disposition of MetLife Hong Kong.
Taxes. Our 2019 effective tax rate on income (loss) before provision for income
tax was 13%. Our effective tax rate differed from the U.S. statutory rate of 21%
primarily due to tax benefits related to non-taxable investment income, tax
credits, tax benefits related to the resolution of an uncertainty regarding the
deemed repatriation transition tax enacted as a part of U.S. Tax Reform and the
settlement of certain tax audits, partially offset by tax charges from foreign
earnings taxed at different rates than the U.S. statutory rate and the impact
from the definitive agreement to sell MetLife Hong Kong. Our 2018 effective tax
rate on income (loss) before provision for income tax was 19%. Our effective tax
rate differed from the U.S. statutory rate of 21% primarily due to tax benefits
related to non-taxable investment income, tax credits, the settlement of tax
audits and a non-cash transfer of assets from a wholly-owned U.K. investment
subsidiary to its U.S. parent. These tax benefits were partially offset by tax
charges from foreign earnings taxed at different rates than the U.S. statutory
rate, U.S. Tax Reform, a non-deductible loss incurred on the mark-to-market and
disposition of FVO Brighthouse Common Stock and a tax adjustment in Chile.

                                       72

--------------------------------------------------------------------------------

Table of Contents



Actuarial Assumption Review and Certain Other Insurance Adjustments. Results for
2019 include a $201 million ($162 million, net of income tax) charge associated
with our annual review of actuarial assumptions related to reserves and DAC, of
which a $31 million loss ($27 million, net of income tax) was recognized in net
derivative gains (losses).
Of the $201 million charge, $49 million ($37 million, net of income tax) was
related to DAC and $152 million ($125 million, net of income tax) was associated
with reserves. The portion of the $201 million charge that was included in
adjusted earnings was $179 million ($143 million, net of income tax).
The $31 million loss ($27 million, net of income tax) recognized in net
derivative gains (losses) associated with our annual review of actuarial
assumptions was included within the other risks in embedded derivatives line in
the table above.
As a result of our annual review of actuarial assumptions, changes were made to
economic, biometric, policyholder behavior, and operational assumptions. The
most significant impacts were in the MetLife Holdings segment, driven by the
projection of closed block results and economic updates. The breakdown of total
2019 results is summarized as follows:
•      Economic assumption updates resulted in a net charge of $151 million ($117

million, net of income tax).

• Changes in biometric assumptions resulted in a net charge of $21 million

($15 million, net of income tax).

• Changes in policyholder behavior assumptions resulted in a favorable

impact of $16 million ($14 million, net of income tax).

• Changes in operational assumptions, most notably related to closed block

projections, resulted in a net charge of $44 million ($44 million, net of

income tax).




Results for 2018 include a $358 million ($272 million, net of income tax) charge
associated with our annual review of actuarial assumptions related to reserves
and DAC, of which a $131 million loss ($94 million, net of income tax) was
recognized in net derivative gains (losses). Of the $358 million charge, $20
million ($20 million, net of income tax) was related to DAC and $338 million
($252 million, net of income tax) was associated with reserves. The portion of
the $358 million charge that is included in adjusted earnings is $53 million
($42 million, net of income tax).
Certain other insurance adjustments recorded in 2019 include a $22 million ($17
million, net of income tax) charge due to a 2019 increase in our IBNR long-term
care reserves reflecting enhancements to our methodology related to potential
claims in our MetLife Holdings segment. Certain other insurance adjustments
recorded in 2018 include a $79 million ($63 million, net of income tax) charge
due to an increase in our IBNR life reserves, reflecting enhancements to our
processes related to potential claims in our MetLife Holdings segment, and a
favorable net insurance adjustment of $47 million ($37 million, net of income
tax) resulting from reserve and DAC modeling improvements in our individual
disability insurance business in our U.S. segment. These adjustments are
included in adjusted earnings.
Adjusted Earnings. As more fully described in "- Non-GAAP and Other Financial
Disclosures," we use adjusted earnings, which does not equate to income (loss)
from continuing operations, net of income tax, as determined in accordance with
GAAP, to analyze our performance, evaluate segment performance and allocate
resources. We believe that the presentation of adjusted earnings and other
financial measures based on adjusted earnings, as we measure it for management
purposes, enhances the understanding of our performance by highlighting the
results of operations and the underlying profitability drivers of the business.
Adjusted earnings and other financial measures based on adjusted earnings allow
analysis of our performance relative to our business plan and facilitate
comparisons to industry results. Adjusted earnings should not be viewed as a
substitute for net income (loss). Adjusted earnings available to common
shareholders and adjusted earnings available to common shareholders on a
constant currency basis should not be viewed as substitutes for net income
(loss) available to MetLife, Inc.'s common shareholders. Adjusted earnings
available to common shareholders increased $306 million, net of income tax, to
$5.8 billion, net of income tax, for 2019 from $5.5 billion, net of income tax,
for 2018.

                                       73

--------------------------------------------------------------------------------

Table of Contents



Reconciliation of net income (loss) to adjusted earnings available to common
shareholders
Year Ended December 31, 2019
                                                                                               MetLife
                                       U.S.        Asia       Latin America        EMEA       Holdings      Corporate& Other       Total
                                                                                 (In millions)
Net income (loss) available to
MetLife, Inc.'s common shareholders  $ 3,148     $ 1,755     $        403

$ 272 $ 780 $ (637 ) $ 5,721 Add: Preferred stock dividends

             -           -                -              -             -                 178           178
Add: Net income (loss) attributable
to noncontrolling interests                -           -                8              3             -                  (1 )          10
Net income (loss)                    $ 3,148     $ 1,755     $        411       $    275     $     780     $          (460 )     $ 5,909
Less: adjustments from net income
(loss) to adjusted earnings
available to common shareholders:
Revenues:
    Net investment gains (losses)         44         232              (22 )           (1 )         294                (103 )         444
    Net derivative gains (losses)        566         467              (11 )          (24 )        (273 )               (97 )         628
    Premiums                               -          71                -              -             -                   -            71
    Universal life and
    investment-type product policy
    fees                                   -         105                -             15            88                   -           208
    Net investment income               (200 )       229               (9 )        1,151          (141 )                 8         1,038
    Other revenues                         -          11                -              -             -                 246           257

Expenses:


    Policyholder benefits and claims
    and policyholder dividends           (37 )       (83 )           (202 )           15          (177 )                 4          (480 )
    Interest credited to
    policyholder account balances         19        (293 )            (53 )       (1,108 )           -                   -        (1,435 )
    Capitalization of DAC                  -          20                -              -             -                   -            20
    Amortization of DAC and VOBA           -         (92 )              -              8           (25 )                 -          (109 )
    Amortization of negative VOBA          -           -                -              -             -                   -             -
    Interest expense on debt               -           -                -              -             -                   -             -
    Other expenses                         -         (54 )             11            (29 )         (87 )              (292 )        (451 )
    Goodwill impairment                    -           -                -              -             -                   -             -
Provision for income tax (expense)
benefit                                  (82 )      (263 )             88            (34 )          67                  (3 )        (227 )
Adjusted earnings                    $ 2,838     $ 1,405     $        609

$ 282 $ 1,034 $ (223 ) $ 5,945 Less: Preferred stock dividends

                                                                                        178           178
Adjusted earnings available to
common shareholders                                                                                        $          (401 )     $ 5,767





                                       74

--------------------------------------------------------------------------------


  Table of Contents

Year Ended December 31, 2018
                                                                                             MetLife
                                       U.S.        Asia       Latin America       EMEA      Holdings      Corporate& Other      Total
                                                                               (In millions)
Net income (loss) available to
MetLife, Inc.'s common shareholders  $ 2,755     $ 1,547     $        471

$ 294 $ 1,016 $ (1,101 ) $ 4,982 Add: Preferred stock dividends

             -           -                -            -             -                 141          141
Add: Net income (loss) attributable
to noncontrolling interests                -           -                6            2             -                  (3 )          5
Net income (loss)                    $ 2,755     $ 1,547     $        477       $  296     $   1,016     $          (963 )    $ 5,128
Less: adjustments from net income
(loss) to adjusted earnings
available to common shareholders:
Revenues:
    Net investment gains (losses)        (72 )       142               18            5          (164 )              (227 )       (298 )
    Net derivative gains (losses)        268         312              (64 )         28           263                  44          851
    Premiums                               -           -                -            -             -                   -            -
    Universal life and
    investment-type product policy
    fees                                   -          (6 )              7           25            94                   -          120
    Net investment income               (274 )      (262 )            (45 )       (488 )        (157 )                 9       (1,217 )
    Other revenues                         -          19                -            -             -                 305          324

Expenses:


    Policyholder benefits and claims
    and policyholder dividends            11           3              (40 )        (31 )        (117 )                 -         (174 )
    Interest credited to
    policyholder account balances          4         218              (21 )        479             -                   -          680
    Capitalization of DAC                  -           -                1            -             -                   -            1
    Amortization of DAC and VOBA           -           5                -            1          (221 )                 -         (215 )
    Amortization of negative VOBA          -           1                -            -             -                   -            1
    Interest expense on debt               -           -                -            -             -                 (63 )        (63 )
    Other expenses                         -          (7 )              4           (7 )           -                (388 )       (398 )
    Goodwill impairment                    -           -                -            -             -                   -            -
Provision for income tax (expense)
benefit                                   14        (115 )             25            7            63                 (80 )        (86 )
Adjusted earnings                    $ 2,804     $ 1,237     $        592

$ 277 $ 1,255 $ (563 ) $ 5,602 Less: Preferred stock dividends

                                                                                      141          141
Adjusted earnings available to
common shareholders                                                                                      $          (704 )    $ 5,461

Adjusted earnings available to
common shareholders on a constant
currency basis (1)                   $ 2,804     $ 1,208     $        565       $  255     $   1,255     $          (704 )    $ 5,383


__________________

(1)  Amounts for U.S., MetLife Holdings and Corporate & Other are shown on a
     reported basis, as constant currency impact is not significant.


Consolidated Results - Adjusted Earnings
Year Ended December 31, 2019 Compared with the Year Ended December 31, 2018
Unless otherwise stated, all amounts discussed below are net of income tax.
Overview. The primary drivers of the increase in adjusted earnings were benefits
from certain tax settlements and higher net investment income due to growth in
the investment portfolio, partially offset by higher interest credited expense,
unfavorable underwriting and the unfavorable impact of our annual actuarial
assumption review.
Foreign Currency. Changes in foreign currency exchange rates had a $78 million
negative impact on adjusted earnings for 2019 compared to 2018. Unless otherwise
stated, all amounts discussed below are net of foreign currency fluctuations.
Foreign currency fluctuations can result in significant variances in the
financial statement line items.

                                       75

--------------------------------------------------------------------------------

Table of Contents



Business Growth. We benefited from positive net flows from many of our
businesses, which increased our invested asset base. Growth in the investment
portfolios of our Asia and U.S. segments resulted in higher net investment
income. However, this was partially offset by a corresponding increase in
interest credited expenses on certain insurance-related liabilities. Higher fee
income in our Asia, Latin America and EMEA segments was largely offset by lower
fee income in our MetLife Holdings segment. Business growth also drove an
increase in commissions, which was offset by higher DAC capitalization. A
decrease in expenses was primarily due to the 2019 abatement of the annual
health insurer fee under the PPACA. The combined impact of the items affecting
our business growth, partially offset by higher DAC amortization, resulted in a
$206 million increase in adjusted earnings.
Market Factors. Market factors, including interest rate levels, variability in
equity market returns, and foreign currency exchange rate fluctuations,
continued to impact our results; however, certain impacts were mitigated by
derivatives used to hedge these risks. Excluding the impact of changes in
foreign currency exchange rates on net investment income in our non-U.S.
segments and changes in inflation rates on our inflation-indexed investments,
investment yields decreased. Investment yields were negatively affected by lower
yields on fixed income securities, lower income from derivatives and lower
returns on real estate investments. In addition, lower earnings from our
securities lending program resulted primarily from lower margins and balances.
These decreases were partially offset by higher prepayment fees and higher
returns on FVO Securities, equity-linked notes and hedge funds. The decrease in
investment yields was more than offset by an increase in asset-based fee income
and lower DAC amortization in MetLife Holdings, both driven by higher equity
returns, and a decrease in average interest credited expenses, primarily in
Asia. The changes in market factors discussed above resulted in a $44 million
increase in adjusted earnings.
Underwriting, Actuarial Assumption Review and Other Insurance Adjustments.
Unfavorable underwriting resulted in a $121 million decrease in adjusted
earnings primarily as a result of higher claims and lapses in our Asia segment,
less favorable mortality in our MetLife Holdings and Latin America segments, and
an increase in non-catastrophe claim costs and adverse prior year development in
our Property & Casualty business, partially offset by favorable claims
experience and favorable mortality, primarily in our Group Benefits business,
and lower catastrophe losses. The impact in 2019 and 2018 of our annual
actuarial assumption review resulted in a net decrease of $101 million in
adjusted earnings, primarily due to less favorable assumption changes in our
MetLife Holdings segment in 2019. Refinements to DAC and certain
insurance-related liabilities, which were recorded in 2019 and 2018, resulted in
an $8 million increase in adjusted earnings.
Interest Expense on Debt. Interest expense on debt decreased by $82 million,
primarily due to the exchange of senior notes for FVO Brighthouse Common Stock
and the redemption of senior notes for cash in 2018, partially offset by a
premium paid in excess of the debt principal and accrued and unpaid interest on
senior notes redeemed in 2019.
Expenses. Expenses increased compared to 2018, which resulted in a $53 million
decrease in adjusted earnings, primarily due to higher costs associated with
corporate initiatives and projects, including the continued investment in our
unit cost initiative and a prior period reduction of a litigation reserve in
Argentina, partially offset by lower legal expenses, interest on uncertain tax
positions and employee-related costs, as well as a decline in costs associated
with certain other enterprise-wide initiatives.
Taxes. Our 2019 effective tax rate on adjusted earnings was 10%. Our effective
tax rate differed from the U.S. statutory rate of 21% primarily due to tax
benefits from non-taxable investment income and tax credits, the resolution of
an uncertainty regarding the deemed repatriation transition tax enacted as a
part of U.S. Tax Reform and the settlement of certain tax audits, partially
offset by tax charges from foreign earnings taxed at different rates than the
U.S. statutory rate. Our 2018 effective tax rate on adjusted earnings was 16%.
Our effective tax rate differed from the U.S. statutory rate of 21% primarily
due to tax benefits from non-taxable investment income, tax credits, the
settlement of tax audits and a non-cash transfer of assets from a wholly-owned
U.K. investment subsidiary to its U.S. parent, partially offset by tax charges
from foreign earnings taxed at different rates than the U.S. statutory rate and
a tax adjustment in Chile.



                                       76

--------------------------------------------------------------------------------

Table of Contents



Segment Results and Corporate & Other
U.S.
Business Overview. Sales increased compared to 2018, primarily driven by our
Group Benefits business, as a result of strong sales in both our core and
voluntary products. In our RIS business, sales were slightly lower than 2018, as
higher funding agreement issuances and structured settlement sales were more
than offset by lower sales of pension risk transfers (driven by a large
transaction in the second quarter of 2018) and stable value products. Changes in
premiums for the RIS business were almost entirely offset by the related changes
in policyholder benefits and claims. In our Property & Casualty business, sales
were relatively flat compared to 2018. In addition, the number of exposures
decreased from 2018, reflecting management actions to improve the quality of the
business.
                                                                Years Ended December 31,
                                                                 2019              2018
                                                                     (In millions)
Adjusted revenues
Premiums                                                    $     26,801       $    28,186
Universal life and investment-type product policy fees             1,078             1,053
Net investment income                                              7,021             6,977
Other revenues                                                       887               821
Total adjusted revenues                                           35,787            37,037
Adjusted expenses
Policyholder benefits and claims and policyholder dividends       26,165    

27,765


Interest credited to policyholder account balances                 1,984             1,790
Capitalization of DAC                                               (484 )            (449 )
Amortization of DAC and VOBA                                         475               477
Interest expense on debt                                              10                12
Other expenses                                                     4,075             3,902
Total adjusted expenses                                           32,225            33,497
Provision for income tax expense (benefit)                           724               736
Adjusted earnings                                           $      2,838       $     2,804


Year Ended December 31, 2019 Compared with the Year Ended December 31, 2018
Unless otherwise stated, all amounts discussed below are net of income tax.
Business Growth. The impact of positive flows from pension risk transfer
transactions in both 2019 and 2018 and funding agreement issuances in 2019
resulted in higher average invested assets, improving net investment income.
However, consistent with the growth in average invested assets, interest
credited expenses on long-duration liabilities increased. Higher volume-related,
premium tax and direct expenses, driven by business growth, were partially
offset by lower employee-related expenses. This net increase in expenses,
partially offset by the decrease due to the 2019 abatement of the annual health
insurer fee under the PPACA, was more than offset by a corresponding increase in
premiums, fees and other revenues. The combined impact of the items affecting
our business growth increased adjusted earnings by $111 million.
Market Factors. Market factors, including interest rate levels, variability in
equity market returns and foreign currency exchange rate fluctuations, continued
to impact our results; however, certain impacts were mitigated by derivatives
used to hedge these risks. Investment yields decreased, primarily due to lower
income from derivatives, lower yields on fixed income securities and real estate
investments, lower returns on private equity funds and lower earnings from our
securities lending program, primarily from lower margins and balances. These
decreases were partially offset by higher prepayment fees and higher yields on
mortgage loans. In addition, net investment income increased as a result of the
impact of an increased crediting rate on interest on economic capital. The
impact of interest rate fluctuations resulted in an increase in our average
interest credited rates on deposit-type liabilities, partially offset by lower
rates on our long-duration liabilities, which drove a net increase in interest
credited expenses. The changes in market factors discussed above resulted in a
$176 million decrease in adjusted earnings.

                                       77

--------------------------------------------------------------------------------

Table of Contents



Underwriting and Other Insurance Adjustments. Favorable claims experience and
the impact of growth in our Group Benefits business resulted in a $95 million
increase in adjusted earnings. This was primarily driven by lower claim
severity, favorable renewal results and an increase in recoveries in our group
disability business. In both our accident & health and individual disability
businesses, the impact of growth in the business and favorable claims experience
also contributed to the increase in adjusted earnings. These favorable results
were partially offset by less favorable dental results, driven by an increase in
utilization and the impact of unfavorable prior period development in 2019.
Favorable mortality, driven by claims experience in our term life business,
primarily due to lower severity in 2019 and the unfavorable impact of the
influenza virus in 2018, partially offset by less favorable mortality in our
pension risk transfer, structured settlement, income annuities and specialized
benefit resources businesses, resulted in a $42 million increase in adjusted
earnings. In our Property & Casualty business, adjusted earnings decreased $77
million, the result of higher non-catastrophe claims costs, driven by higher
severities in both our auto and homeowner businesses and a net increase in
frequencies, with an increase in our auto business being mostly offset in our
homeowner business, coupled with higher losses in the commercial business. In
addition, adverse prior year development, due to auto non-catastrophe claims
costs impacting the estimate of ultimate losses for prior accident years,
predominantly for casualty coverages, contributed to this decrease. These
unfavorable results were partially offset by lower catastrophe costs.
Refinements to certain insurance and other liabilities recorded in both 2019 and
2018 resulted in a $48 million increase to adjusted earnings, which included the
impact of favorable insurance adjustments resulting from enhancements to our
claim-related processes, and the 2018 favorable net insurance adjustments
resulting from reserve and DAC modeling improvements in our individual
disability insurance business.
Asia
Business Overview. Sales decreased compared to 2018, primarily driven by lower
sales of foreign currency-denominated annuity products in Japan, a large group
case in Australia in the prior period, and the pending disposition of MetLife
Hong Kong, partially offset by higher sales in Korea due to higher sales of
retirement products and a new life product launch.
                                                               Years Ended December 31,
                                                                 2019             2018
                                                                     (In millions)
Adjusted revenues
Premiums                                                    $     6,632       $     6,766
Universal life and investment-type product policy fees            1,674             1,630
Net investment income                                             3,691             3,317
Other revenues                                                       56                51
Total adjusted revenues                                          12,053            11,764
Adjusted expenses
Policyholder benefits and claims and policyholder dividends       5,185     

5,326


Interest credited to policyholder account balances                1,710             1,465
Capitalization of DAC                                            (1,913 )          (1,915 )
Amortization of DAC and VOBA                                      1,288             1,302
Amortization of negative VOBA                                       (25 )             (39 )
Other expenses                                                    3,818             3,840
Total adjusted expenses                                          10,063             9,979
Provision for income tax expense (benefit)                          585               548
Adjusted earnings                                           $     1,405       $     1,237


Year Ended December 31, 2019 Compared with the Year Ended December 31, 2018
Unless otherwise stated, all amounts discussed below are net of income tax.
Foreign Currency. Changes in foreign currency exchange rates decreased adjusted
earnings by $29 million for 2019 compared to 2018, primarily due to the
weakening of the Japanese yen and Korean won against the U.S. dollar. Unless
otherwise stated, all amounts discussed below are net of foreign currency
fluctuations. Foreign currency fluctuations can result in significant variances
in the financial statement line items.

                                       78

--------------------------------------------------------------------------------

Table of Contents



Business Growth. Asia's premiums, fees and other revenues decreased slightly as
compared to 2018, mainly driven by the pending disposition of MetLife Hong Kong
and a decrease in premiums from yen-denominated life products in Japan,
partially offset by a related decline in policyholder benefits, as well as
growth in accident & health and foreign currency-denominated life products in
Japan. Positive net flows in Japan and Korea resulted in higher average invested
assets, which improved net investment income. The increase in net investment
income was partially offset by a corresponding increase in interest credited
expenses on certain insurance liabilities. The combined impact of the items
affecting our business growth improved adjusted earnings by $122 million.
Market Factors. Market factors, including interest rate levels and variability
in equity market returns, continued to impact our results; however, certain
impacts were mitigated by derivatives used to hedge these risks. Investment
results were favorably impacted by higher derivative income, earnings from our
operating joint venture in China (mainly driven by a regulatory change), returns
from hedge funds, private equities and real estate investments, as well as
higher yields on mortgage loans. These increases were partially offset by lower
yields on fixed income securities supporting U.S. dollar-denominated products
sold in Japan, and fixed income securities in Bangladesh and Korea. In addition,
lower interest credited rates improved adjusted earnings. The changes in market
factors discussed above increased adjusted earnings by $102 million.
Underwriting, Actuarial Assumption Review and Other Insurance Adjustments.
Higher claims and lapses primarily in Japan and Korea decreased adjusted
earnings by $99 million. The impact in 2019 and 2018 of our annual actuarial
assumption review resulted in a net increase of $67 million in adjusted
earnings. Refinements to certain insurance and other liabilities, which were
recorded in 2019 and 2018, resulted in a slight increase in adjusted earnings.
Expenses and Taxes. Expenses increased as compared to 2018, which reduced
adjusted earnings by $5 million. Various tax items in both 2019 and 2018
resulted in a $9 million increase in adjusted earnings. Results for 2019 include
a charge of $8 million related to a withholding tax provision on dividends from
our operating joint venture in China and a $6 million benefit due to reduced tax
charges as a result of recently issued tax regulations related to U.S. Tax
Reform and the filing of the Company's 2018 U.S. tax return.
Latin America
Business Overview. Total sales for Latin America increased compared to 2018,
driven by higher group and individual medical sales in Mexico, higher universal
and variable life sales in Mexico and Chile, and higher dental and life sales in
Brazil, partially offset by lower retirement sales in Chile.
                                                               Years Ended December 31,
                                                                 2019             2018
                                                                     (In millions)
Adjusted revenues
Premiums                                                    $     2,723       $     2,760
Universal life and investment-type product policy fees            1,094             1,050
Net investment income                                             1,271             1,239
Other revenues                                                       44                35
Total adjusted revenues                                           5,132             5,084
Adjusted expenses
Policyholder benefits and claims and policyholder dividends       2,623     

2,602


Interest credited to policyholder account balances                  332               394
Capitalization of DAC                                              (396 )            (377 )
Amortization of DAC and VOBA                                        291               209
Amortization of negative VOBA                                         -                (1 )
Interest expense on debt                                              3                 6
Other expenses                                                    1,443             1,421
Total adjusted expenses                                           4,296             4,254
Provision for income tax expense (benefit)                          227               238
Adjusted earnings                                           $       609       $       592



                                       79

--------------------------------------------------------------------------------

Table of Contents



Year Ended December 31, 2019 Compared with the Year Ended December 31, 2018
Unless otherwise stated, all amounts discussed below are net of income tax.
Foreign Currency. Changes in foreign currency exchange rates decreased adjusted
earnings by $27 million for 2019 compared to 2018, mainly due to the weakening
of the Argentine and Chilean pesos against the U.S. dollar. Unless otherwise
stated, all amounts discussed below are net of foreign currency fluctuations.
Foreign currency fluctuations can result in significant variances in the
financial statement line items.
Business Growth. Latin America experienced growth across several lines of
business primarily within Chile and Mexico. This growth resulted in increased
premiums and policy fee income, which was partially offset by related changes in
policyholder benefits. Positive net flows, primarily from Chile and Argentina,
partially offset by Mexico, resulted in an increase in average invested assets
and generated higher net investment income. Although business growth drove an
increase in commissions, net of DAC capitalization, this was more than offset by
decreases in interest credited expense on certain insurance liabilities and
other variable expenses. The combined impact of the items affecting business
growth, including higher DAC amortization, increased adjusted earnings by
$62 million.
Market Factors. Market factors, including interest rate levels and variability
in equity market returns, continued to impact our results; however, certain
impacts were mitigated by derivatives used to hedge these risks. Investment
yields increased, driven by higher yields on FVO Securities, due to the
favorable impact of equity markets on our Chilean encaje and fixed income
securities in Argentina, Chile and Mexico. These increases in investment yields
were partially offset by lower private equity returns in Chile and Mexico, as
well as lower yields on mortgage loans and lower derivative income, both in
Chile. The changes in market factors discussed above increased adjusted earnings
by $61 million.
Underwriting, Actuarial Assumption Review and Other Insurance Adjustments. Less
favorable underwriting resulted in a $23 million decrease to adjusted earnings
primarily driven by higher claims experience in Mexico. The impact in 2019 and
2018 of our annual actuarial assumption review resulted in a net decrease of $18
million in adjusted earnings. In addition, refinements to certain insurance
liabilities and other adjustments in 2019 and 2018, primarily in Brazil,
resulted in a $12 million increase to adjusted earnings.
Expenses and Taxes. A $60 million increase in expenses was primarily the result
of a prior period reduction of a litigation reserve in Argentina, along with
various other expense increases. Adjusted earnings increased by $13 million due
to reduced tax charges as a result of recently issued tax regulations related to
U.S. Tax Reform and the filing of the Company's 2018 U.S. tax return. Other
tax-related adjustments in 2019 and 2018, primarily related to foreign exchange
volatility in Argentina, resulted in a net decrease in adjusted earnings of $29
million. Results for 2018 also include tax expenses of $24 million driven by a
$17 million tax charge related to a tax adjustment in Chile and a $5 million tax
charge in Colombia to establish a deferred tax liability due to a change in tax
status.

                                       80

--------------------------------------------------------------------------------

Table of Contents

EMEA

Business Overview. Sales increased compared to 2018 primarily driven by increases in our credit life business in Turkey and in our employee benefits business in the U.K. and Egypt.


                                                               Years Ended December 31,
                                                                 2019             2018
                                                                     (In millions)
Adjusted revenues
Premiums                                                    $     2,177       $     2,131
Universal life and investment-type product policy fees              423               431
Net investment income                                               291               293
Other revenues                                                       54                66
Total adjusted revenues                                           2,945             2,921
Adjusted expenses
Policyholder benefits and claims and policyholder dividends       1,176     

1,127


Interest credited to policyholder account balances                   98               100
Capitalization of DAC                                              (505 )            (468 )
Amortization of DAC and VOBA                                        428               434
Amortization of negative VOBA                                        (8 )             (15 )
Other expenses                                                    1,399             1,378
Total adjusted expenses                                           2,588             2,556
Provision for income tax expense (benefit)                           75                88
Adjusted earnings                                           $       282       $       277


Year Ended December 31, 2019 Compared with the Year Ended December 31, 2018
Unless otherwise stated, all amounts discussed below are net of income tax.
Foreign Currency. Changes in foreign currency exchange rates decreased adjusted
earnings by $22 million for 2019 as compared to 2018, primarily driven by the
strengthening of the U.S. dollar against the Turkish lira, the euro, the British
pound and the Polish zloty. Unless otherwise stated, all amounts discussed below
are net of foreign currency fluctuations. Foreign currency fluctuations can
result in significant variances in the financial statement line items.
Business Growth. Growth from our accident & health and credit life businesses in
Turkey and across several European markets, partially offset by a decrease in
our pensions business in Romania due to regulatory changes, increased adjusted
earnings by $10 million.
Market Factors. Market factors, including interest rate levels and variability
in equity market returns, impacted our results favorably by $4 million primarily
due to higher investment yields in Turkey and Ukraine.
Underwriting, Actuarial Assumption Review and Other Insurance Adjustments.
Unfavorable underwriting decreased adjusted earnings by $5 million as a result
of unfavorable experience in (i) our credit life business in Turkey and (ii)
across several businesses in European markets (primarily our employee benefits
business in the U.K.), partially offset by favorable experience in our employee
benefits and accident & health businesses in the Gulf region. The impact in 2019
and 2018 of our annual actuarial assumption review resulted in a net increase of
$10 million in adjusted earnings. Refinements to certain insurance-related
assets and liabilities that were recorded in 2019 and 2018 resulted in an $8
million increase in adjusted earnings.
Expenses and Taxes. Adjusted earnings decreased by $6 million, primarily driven
by higher expenses in Europe due to transformation costs and regulatory fees,
partially offset by lower costs associated with enterprise-wide initiatives.
Adjusted earnings increased by $6 million due to reduced tax charges as a result
of recently issued tax regulations related to U.S. Tax Reform and the filing of
the Company's 2018 U.S. tax return, partially offset by the prior period release
of provisions arising from the finalization of historical corporate tax filings
and changes in business mix among tax jurisdictions.

                                       81

--------------------------------------------------------------------------------

Table of Contents

MetLife Holdings
Business Overview. Our MetLife Holdings segment consists of operations relating
to products and businesses, previously included in our former retail business,
that we no longer actively market in the United States. We anticipate an average
decline in premiums, fees and other revenues of approximately 5% per year from
expected business run-off. A significant portion of our adjusted earnings is
driven by separate account balances. Most directly, these balances determine
asset-based fee income but they also impact DAC amortization and asset-based
commissions. Separate account balances are driven by movements in the market,
surrenders, deposits, withdrawals, benefit payments, transfers and policy
charges. Although we have discontinued selling our long-term care product, we
continue to collect premiums and administer the existing block of business,
which contributed to asset growth in the segment, and we expect the related
reserves to grow as this block matures. As of December 31, 2019, our future
policyholder benefit liability for our long-term care business was $12.5
billion.
                                                               Years Ended December 31,
                                                                 2019             2018
                                                                     (In millions)
Adjusted revenues
Premiums                                                    $     3,748       $     3,879
Universal life and investment-type product policy fees            1,124             1,218
Net investment income                                             5,281             5,379
Other revenues                                                      253               250
Total adjusted revenues                                          10,406            10,726
Adjusted expenses
Policyholder benefits and claims and policyholder dividends       6,970     

6,833


Interest credited to policyholder account balances                  905               944
Capitalization of DAC                                               (28 )             (36 )
Amortization of DAC and VOBA                                        299               332
Interest expense on debt                                              8                 9
Other expenses                                                      969             1,081
Total adjusted expenses                                           9,123             9,163
Provision for income tax expense (benefit)                          249               308
Adjusted earnings                                           $     1,034       $     1,255


Year Ended December 31, 2019 Compared with the Year Ended December 31, 2018
Unless otherwise stated, all amounts discussed below are net of income tax.
Business Growth. Negative net flows from our deferred annuities business and a
decrease in universal life deposits resulted in lower fee income. Lower net
investment income, resulting from a reduced invested asset base, primarily in
fixed income securities, also decreased adjusted earnings. The reduced invested
asset base was primarily the result of the negative net flows in our deferred
annuities and life businesses. The decline was partially offset by invested
asset growth from our long-term care business. The combined impact of the items
affecting our business growth, partially offset by lower DAC amortization,
resulted in a $103 million decrease in adjusted earnings.
Market Factors. Market factors, including interest rate levels, variability in
equity market returns, and foreign currency exchange rate fluctuations,
continued to impact our results; however, certain impacts were mitigated by
derivatives used to hedge these risks. In our deferred annuity business, higher
equity returns drove an increase in asset-based fee income and lower DAC
amortization, increasing adjusted earnings. Investment yields decreased
primarily due to lower yields on fixed income securities and lower returns on
real estate investments. The decline in investment yields was partially offset
by increased prepayment fees and higher returns on hedge funds. The changes in
market factors discussed above resulted in a $17 million increase in adjusted
earnings.

                                       82

--------------------------------------------------------------------------------

Table of Contents



Underwriting, Actuarial Assumption Review, and Other Insurance Adjustments.
Adjusted earnings decreased $47 million, primarily driven by less favorable
underwriting in our traditional life business. The impact in 2019 and 2018 of
our annual actuarial assumption review resulted in a net decrease of $160
million in adjusted earnings. Changes mainly in mortality, and economic and
operational assumptions, including updates to closed block projections, were
less favorable in 2019. Refinements to DAC and certain insurance-related
liabilities that were recorded in 2019 and 2018 resulted in a $62 million
decrease in adjusted earnings. This includes a 2019 charge due to an increase in
our IBNR long-term care reserves, reflecting enhancements to our methodology
related to potential claims, as well as the following 2018 refinements: (i) a
favorable reserve adjustment relating to certain variable annuity guarantees
assumed from a former joint venture in Japan; (ii) favorable reserve adjustments
resulting from modeling improvements in our life business; and (iii) a charge
due to an increase in our IBNR life reserves, reflecting enhancements to our
processes related to potential claims.
Expenses. Adjusted earnings increased by $114 million due to declines in
employee-related costs and lower operational expenses as a result of
enterprise-wide initiatives.

Corporate & Other
                                                               Years Ended December 31,
                                                                 2019             2018
                                                                     (In millions)
Adjusted revenues
Premiums                                                    $        83       $       118
Universal life and investment-type product policy fees                2                 -
Net investment income                                               275               178
Other revenues                                                      291               333
Total adjusted revenues                                             651               629
Adjusted expenses
Policyholder benefits and claims and policyholder dividends          73                80
Capitalization of DAC                                               (12 )              (8 )
Amortization of DAC and VOBA                                          6                 6
Interest expense on debt                                            934             1,032
Other expenses                                                    1,074               907
Total adjusted expenses                                           2,075             2,017
Provision for income tax expense (benefit)                       (1,201 )            (825 )
Adjusted earnings                                                  (223 )            (563 )
Less: Preferred stock dividends                                     178     

141

Adjusted earnings available to common shareholders $ (401 )

  $      (704 )



                                       83

--------------------------------------------------------------------------------

Table of Contents



The table below presents adjusted earnings available to common shareholders by
source:
                                                              Years Ended December 31,
                                                                2019             2018
                                                                    (In millions)
Business activities                                        $        70       $        41
Net investment income                                              290               263
Interest expense on debt                                          (978 )          (1,076 )
Corporate initiatives and projects                                (563 )            (405 )
Other                                                             (330 )    

(368 ) Provision for income tax (expense) benefit and other tax-related items

                                                1,288      

982


Preferred stock dividends                                         (178 )            (141 )
Adjusted earnings available to common shareholders         $      (401 )

$ (704 )




Year Ended December 31, 2019 Compared with the Year Ended December 31, 2018
Unless otherwise stated, all amounts discussed below are net of income tax.
Business Activities. Adjusted earnings from business activities increased $23
million. This was primarily related to improved results from certain of our
businesses.
Net Investment Income. Variability in equity market results increased returns on
both FVO Securities and equity-linked notes. In addition, lower losses on tax
credit partnerships favorably impacted net investment income. These increases
were partially offset by decreased income on fixed income securities, mortgage
loans and lower returns on private equities and real estate investments,
resulting in an increase of $21 million in net investment income.
Interest Expense on Debt. Interest expense on debt decreased by $77 million,
primarily due to the exchange of senior notes for FVO Brighthouse Common Stock
and the redemption of senior notes for cash in 2018, partially offset by a
premium paid in excess of the debt principal and accrued and unpaid interest on
senior notes redeemed in 2019.
Corporate Initiatives and Projects. Adjusted earnings decreased $125 million due
to higher expenses associated with corporate initiatives and projects, most
notably, costs associated with the continued investment in our unit cost
initiative, partially offset by lower costs associated with certain other
enterprise-wide initiatives.
Provision for Income Tax (Expense) Benefit and Other Tax-Related Items. A
favorable change in Corporate & Other's effective tax rate was primarily due to
tax benefits related to the resolution of an uncertainty regarding the deemed
repatriation transition tax enacted as a part of U.S. Tax Reform. Additionally,
2019 and 2018 include benefits from the settlement of tax audits related to the
tax treatment of a wholly-owned U.K. investment subsidiary of MLIC. The 2018
provision for income tax (expense) benefit and other tax related items also
included a tax benefit from a non-cash transfer of assets from a wholly-owned
U.K. investment subsidiary to its U.S. parent and a reduction in adjusted
earnings related to certain tax impacts on tax credit partnership investments.
Other. Adjusted earnings increased $30 million, primarily as a result of lower
interest expenses on certain tax positions, lower legal expenses and declines in
various other expenses, partially offset by a loss related to the sale of a
run-off business that was previously reinsured, as well as increases in certain
corporate-related expenses.
Preferred Stock Dividends. Preferred stock dividends increased $37 million as a
result of the issuance of MetLife, Inc.'s 5.875% Fixed-to-Floating Rate
Non-Cumulative Preferred Stock, Series D ("Series D preferred stock") and
MetLife, Inc.'s 5.625% Non-Cumulative Preferred Stock, Series E ("Series E
preferred stock") in 2018.
Effects of Inflation
Management believes that inflation has not had a material effect on the
Company's consolidated results of operations, except insofar as inflation may
affect interest rates.

                                       84

--------------------------------------------------------------------------------

Table of Contents



An increase in inflation could affect our business in several ways. During
inflationary periods, the value of fixed income investments falls which could
increase realized and unrealized losses. Inflation also increases expenses for
labor and other materials, potentially putting pressure on profitability if such
costs cannot be passed through in our product prices. Inflation could also lead
to increased costs for losses and loss adjustment expenses in certain of our
businesses, which could require us to adjust our pricing to reflect our
expectations for future inflation. Prolonged and elevated inflation could
adversely affect the financial markets and the economy generally, and dispelling
it may require governments to pursue a restrictive fiscal and monetary policy,
which could constrain overall economic activity, inhibit revenue growth and
reduce the number of attractive investment opportunities.
Investments
Investment Risks
Our primary investment objective is to optimize, net of income tax,
risk-adjusted net investment income and risk-adjusted total return while
ensuring that assets and liabilities are managed on a cash flow and duration
basis. The Investments Department, led by the Chief Investment Officer, manages
investment risks using a risk control framework comprised of policies,
procedures and limits, as discussed further below. The Investment Risk Committee
and Asset-Liability Steering Committee review and monitor investment risk limits
and tolerances.
We are exposed to the following primary sources of investment risks:
•      credit risk, relating to the uncertainty associated with the continued
       ability of a given obligor to make timely payments of principal and
       interest;

• interest rate risk, relating to the market price and cash flow variability

associated with changes in market interest rates. Changes in market

interest rates will impact the net unrealized gain (loss) position of our


       fixed income investment portfolio and the rates of return we receive on
       both new funds invested and reinvestment of existing funds;


•      liquidity risk, relating to the diminished ability to sell certain
       investments, in times of strained market conditions;

• market valuation risk, relating to the variability in the estimated fair

value of investments associated with changes in market factors such as

credit spreads and equity market levels. A widening of credit spreads will

adversely impact the net unrealized gain (loss) position of the fixed

income investment portfolio, will increase losses associated with

credit-based non-qualifying derivatives where we assume credit exposure,


       and, if credit spreads widen significantly or for an extended period of
       time, will likely result in higher OTTI. Credit spread tightening will

reduce net investment income associated with purchases of fixed income


       investments and will favorably impact the net unrealized gain (loss)
       position of the fixed income investment portfolio;

• currency risk, relating to the variability in currency exchange rates for

foreign denominated investments including as a result of the U.K.'s

withdrawal from the EU. This risk relates to potential decreases in

estimated fair value and net investment income resulting from changes in

currency exchange rates versus the U.S. dollar. In general, the weakening


       of foreign currencies versus the U.S. dollar will adversely affect the
       estimated fair value of our foreign denominated investments; and

• real estate risk, relating to commercial, agricultural and residential

real estate, and stemming from factors, which include, but are not limited

to, market conditions, including the supply and demand of leasable

commercial space, creditworthiness of borrowers, tenants and our joint

venture partners, capital markets volatility, changes in market interest

rates, commodity prices, farm incomes and U.S. housing market conditions.





                                       85

--------------------------------------------------------------------------------

Table of Contents



We manage investment risk through in-house fundamental credit analysis of the
underlying obligors, issuers, transaction structures and real estate properties.
We also manage credit, market and liquidity risk through industry and issuer
diversification and asset allocation. These risk limits, approved annually by
the Investment Risk Committee, promote diversification by asset sector, avoid
concentrations in any single issuer and limit overall aggregate credit and
equity risk exposure, as measured by our economic capital framework. For real
estate assets, we manage credit and market risk through asset allocation and by
diversifying by geography, property and product type. We manage interest rate
risk as part of our ALM strategies which are reviewed and approved by the
Asset-Liability Steering Committee. These strategies include maintaining an
investment portfolio with diversified maturities that has a weighted average
duration that reflects the duration of our estimated liability cash flow
profile, and utilizing product design, such as the use of market value
adjustment features and surrender charges, to manage interest rate risk. We also
manage interest rate risk through proactive monitoring and management of certain
NGEs of our products, such as the resetting of credited interest and dividend
rates for policies that permit such adjustments. In addition to hedging with
foreign currency derivatives, we manage currency risk by matching much of our
foreign currency liabilities in our foreign subsidiaries with their respective
foreign currency assets, thereby reducing our risk to foreign currency exchange
rate fluctuation. We also use certain derivatives in the management of credit,
interest rate, and market valuation risk.
We enter into market standard purchased and written credit default swap
contracts. Payout under such contracts is triggered by certain credit events
experienced by the referenced entities. For credit default swaps covering North
American corporate issuers, credit events typically include bankruptcy and
failure to pay on borrowed money. For European corporate issuers, credit events
typically also include involuntary restructuring. With respect to credit default
contracts on sovereign debt, credit events typically include failure to pay debt
obligations, repudiation, moratorium, or involuntary restructuring. In each
case, payout on a credit default swap is triggered only after the Credit
Derivatives Determinations Committee of the International Swaps and Derivatives
Association determines that a credit event has occurred.
We use purchased credit default swaps to mitigate credit risk in our investment
portfolio. Generally, we purchase credit protection by entering into credit
default swaps referencing the issuers of specific assets we own. In certain
cases, basis risk exists between these credit default swaps and the specific
assets we own. For example, we may purchase credit protection on a macro basis
to reduce exposure to specific industries or other portfolio concentrations. In
such instances, the referenced entities and obligations under the credit default
swaps may not be identical to the individual obligors or securities in our
investment portfolio. In addition, our purchased credit default swaps may have
shorter tenors than the underlying investments they are hedging, which gives us
more flexibility in managing our credit exposures. We believe that our purchased
credit default swaps serve as effective economic hedges of our credit exposure.
Current Environment
As a global insurance company, we continue to be impacted by the changing global
financial and economic environment, as well as the monetary policy of central
banks around the world. See "- Industry Trends - Financial and Economic
Environment." Measures taken by central banks, including with respect to the
level of interest rates, may have an impact on the pricing levels of
risk-bearing investments and may adversely impact our business operations,
investment portfolio and derivatives. The current environment continues to
impact our net investment income, net investment gains (losses), net derivative
gains (losses), level of unrealized gains (losses) within the various asset
classes in our investment portfolio, and our level of investment in lower
yielding cash equivalents, short-term investments and government securities. See
"Risk Factors - Economic Environment and Capital Markets Risks - Difficult
Economic Conditions May Harm Our Businesses, Results of Operations or Financial
Condition."
Selected Country and Sector Investments
We have country-specific exposure to volatility as a result of our general
account investments which support our insurance operations and related
policyholder liabilities, as well as our global portfolio diversification
objectives.
We also have sector-specific exposure to volatility, in the energy sector, as a
result of variable oil prices.

                                       86

--------------------------------------------------------------------------------

Table of Contents



Selected Country: The following table presents a summary of selected country
fixed maturity securities AFS, at estimated fair value. The information below is
presented on a "country of risk basis" (e.g. where the issuer primarily conducts
business). Sovereign includes government and agency.
                                                   Selected Country Fixed 

Maturity Securities AFS at December 31, 2019


                                                           Financial          Non-Financial
                                         Sovereign          Services            Services          Structured        Total (1)
                                                                          (Dollars in millions)
United Kingdom                          $      27       $       5,295       $       12,208       $     133       $       17,663
China                                         313                   5                  347               -                  665
Hong Kong SAR                                  91                  30                  212               -                  333
Argentina                                     256                   3                   17               -                  276
Turkey                                        192                   1                   37               -                  230
Total                                   $     879       $       5,334       $       12,821       $     133       $       19,167
Investment grade %                           49.0 %              99.9 %               96.3 %          69.5 %               94.9 %


__________________

(1) The par value and amortized cost of these selected country fixed maturity

securities AFS were $17.7 billion and $18.2 billion, respectively, at

December 31, 2019. Our exposure net of purchased credit default swaps was

$19.1 billion at December 31, 2019. The notional value and estimated fair

value of the purchased credit default swaps was $23 million and $2 million,

respectively, at December 31, 2019.




Selected Sector: Our exposure to energy sector fixed maturity securities AFS was
$10.0 billion, of which 89% were investment grade, with unrealized gains of $849
million at December 31, 2019. We maintain a diversified energy sector fixed
maturities securities portfolio across sub-sectors and issuers. This portfolio
comprised less than 3% of total investments at December 31, 2019.
We manage direct and indirect investment exposure in the selected countries and
the energy sector through fundamental credit analysis and we continually monitor
and adjust our level of investment exposure. We do not expect that our general
account investments in these countries or the energy sector will have a material
adverse effect on our results of operations or financial condition.
Investment Portfolio Results
The reconciliation of net investment income under GAAP to net investment income,
as reported on an adjusted earnings basis, is presented below.
                                                               For the Years Ended December 31,
                                                                   2019                 2018
                                                                         (In millions)
Net investment income - GAAP basis                          $        18,868       $        16,166
Investment hedge adjustments                                            469                   475
Unit-linked contract income                                          (1,475 )                 683
Other                                                                   (32 )                  59

Net investment income, as reported on an adjusted basis (1) $ 17,830

$ 17,383

__________________


(1)  See "Financial Measures and Segment Accounting Policies" in Note 2 of the
     Notes to the Consolidated Financial Statements for a discussion of the
     adjustments made to net investment income under GAAP in calculating net
     investment income, as reported on an adjusted basis.



                                       87

--------------------------------------------------------------------------------

Table of Contents

The following yield table presentation is consistent with how we measure our investment performance for management purposes, and we believe it enhances understanding of our investment portfolio results.


                                                      For the Years Ended December 31,
                                                       2019                       2018
                                             Yield% (1)      Amount     Yield% (1)      Amount
                                                            (Dollars in millions)
Fixed maturity securities AFS (2) (3)             4.22   % $ 11,743          4.26   % $ 11,678
Mortgage loans (3)                                4.82   %    3,782          4.66   %    3,340
Real estate and real estate joint ventures        3.20   %      327          3.59   %      352
Policy loans                                      5.29   %      512          5.21   %      506
Equity securities                                 5.25   %       61          4.79   %       64
Other limited partnership interests              11.81   %      840         12.97   %      792
Cash and short-term investments                   2.47   %      256          2.41   %      244
Other invested assets                                           901                        887
Investment income                                 4.56   %   18,422          4.56   %   17,863
Investment fees and expenses                     (0.14 )       (545 )       (0.12 )       (479 )
Net investment income including divested
businesses (4)                                    4.42   %   17,877          4.44   %   17,384
Less: net investment income from divested
businesses (4)                                                   47                          1
Net investment income, as reported on an
adjusted basis                                             $ 17,830                   $ 17,383


__________________

(1) We calculate yields using average quarterly asset carrying values. Yields

exclude recognized gains (losses) and include the impact of changes in

foreign currency exchange rates. Asset carrying values exclude unrealized

gains (losses), collateral received in connection with our securities

lending program, annuities funding structured settlement claims,

freestanding derivative assets, collateral received from derivative

counterparties, the effects of consolidating under GAAP certain variable

interest entities that are treated as consolidated securitization entities

("CSEs") and contractholder-directed equity securities. A yield is not

presented for other invested assets, as it is not considered a meaningful

measure of performance for this asset class.

(2) Investment income from fixed maturity securities AFS includes amounts from

FVO Securities of $184 million and $51 million for the years ended

December 31, 2019 and 2018, respectively.

(3) Investment income from fixed maturity securities AFS and mortgage loans


     includes prepayment fees.


(4)  See "Financial Measures and Segment Accounting Policies" in Note 2 of the

Notes to the Consolidated Financial Statements for discussion of divested

businesses.

See "- Results of Operations - Consolidated Results - Adjusted Earnings" for an analysis of the period over period changes in investment portfolio results.


                                       88

--------------------------------------------------------------------------------

Table of Contents

Fixed Maturity Securities AFS and Equity Securities
The following table presents fixed maturity securities AFS and equity securities
by type (public or private) and information about perpetual and redeemable
securities held at:
                                                December 31, 2019            December 31, 2018
                                             Estimated Fair     % of      Estimated Fair     % of
                                                  Value         Total          Value         Total
                                                            (Dollars in millions)
Fixed maturity securities AFS
 Publicly-traded                            $       267,617      81.6 %  $       249,595      83.7 %
 Privately-placed                                    60,203      18.4             48,670      16.3

Total fixed maturity securities AFS $ 327,820 100.0 % $

298,265 100.0 %


  Percentage of cash and invested assets               66.8 %                       66.0 %
Equity securities
 Publicly-traded                            $         1,156      86.1 %  $         1,282        89 %
 Privately-held                                         186      13.9                158        11
  Total equity securities                   $         1,342     100.0 %  $         1,440     100.0 %
  Percentage of cash and invested assets                0.3 %                        0.3 %
Perpetual and redeemable securities
Perpetual securities included within fixed
maturity securities AFS and equity
securities                                  $           363              $  

367


Redeemable preferred stock with a stated
maturity included within fixed maturity
securities AFS                              $           960              $  

911




Included within fixed maturity securities AFS are structured securities
including residential mortgage-backed securities ("RMBS"), ABS and commercial
mortgage-backed securities ("CMBS") (collectively, "Structured Products").
Perpetual securities are included within fixed maturity securities AFS and
equity securities. Upon acquisition, we classify perpetual securities that have
attributes of both debt and equity as fixed maturity securities AFS if the
securities have an interest rate step-up feature which, when combined with other
qualitative factors, indicates that the securities have more debt-like
characteristics; while those with more equity-like characteristics are
classified as equity securities. Many of such securities, commonly referred to
as "perpetual hybrid securities," have been issued by non-U.S. financial
institutions that are accorded the highest two capital treatment categories by
their respective regulatory bodies (i.e. core capital, or "Tier 1 capital" and
perpetual deferrable securities, or "Upper Tier 2 capital").
Redeemable preferred stock with a stated maturity is included within fixed
maturity securities AFS. These securities, which are commonly referred to as
"capital securities," primarily have cumulative interest deferral features and
are primarily issued by U.S. financial institutions.

                                       89

--------------------------------------------------------------------------------

Table of Contents



Valuation of Securities. We are responsible for the determination of the
estimated fair value of our investments. We determine the estimated fair value
of publicly-traded securities after considering one of three primary sources of
information: quoted market prices in active markets, independent pricing
services, or independent broker quotations. We determine the estimated fair
value of privately-placed securities after considering one of three primary
sources of information: market standard internal matrix pricing, market standard
internal discounted cash flow techniques, or independent pricing services (after
we determine the independent pricing services' use of available observable
market data). For publicly-traded securities, the number of quotations obtained
varies by instrument and depends on the liquidity of the particular instrument.
Generally, we obtain prices from multiple pricing services to cover all asset
classes and obtain multiple prices for certain securities, but ultimately
utilize the price with the highest placement in the fair value hierarchy.
Independent pricing services that value these instruments use market standard
valuation methodologies based on data about market transactions and inputs from
multiple pricing sources that are market observable or can be derived
principally from or corroborated by observable market data. See Note 10 of the
Notes to the Consolidated Financial Statements for a discussion of the types of
market standard valuation methodologies utilized and key assumptions and
observable inputs used in applying these standard valuation methodologies. When
a price is not available in the active market or through an independent pricing
service, management values the security primarily using market standard internal
matrix pricing or discounted cash flow techniques, and non-binding quotations
from independent brokers who are knowledgeable about these securities.
Independent non-binding broker quotations utilize inputs that may be difficult
to corroborate with observable market data. As shown in the following section,
less than 1% of our fixed maturity securities AFS were valued using non-binding
quotations from independent brokers at December 31, 2019.
Senior management, independent of the trading and investing functions, is
responsible for the oversight of control systems and valuation policies for
securities, mortgage loans and derivatives. On a quarterly basis, new
transaction types and markets are reviewed and approved to ensure that
observable market prices and market-based parameters are used for valuation,
wherever possible, and for determining that valuation adjustments, when applied,
are based upon established policies and are applied consistently over time.
Senior management oversees the selection of independent third-party pricing
providers and the controls and procedures to evaluate third-party pricing.
We review our valuation methodologies on an ongoing basis and revise those
methodologies when necessary based on changing market conditions. Assurance is
gained on the overall reasonableness and consistent application of input
assumptions, valuation methodologies and compliance with fair value accounting
standards through controls designed to ensure valuations represent an exit
price. Several controls are utilized, including certain monthly controls, which
include, but are not limited to, analysis of portfolio returns to corresponding
benchmark returns, comparing a sample of executed prices of securities sold to
the fair value estimates, comparing fair value estimates to management's
knowledge of the current market, reviewing the bid/ask spreads to assess
activity, comparing prices from multiple independent pricing services and
ongoing due diligence to confirm that independent pricing services use
market-based parameters. The process includes a determination of the
observability of inputs used in estimated fair values received from independent
pricing services or brokers by assessing whether these inputs can be
corroborated by observable market data. We ensure that prices received from
independent brokers, also referred to herein as "consensus pricing," are
representative of estimated fair value by considering such pricing relative to
our knowledge of the current market dynamics and current pricing for similar
financial instruments. While independent non-binding broker quotations are
utilized, they are not used for a significant portion of the portfolio.
We also apply a formal process to challenge any prices received from independent
pricing services that are not considered representative of estimated fair value.
If prices received from independent pricing services are not considered
reflective of market activity or representative of estimated fair value,
independent non-binding broker quotations are obtained, or an internally
developed valuation is prepared. Internally developed valuations of current
estimated fair value, compared with pricing received from the independent
pricing services, did not produce material differences in the estimated fair
values for the majority of the portfolio; accordingly, overrides were not
material. This is, in part, because internal estimates are generally based on
available market evidence and estimates used by other market participants. In
the absence of such market-based evidence, management's best estimate is used.
We have reviewed the significance and observability of inputs used in the
valuation methodologies to determine the appropriate fair value hierarchy level
for each of our securities. Based on the results of this review and investment
class analysis, each instrument is categorized as Level 1, 2 or 3 based on the
lowest level significant input to its valuation. See Note 10 of the Notes to the
Consolidated Financial Statements for information regarding the valuation
techniques and inputs by level within the three-level fair value hierarchy by
major classes of invested assets.

                                       90

--------------------------------------------------------------------------------

Table of Contents



Fair Value of Fixed Maturity Securities AFS and Equity Securities
Fixed maturity securities AFS and equity securities measured at estimated fair
value on a recurring basis and their corresponding fair value pricing sources
are as follows:
                                                        December 31, 2019
                                           Fixed Maturity                   Equity
                                           Securities AFS                 Securities
                                                      (Dollars in millions)
Level 1
Quoted prices in active markets for
identical assets                     $   21,061           6.4 %   $      794          59.2 %
Level 2
Independent pricing sources             287,218          87.7             80           6.0
Internal matrix pricing or
discounted cash flow techniques             730           0.2             38           2.8
Significant other observable inputs     287,948          87.9            118           8.8
Level 3
Independent pricing sources              15,737           4.8            281          20.9
Internal matrix pricing or
discounted cash flow techniques           2,637           0.8            143          10.7
Independent broker quotations               437           0.1              6           0.4
Significant unobservable inputs          18,811           5.7            430          32.0
Total estimated fair value           $  327,820         100.0 %   $    1,342         100.0 %


See Note 10 of the Notes to the Consolidated Financial Statements for the fixed
maturity securities AFS and equity securities fair value hierarchy.
The majority of the Level 3 fixed maturity securities AFS and equity
securities were concentrated in three sectors at December 31, 2019: foreign
corporate securities, U.S. corporate securities and RMBS. During the year ended
December 31, 2019, Level 3 fixed maturity securities AFS increased by $4.0
billion, or 26%, as compared to the prior year. The increase was driven by
purchases in excess of sales and by an increase in estimated fair value
recognized in other comprehensive income (loss), partially offset by transfers
out of Level 3 in excess of transfers into Level 3.
See "- Fixed Maturity Securities AFS and Equity Securities - Valuation of
Securities" for further information regarding the composition of fair value
pricing sources for securities. See Note 10 of the Notes to the Consolidated
Financial Statements for a rollforward of the fair value measurements for
securities measured at estimated fair value on a recurring basis using
significant unobservable (Level 3) inputs; transfers into and/or out of Level 3;
and further information about the valuation approaches and inputs by level by
major classes of invested assets that affect the amounts reported above.
Fixed Maturity Securities AFS
See Notes 1 and 8 of the Notes to the Consolidated Financial Statements for
information about fixed maturity securities AFS by sector, contractual
maturities and continuous gross unrealized losses.
Fixed Maturity Securities AFS Credit Quality - Ratings
The Securities Valuation Office of the NAIC evaluates the fixed maturity
security investments of insurers for regulatory reporting and capital assessment
purposes and assigns securities to one of six credit quality categories called
"NAIC designations." If no designation is available from the NAIC, then, as
permitted by the NAIC, an internally developed designation is used. The NAIC
designations are generally similar to the credit quality ratings of the NRSRO
for fixed maturity securities AFS, except for certain non-agency RMBS and CMBS
as described below. Rating agency ratings are based on availability of
applicable ratings from rating agencies on the NAIC credit rating provider list,
including Moody's Investor Service ("Moody's"), S&P, Fitch Ratings ("Fitch"),
Dominion Bond Rating Service, A.M. Best Company ("A.M. Best"), Kroll Bond Rating
Agency, Egan Jones Ratings Company and Morningstar Credit Ratings, LLC
("Morningstar"). If no rating is available from a rating agency, then an
internally developed rating is used.

                                       91

--------------------------------------------------------------------------------

Table of Contents



The NAIC has adopted revised methodologies for non-agency RMBS, and CMBS. The
NAIC's objective with the revised methodologies for non-agency RMBS and CMBS was
to increase the accuracy in assessing expected losses, and to use the improved
assessment to determine a more appropriate capital requirement for non-agency
RMBS and CMBS. The revised methodologies reduce regulatory reliance on rating
agencies and allow for greater regulatory input into the assumptions used to
estimate expected losses from non-agency RMBS and CMBS. We apply the revised
NAIC methodologies to non-agency RMBS and CMBS held by MetLife, Inc.'s insurance
subsidiaries that maintain the NAIC statutory basis of accounting. The NAIC's
present methodology is to evaluate non-agency RMBS and CMBS held by insurers
using the revised NAIC methodologies on an annual basis. If MetLife, Inc.'s
insurance subsidiaries acquire non-agency RMBS and CMBS that have not been
previously evaluated by the NAIC, but are expected to be evaluated by the NAIC
in the upcoming annual review, an internally developed designation is used until
a NAIC designation becomes available. NAIC designations may not correspond to
NRSRO ratings.
The following table presents total fixed maturity securities AFS by NRSRO rating
and the applicable NAIC designation from the NAIC published comparison of NRSRO
ratings to NAIC designations, except for non-agency RMBS and CMBS, which are
presented using the revised NAIC methodologies, as well as the percentage, based
on estimated fair value that each NAIC designation is comprised of at:
                                                                                     December 31,
                                                           2019                                                       2018
                                                                    Estimated                                                  Estimated
   NAIC                             Amortized       Unrealized         Fair        % of        Amortized       Unrealized         Fair        % of
Designation      NRSRO Rating          Cost        Gain (Loss)        Value       Total           Cost        Gain (Loss)        Value       Total
                                                                                 (Dollars in millions)
     1        Aaa/Aa/A             $  207,742     $     22,966     $  230,708       70.4 %    $  197,604     $     11,202     $  208,806       70.0 %
     2        Baa                      74,568            6,857         81,425       24.8          72,482              659         73,141       24.5
              Subtotal
              investment grade        282,310           29,823        312,133       95.2         270,086           11,861        281,947       94.5
     3        Ba                       11,210              442         11,652        3.6          11,249              (91 )       11,158        3.7
     4        B                         3,297               40          3,337        1.0           4,745             (247 )        4,498        1.6
     5        Caa and lower               832             (139 )          693        0.2             720              (73 )          647        0.2
     6        In or near default            6               (1 )            5          -              16               (1 )           15          -
              Subtotal below
              investment grade         15,345              342         15,687        4.8          16,730             (412 )       16,318        5.5
              Total fixed
              maturity
              securities AFS       $  297,655     $     30,165     $  327,820      100.0 %    $  286,816     $     11,449     $  298,265      100.0 %



                                       92

--------------------------------------------------------------------------------

Table of Contents



The following tables present total fixed maturity securities AFS, based on
estimated fair value, by sector classification and by NRSRO rating and the
applicable NAIC designations from the NAIC published comparison of NRSRO ratings
to NAIC designations, except for non-agency RMBS and CMBS, which are presented
using the revised NAIC methodologies:
                                          Fixed Maturity Securities AFS - 

by Sector & Credit Quality Rating



NAIC Designation:             1                 2              3            4           5              6             Total
                                                                                     Caa and       In or Near      Estimated
NRSRO Rating:             Aaa/Aa/A             Baa             Ba           B         Lower         Default        Fair Value
                                                                (Dollars in millions)
     December 31, 2019
U.S. corporate         $     41,504       $   37,915       $  5,760     $ 2,199     $    374     $        1       $   87,753
Foreign government           58,325            5,866          2,383         392          263              -           67,229
Foreign corporate            26,078           34,674          2,810         556           47              -           64,165
U.S. government and
agency                       41,577              507              -           -            -              -           42,084
RMBS                         27,957              403            102          75            7              3           28,547
ABS                          12,727            1,339            448          25            2              1           14,542
Municipals                   12,397              624             32           -            -              -           13,053
CMBS                         10,143               97            117          90            -              -           10,447
Total fixed maturity
securities AFS         $    230,708       $   81,425       $ 11,652     $ 3,337     $    693     $        5       $  327,820
Percentage of total            70.4 %           24.8 %          3.6 %       1.0 %        0.2 %            - %          100.0 %
     December 31, 2018
U.S. corporate         $     34,363       $   35,081       $  5,850     $ 3,102     $    544     $        8       $   78,948
Foreign government           54,149            5,140          2,389         604            5              1           62,288
Foreign corporate            22,602           30,849          2,534         669           49              -           56,703
U.S. government and
agency                       38,915              407              -           -            -              -           39,322
RMBS                         27,370              350            138          94            3              6           27,961
ABS                          11,467              772            204          26            3              -           12,472
Municipals                   11,056              439             38           -            -              -           11,533
CMBS                          8,884              103              5           3           43              -            9,038
Total fixed maturity
securities AFS         $    208,806       $   73,141       $ 11,158     $ 4,498     $    647     $       15       $  298,265
Percentage of total            70.0 %           24.5 %          3.7 %       1.6 %        0.2 %            - %          100.0 %


U.S. and Foreign Corporate Fixed Maturity Securities AFS
We maintain a diversified portfolio of corporate fixed maturity securities AFS
across industries and issuers. This portfolio does not have any exposure to any
single issuer in excess of 1% of total investments and the top 10 holdings
comprised 2% and 1% of total investments at December 31, 2019 and 2018,
respectively. The tables below present our U.S. and foreign corporate securities
holdings by industry at:
                               December 31,
                       2019                    2018
                Estimated               Estimated
                  Fair        % of        Fair        % of
                  Value       Total       Value       Total
                           (Dollars in millions)
Industrial     $   46,018     30.3 %   $   40,556     29.9 %
Finance            34,776     22.9         30,546     22.5
Consumer           31,952     21.0         30,140     22.2
Utility            25,763     17.0         22,206     16.4
Communications     11,471      7.5         10,406      7.7
Other               1,938      1.3          1,797      1.3
Total          $  151,918    100.0 %   $  135,651    100.0 %



                                       93

--------------------------------------------------------------------------------

Table of Contents



Structured Products
We held $53.5 billion and $49.5 billion of Structured Products, at estimated
fair value, at December 31, 2019 and 2018, respectively, as presented in the
RMBS, ABS and CMBS sections below.
RMBS
Our RMBS portfolio is diversified by security type and risk profile. The
following table presents our RMBS portfolio by security type, risk profile and
ratings profile at:
                                                                 December 31,
                                              2019                                            2018
                           Estimated                        Net             Estimated                       Net
                             Fair          % of          Unrealized           Fair          % of        Unrealized
                             Value         Total       Gains (Losses)         Value        Total      Gains (Losses)
                                                             (Dollars in millions)
By security type:
Collateralized mortgage
obligations              $    16,315        57.2 %   $          1,185     $    15,302       54.7 %   $         726
Pass-through
mortgage-backed
securities                    12,232        42.8                  311          12,659       45.3              (174 )
Total RMBS               $    28,547       100.0 %   $          1,496     $    27,961      100.0 %   $         552
By risk profile:
Agency                   $    19,563        68.5 %   $            797     $    19,834       70.9 %   $           5
Prime                          1,142         4.0                   48           1,123        4.0                47
Alt-A                          3,323        11.7                  347           3,361       12.0               277
Sub-prime                      4,519        15.8                  304           3,643       13.1               223
Total RMBS               $    28,547       100.0 %   $          1,496     $    27,961      100.0 %   $         552
Ratings profile:
Rated Aaa/AAA            $    21,122        74.0 %                        $    20,666       73.9 %
Designated NAIC 1        $    27,957        97.9 %                        $    27,370       97.9 %


Collateralized mortgage obligations are structured by dividing the cash flows of
mortgage loans into separate pools or tranches of risk that create multiple
classes of bonds with varying maturities and priority of payments. Pass-through
mortgage-backed securities are secured by a mortgage loan or collection of
mortgage loans. The monthly mortgage loan payments from homeowners pass from the
originating bank through an intermediary, such as a government agency or
investment bank, which collects the payments and, for a fee, remits or passes
these payments through to the holders of the pass-through securities.
The majority of our RMBS holdings were rated Aaa/AAA by Moody's, S&P or Fitch;
and were designated NAIC 1 by the NAIC at December 31, 2019 and 2018. Agency
RMBS were guaranteed or otherwise supported by Federal National Mortgage
Association, Federal Home Loan Mortgage Corporation or Government National
Mortgage Association. Non-agency RMBS include prime, alternative residential
mortgage loans ("Alt-A") and sub-prime RMBS. Prime residential mortgage lending
includes the origination of residential mortgage loans to the most creditworthy
borrowers with high quality credit profiles. Alt-A is a classification of
mortgage loans where the risk profile of the borrower is between prime and
sub-prime. Sub-prime mortgage lending is the origination of residential mortgage
loans to borrowers with weak credit profiles.
Historically, we have managed our exposure to sub-prime RMBS holdings by
focusing primarily on senior tranche securities, stress testing the portfolio
with severe loss assumptions and closely monitoring the performance of the
portfolio. Our sub-prime RMBS portfolio consists predominantly of securities
that were purchased after 2012 at significant discounts to par value and
discounts to the expected principal recovery value of these securities. The vast
majority of these securities are investment grade under the NAIC designations
(e.g., NAIC 1 and NAIC 2).

                                       94

--------------------------------------------------------------------------------

Table of Contents

ABS

Our ABS portfolio is diversified by collateral type and issuer. The following table presents our ABS portfolio by collateral type and ratings profile at:


                                                                December 31,
                                            2019                                            2018
                         Estimated                         Net            Estimated                        Net
                           Fair           % of         Unrealized           Fair           % of         Unrealized
                           Value         Total       Gains (Losses)         Value         Total       Gains (Losses)
                                                           (Dollars in millions)
By collateral type:
Collateralized
obligations (1)        $     7,974         54.8 %   $         (54 )     $     6,724         53.9 %   $         (112 )
Student loans                1,350          9.3                (5 )           1,256         10.1                 13
Consumer loans               1,181          8.1                 9               580          4.7                  4
Foreign residential
loans                        1,088          7.5                14             1,066          8.5                 11
Automobile loans               813          5.6                 7               895          7.2                  1
Credit card loans              454          3.1                 4               668          5.3                  -
Other loans                  1,682         11.6                20             1,283         10.3                  3
Total                  $    14,542        100.0 %   $          (5 )     $    12,472        100.0 %   $          (80 )
Ratings profile:
Rated Aaa/AAA          $     7,711         53.0 %                       $     7,142         57.3 %
Designated NAIC 1      $    12,727         87.5 %                       $    11,467         91.9 %


(1) Includes primarily collateralized loan obligations.
CMBS
Our CMBS portfolio is comprised primarily of securities collateralized by
multiple commercial mortgage loans and our portfolio is diversified by property
type, borrower, geography and vintage year. The following tables present our
CMBS portfolio by NRSRO rating and vintage year at:
                                                                                            December 31, 2019
                                                                                                                                              Below
                                                                                                                                            Investment
                          Aaa                           Aa                             A                           Baa                        Grade                        Total
                              Estimated                     Estimated                     Estimated                    Estimated                    Estimated                    Estimated
               Amortized         Fair        Amortized         Fair        Amortized         Fair        Amortized       Fair        Amortized        Fair        Amortized        Fair
                  Cost          Value           Cost          Value           Cost          Value          Cost          Value          Cost          Value          Cost          Value
                                                                                          (Dollars in millions)

2003 - 2012   $       402    $      424     $       335    $      341     $       121    $      123     $        7    $       7     $         -    $       -     $       865    $     895
2013                  707           745             638           666             247           253             30           29              52           41           1,674        1,734
2014                  372           389             486           502             114           119              -            -               -            -             972        1,010
2015                  419           436              65            67              31            33              -            -               -            -             515          536
2016                  285           298              71            73              55            56              -            -               -            -             411          427
2017                  668           689             589           608             181           182              -            -               -            -           1,438        1,479
2018                1,713         1,804             704           739             240           249             22           22               -            -           2,679        2,814
2019                  744           754             143           143             652           655              -            -               -            -           1,539        1,552

Total $ 5,310 $ 5,539 $ 3,031 $ 3,139 $

1,641 $ 1,670 $ 59 $ 58 $ 52 $

   41     $    10,093    $  10,447
Ratings
 Distribution                      53.0 %                        30.0 %                        16.0 %                       0.6 %                        0.4 %                      100.0 %



                                       95

--------------------------------------------------------------------------------


  Table of Contents

                                                                                            December 31, 2018
                                                                                                                                              Below
                                                                                                                                            Investment
                          Aaa                           Aa                             A                           Baa                        Grade                         Total
                              Estimated                     Estimated                     Estimated                    Estimated                    Estimated                    Estimated
               Amortized         Fair        Amortized         Fair        Amortized         Fair        Amortized       Fair        Amortized        Fair        Amortized         Fair
                  Cost          Value           Cost          Value           Cost          Value          Cost          Value          Cost          Value          Cost          Value
                                                                                          (Dollars in millions)

2003 - 2012   $       488    $      508     $       266    $      264     $       229    $      227     $        7    $       6     $         -    $       -     $       990    $    1,005
2013                  723           746             644           655             279           277              -            -              59           43           1,705         1,721
2014                  381           379             488           485             128           127              -            -               -            -             997           991
2015                  523           514              81            80              34            34              -            -               -            -             638           628
2016                  345           339              84            80              46            46              -            -               -            -             475           465
2017                  862           851             666           654             234           228             39           39               -            -           1,801         1,772
2018                1,434         1,445             690           695             292           293             23           23               -            -           2,439         2,456
Total         $     4,756    $    4,782     $     2,919    $    2,913     $     1,242    $    1,232     $       69    $      68     $        59    $      43     $     9,045    $    9,038
Ratings
 Distribution                      52.9 %                        32.2 %                        13.6 %                       0.8 %                        0.5 %                       100.0 %


The tables above reflect NRSRO ratings including Moody's, S&P, Fitch and
Morningstar. CMBS designated NAIC 1 were 97.1% and 98.3% of total CMBS at
December 31, 2019 and 2018, respectively.
Evaluation of Fixed Maturity Securities AFS for OTTI and Evaluating Temporarily
Impaired Fixed Maturity Securities AFS
See Note 8 of the Notes to the Consolidated Financial Statements for information
about the evaluation of fixed maturity securities AFS for OTTI and evaluation of
temporarily impaired fixed maturity securities AFS.
OTTI Losses on Fixed Maturity Securities AFS Recognized in Earnings
See Note 8 of the Notes to the Consolidated Financial Statements for information
about OTTI losses and gross gains and gross losses on fixed maturity securities
AFS sold.
Fixed Maturity Securities AFS OTTI Losses Recognized in Earnings
Overall OTTI losses recognized in earnings on fixed maturity securities AFS were
$129 million for the year ended December 31, 2019, as compared to $40 million
for the year ended December 31, 2018. The most significant increase in OTTI
losses was in foreign government securities, which comprised $81 million for the
year ended December 31, 2019, as compared to $9 million for the year ended
December 31, 2018. An increase of $72 million in OTTI losses was concentrated in
Argentine foreign government securities and was due to the weakening of the
Argentine peso and issuer specific concerns.
Future Impairments
Future impairments on fixed maturity securities AFS will depend primarily on
economic fundamentals, issuer performance (including changes in the present
value of future cash flows expected to be collected), changes in credit ratings,
and collateral valuation. If economic fundamentals deteriorate or if there are
adverse changes in the above factors, credit losses may be incurred in upcoming
periods. See Note 1 of the Notes to the Consolidated Financial Statements for a
description of new guidance to be adopted in 2020 regarding the measurement of
credit losses on financial instruments.
Contractholder-Directed Equity Securities and Fair Value Option Securities
The estimated fair value of these investments, which are primarily comprised of
Unit-linked investments, was $13.1 billion and $12.6 billion, or 2.7% and 2.8%
of cash and invested assets, at December 31, 2019 and 2018, respectively. See
Notes 1 and 10 of the Notes to the Consolidated Financial Statements for a
description of this portfolio, its fair value hierarchy and a rollforward of the
fair value measurements for these investments measured at estimated fair value
on a recurring basis using significant unobservable (Level 3) inputs.
Securities Lending, Repurchase Agreements and FHLB of Boston Advance Agreements
We participate in a securities lending program whereby securities are loaned to
third parties, primarily brokerage firms and commercial banks. We also
participate in short-term repurchase agreement transactions with unaffiliated
financial institutions. In addition, a subsidiary of the Company has entered
into short-term advance agreements with the FHLB of Boston. See "- Liquidity and
Capital Resources - The Company - Liquidity and Capital Uses - Securities
Lending and Repurchase Agreements" and Notes 1 and 8 of the Notes to the
Consolidated Financial Statements for further information.

                                       96

--------------------------------------------------------------------------------

Table of Contents

Mortgage Loans Our mortgage loans held-for-investment are principally collateralized by commercial, agricultural and residential properties. Mortgage loans held-for-investment are carried at amortized cost and the related valuation allowances are summarized as follows at:


                                                             December 31,
                                     2019                                                    2018
                                                          % of                                                    % of
               Recorded       % of      Valuation       Recorded       Recorded       % of      Valuation       Recorded
              Investment      Total     Allowance      Investment     Investment      Total     Allowance      Investment
                                                         (Dollars in millions)
Commercial   $     49,624     61.5 %   $       246         0.5 %     $     48,463     63.9 %   $       238         0.5 %
Agricultural       16,695     20.7              52         0.3 %           14,905     19.7              46         0.3 %
Residential        14,316     17.8              55         0.4 %           12,427     16.4              58         0.5 %
Total        $     80,635    100.0 %   $       353         0.4 %     $     75,795    100.0 %   $       342         0.5 %


The carrying value of all mortgage loans, net of valuation allowance, was 16.4%
and 16.8% of cash and invested assets at December 31, 2019 and 2018,
respectively.
We diversify our mortgage loan portfolio by both geographic region and property
type to reduce the risk of concentration. Of our commercial and agricultural
mortgage loan held-for-investment portfolios, 83% are collateralized by
properties located in the United States, with the remaining 17% collateralized
by properties located outside the United States, which includes 5% of properties
located in the U.K., at December 31, 2019. The carrying values of our commercial
and agricultural mortgage loans held-for-investment located in California, New
York and Texas were 18%, 11% and 7%, respectively, of total commercial and
agricultural mortgage loans held-for-investment at December 31, 2019.
Additionally, we manage risk when originating commercial and agricultural
mortgage loans by generally lending up to 75% of the estimated fair value of the
underlying real estate collateral.
We manage our residential mortgage loan held-for-investment portfolio in a
similar manner to reduce risk of concentration, with 93% collateralized by
properties located in the United States, and the remaining 7% collateralized by
properties located outside the United States, at December 31, 2019. The carrying
values of our residential mortgage loans located in California, Florida, and New
York were 33%, 9%, and 6%, respectively, of total residential mortgage loans at
December 31, 2019.

                                       97

--------------------------------------------------------------------------------

Table of Contents



Commercial Mortgage Loans by Geographic Region and Property Type. Commercial
mortgage loans are the largest component of the mortgage loan invested asset
class. The tables below present the diversification across geographic regions
and property types of commercial mortgage loans held-for-investment at:
                                                          December 31,
                                                   2019                  2018
                                                         % of                  % of
                                             Amount      Total     Amount      Total
                                                      (Dollars in millions)
Region
Pacific                                     $ 10,169     20.5 %   $ 10,884     22.5 %
Non-U.S.                                      10,093     20.3        9,281     19.1
Middle Atlantic                                8,302     16.7        7,911     16.3
South Atlantic                                 6,487     13.1        6,347     13.1
West South Central                             4,255      8.6        3,951      8.1
East North Central                             3,066      6.2        2,840      5.9
Mountain                                       1,602      3.2        1,387      2.9
New England                                    1,433      2.9        1,481      3.1
West North Central                               607      1.2          594      1.2
East South Central                               502      1.0          564      1.2
Multi-Region and Other                         3,108      6.3        3,223      6.6
Total recorded investment                     49,624    100.0 %     48,463    100.0 %
Less: valuation allowances                       246                   238
Carrying value, net of valuation allowances $ 49,378              $ 48,225
Property Type
Office                                      $ 22,925     46.2 %   $ 23,995     49.5 %
Retail                                         9,052     18.2        9,089     18.7
Apartment                                      8,212     16.6        7,018     14.5
Industrial                                     3,985      8.0        3,719      7.7
Hotel                                          3,471      7.0        3,479      7.2
Other                                          1,979      4.0        1,163      2.4
Total recorded investment                     49,624    100.0 %     48,463    100.0 %
Less: valuation allowances                       246                   238
Carrying value, net of valuation allowances $ 49,378              $ 48,225

__________________


Mortgage Loan Credit Quality - Monitoring Process. We monitor our mortgage loan
investments on an ongoing basis, including a review of loans that are current,
past due, restructured and under foreclosure. See Note 8 of the Notes to the
Consolidated Financial Statements for further information regarding mortgage
loans by credit quality indicator, past due and nonaccrual mortgage loans and
impaired mortgage loans.
We review our commercial mortgage loans on an ongoing basis. These reviews may
include an analysis of the property financial statements and rent roll, lease
rollover analysis, property inspections, market analysis, estimated valuations
of the underlying collateral, loan-to-value ratios, debt service coverage ratios
and tenant creditworthiness. The monitoring process focuses on higher risk
loans, which include those that are classified as restructured, delinquent or in
foreclosure, as well as loans with higher loan-to-value ratios and lower debt
service coverage ratios. The monitoring process for agricultural mortgage loans
is generally similar, with a focus on higher risk loans, such as loans with
higher loan-to-value ratios, including reviews on a geographic and sector basis.
We review our residential mortgage loans on an ongoing basis. See Note 8 of the
Notes to the Consolidated Financial Statements for information on our evaluation
of residential mortgage loans and related valuation allowance methodology.

                                       98

--------------------------------------------------------------------------------

Table of Contents



Loan-to-value ratios and debt service coverage ratios are common measures in the
assessment of the quality of commercial mortgage loans. Loan-to-value ratios are
a common measure in the assessment of the quality of agricultural mortgage
loans. Loan-to-value ratios compare the amount of the loan to the estimated fair
value of the underlying collateral. A loan-to-value ratio greater than 100%
indicates that the loan amount is greater than the collateral value. A
loan-to-value ratio of less than 100% indicates an excess of collateral value
over the loan amount. Generally, the higher the loan-to-value ratio, the higher
the risk of experiencing a credit loss. The debt service coverage ratio compares
a property's net operating income to amounts needed to service the principal and
interest due under the loan. Generally, the lower the debt service coverage
ratio, the higher the risk of experiencing a credit loss. For our commercial
mortgage loans, our average loan-to-value ratio was 55% at both December 31,
2019 and 2018, and our average debt service coverage ratio was 2.4x and 2.5x at
December 31, 2019 and 2018, respectively. The debt service coverage ratio, as
well as the values utilized in calculating the ratio, is updated annually on a
rolling basis, with a portion of the portfolio updated each quarter. In
addition, the loan-to-value ratio is routinely updated for all but the lowest
risk loans as part of our ongoing review of our commercial mortgage loan
portfolio. For our agricultural mortgage loans, our average loan-to-value ratio
was 47% and 46% at December 31, 2019 and 2018, respectively. The values utilized
in calculating the agricultural mortgage loan loan-to-value ratio are developed
in connection with the ongoing review of the agricultural loan portfolio and are
routinely updated.
Mortgage Loan Valuation Allowances. Our valuation allowances are established
both on a loan specific basis for those loans considered impaired where a
property specific or market specific risk has been identified that could likely
result in a future loss, as well as for pools of loans with similar risk
characteristics where a property specific or market specific risk has not been
identified, but for which we expect to incur a loss. Accordingly, a valuation
allowance is provided to absorb these estimated probable credit losses.
The determination of the amount of valuation allowances is based upon our
periodic evaluation and assessment of known and inherent risks associated with
our loan portfolios. Such evaluations and assessments are based upon several
factors, including our experience for loan losses, defaults and loss severity,
and loss expectations for loans with similar risk characteristics. These
evaluations and assessments are revised as conditions change and new information
becomes available, which can cause the valuation allowances to increase or
decrease over time as such evaluations are revised. Negative credit migration,
including an actual or expected increase in the level of problem loans, will
result in an increase in the valuation allowance. Positive credit migration,
including an actual or expected decrease in the level of problem loans, will
result in a decrease in the valuation allowance.
See Note 1 of the Notes to the Consolidated Financial Statements for a
description of new guidance to be adopted in 2020 regarding the measurement of
credit losses on financial instruments.
See Note 8 of the Notes to the Consolidated Financial Statements for information
about how valuation allowances are established and monitored and activity in and
balances of the valuation allowance as of and for the years ended December 31,
2019, 2018 and 2017.
Real Estate and Real Estate Joint Ventures
Real estate and real estate joint ventures is comprised of wholly-owned real
estate and joint ventures with interests in single property income-producing
real estate, and to a lesser extent joint ventures with interests in
multi-property projects with varying strategies ranging from the development of
properties to the operation of income-producing properties, as well as a runoff
portfolio. The carrying values of real estate and real estate joint ventures was
$10.7 billion and $9.7 billion, or 2.2% and 2.1% of cash and invested assets, at
December 31, 2019 and 2018, respectively.
Impairments recognized on real estate and real estate joint ventures were $10
million for the year ended December 31, 2019. There were no impairments for the
year ended December 31, 2018.
We diversify our real estate investments by both geographic region and property
type to reduce risk of concentration.
Geographical diversification: Of our real estate investments, excluding funds,
61% were located in the United States, with the remaining 39% located outside
the United States, at December 31, 2019. The carrying value of our real estate
investments, excluding funds, located in Japan, California and Washington, D.C.
were 34%, 11% and 10%, respectively, of total real estate investments, excluding
funds, at December 31, 2019. Real estate funds were 24% of our real estate
investments at December 31, 2019. The majority of these funds hold underlying
real estate investments that are well diversified across the United States.

                                       99

--------------------------------------------------------------------------------

Table of Contents

Property type diversification: Real estate and real estate joint venture investments by property type are categorized by sector as follows at:


                                                           December 31,
                                                2019                          2018
                                       Carrying         % of         Carrying         % of
                                         Value          Total          Value          Total
                                                       (Dollars in millions)
Office                               $     3,678          34.2 %   $     3,922          40.4 %
Real estate funds                          2,539          23.6           1,921          19.8
Retail                                     1,260          11.7           1,206          12.4
Apartment                                  1,211          11.3             872           9.0
Land                                         669           6.2             676           7.0
Hotel                                        599           5.6             555           5.7
Industrial                                   393           3.7             307           3.2
Agriculture                                   21           0.2              27           0.3
Other                                        371           3.5             212           2.2
Total real estate and real estate
joint ventures                       $    10,741         100.0 %   $     

9,698 100.0 %




Other Limited Partnership Interests
Other limited partnership interests are comprised of investments in private
funds, including private equity funds and hedge funds. At December 31, 2019 and
2018, the carrying value of other limited partnership interests was $7.7 billion
and $6.6 billion, which included $575 million and $634 million of hedge funds,
respectively. Other limited partnership interests were 1.6% and 1.5% of cash and
invested assets at December 31, 2019 and 2018, respectively. Cash distributions
on these investments are generated from investment gains, operating income from
the underlying investments of the funds and liquidation of the underlying
investments of the funds.
Other Invested Assets
The following table presents the carrying value of our other invested assets by
type at:
                                                                 December 31,
                                                    2019                              2018

                                        Carrying Value     % of Total     Carrying Value     % of Total
                                                               (Dollars in millions)

  Freestanding derivatives with
  positive estimated fair values       $       10,084          53.0 %    $        8,969          49.3 %
  Tax credit and renewable energy
  partnerships                                  1,993          10.5               2,457          13.5
  Annuities funding structured
  settlement claims                             1,271           6.7               1,279           7.0
  Direct financing leases                       1,247           6.6               1,192           6.5
  Leveraged leases                              1,052           5.5               1,108           6.1
  Operating joint ventures                        838           4.4                 796           4.4
  FHLB common stock                               809           4.3                 793           4.4
  Funds withheld                                  470           2.5                 416           2.3
  Other                                         1,251           6.6               1,180           6.5
  Total                                $       19,015           100 %    $       18,190           100 %
  Percentage of cash and invested
  assets                                          3.9 %                             4.0 %


See Notes 1, 8 and 9 of the Notes to the Consolidated Financial Statements for
information regarding freestanding derivatives with positive estimated fair
values, tax credit and renewable energy partnerships, direct financing and
leveraged leases, annuities funding structured settlement claims, FHLB common
stock, operating joint ventures and funds withheld.
See Note 8 of the Notes to the Consolidated Financial Statements for information
regarding gains (losses) on disposals of, and impairments of, tax credit and
renewable energy partnerships, and leveraged lease impairment losses.

                                      100

--------------------------------------------------------------------------------

Table of Contents



See Note 1 of the Notes to the Consolidated Financial Statements for a
description of new guidance to be adopted in 2020 regarding the measurement of
credit losses on financial instruments, including direct financing and leveraged
leases.
Derivatives
Derivative Risks
We are exposed to various risks relating to our ongoing business operations,
including interest rate, foreign currency exchange rate, credit and equity
market. We use a variety of strategies to manage these risks, including the use
of derivatives. See Note 9 of the Notes to the Consolidated Financial Statements
for:
•      A comprehensive description of the nature of our derivatives, including

the strategies for which derivatives are used in managing various risks.

• Information about the primary underlying risk exposure, gross notional

amount, and estimated fair value of our derivatives by type of hedge

designation, excluding embedded derivatives held at December 31, 2019 and

2018.

• The statement of operations effects of derivatives in net investments in

foreign operations, cash flow, fair value, or nonqualifying hedge

relationships for the years ended December 31, 2019, 2018 and 2017.




See "Quantitative and Qualitative Disclosures About Market Risk - Management of
Market Risk Exposures - Hedging Activities" for more information about our use
of derivatives by major hedge program.
Fair Value Hierarchy
See Note 10 of the Notes to the Consolidated Financial Statements for
derivatives measured at estimated fair value on a recurring basis and their
corresponding fair value hierarchy.
The valuation of Level 3 derivatives involves the use of significant
unobservable inputs and generally requires a higher degree of management
judgment or estimation than the valuations of Level 1 and Level 2 derivatives.
Although Level 3 inputs are unobservable, management believes they are
consistent with what other market participants would use when pricing such
instruments and are considered appropriate given the circumstances. The use of
different inputs or methodologies could have a material effect on the estimated
fair value of Level 3 derivatives and could materially affect net income.
Derivatives categorized as Level 3 at December 31, 2019 include: interest rate
forwards with maturities which extend beyond the observable portion of the yield
curve; interest rate total return swaps with unobservable repurchase rates;
foreign currency swaps and forwards with certain unobservable inputs, including
the unobservable portion of the yield curve; credit default swaps priced using
unobservable credit spreads, or that are priced through independent broker
quotations; equity variance swaps with unobservable volatility inputs; and
equity index options with unobservable correlation inputs. At December 31, 2019,
less than 1% of the estimated fair value of our derivatives was priced through
independent broker quotations.
See Note 10 of the Notes to the Consolidated Financial Statements for a
rollforward of the fair value measurements for derivatives measured at estimated
fair value on a recurring basis using significant unobservable (Level 3) inputs.
The gain (loss) on Level 3 derivatives primarily relates to foreign currency
swaps and forwards that are valued using an unobservable portion of the swap
yield curves. Other significant inputs, which are observable, include equity
index levels, equity volatility and the swap yield curves. We validate the
reasonableness of these inputs by valuing the positions using internal models
and comparing the results to broker quotations.
The gain (loss) on Level 3 derivatives, percentage of gain (loss) attributable
to observable and unobservable inputs, and the primary drivers of observable
gain (loss) are summarized as follows:
                                               Year Ended December 31, 2019
Gain (loss) recognized in net income
(loss)                                                    ($108)
Approximate percentage of gain (loss)
attributable to observable inputs                          45%
                                         Increases in interest rates on new
                                         interest rate total return swaps 

and

Primary drivers of observable gain increases in certain equity index levels (loss)

                                   on equity derivatives.
Approximate percentage of gain (loss)
attributable to unobservable inputs                        55%



                                      101

--------------------------------------------------------------------------------

Table of Contents



See "- Summary of Critical Accounting Estimates - Derivatives" for further
information on the estimates and assumptions that affect derivatives.
Credit Risk
See Note 9 of the Notes to the Consolidated Financial Statements for information
about how we manage credit risk related to derivatives and for the estimated
fair value of our net derivative assets and net derivative liabilities after the
application of master netting agreements and collateral.
Our policy is not to offset the fair value amounts recognized for derivatives
executed with the same counterparty under the same master netting agreement.
This policy applies to the recognition of derivatives on the consolidated
balance sheets, and does not affect our legal right of offset.
Credit Derivatives
The following table presents the gross notional amount and estimated fair value
of credit default swaps at:
                                           December 31,
                                 2019                        2018
                         Gross                       Gross
                        Notional     Estimated      Notional     Estimated
Credit Default Swaps     Amount      Fair Value      Amount      Fair Value
                                           (In millions)
Purchased              $   2,944    $     (98 )    $   1,903    $     (14 )
Written                   11,520          271         11,391           82
Total                  $  14,464    $     173      $  13,294    $      68


The following table presents the gross gains, gross losses and net gains
(losses) recognized in net derivative gains (losses) for credit default swaps as
follows:
                                               Years Ended December 31,
                                      2019                                  2018
                                                   Net                                  Net
                         Gross       Gross        Gains       Gross       Gross        Gains
Credit Default Swaps    Gains       Losses       (Losses)     Gains      Losses      (Losses)
                                                    (In millions)
Purchased (1)          $      2    $    (40 )   $    (38 )   $    17    $   (11 )   $       6
Written (1)                 257          (9 )        248          24       (156 )        (132 )
Total                  $    259    $    (49 )   $    210     $    41    $  (167 )   $    (126 )


__________________

(1) Gains (losses) do not include earned income (expense) on credit default

swaps.




The favorable change in net gains (losses) on written credit default swaps of
$380 million was due to certain credit spreads on certain credit default swaps
used as replications narrowing in the current period as compared to widening in
the prior period.
The maximum amount at risk related to our written credit default swaps is equal
to the corresponding gross notional amount. In a replication transaction, we
pair an asset on our balance sheet with a written credit default swap to
synthetically replicate a corporate bond, a core asset holding of life insurance
companies. Replications are entered into in accordance with the guidelines
approved by state insurance regulators and the NAIC and are an important tool in
managing the overall corporate credit risk within the Company. In order to match
our long-dated insurance liabilities, we seek to buy long-dated corporate bonds.
In some instances, these may not be readily available in the market, or they may
be issued by corporations to which we already have significant corporate credit
exposure. For example, by purchasing Treasury bonds (or other high quality
assets) and associating them with written credit default swaps on the desired
corporate credit name, we can replicate the desired bond exposures and meet our
ALM needs. In addition, given the shorter tenor of the credit default swaps
(generally five-year tenors) versus a long-dated corporate bond, we have more
flexibility in managing our credit exposures.

                                      102

--------------------------------------------------------------------------------

Table of Contents



Embedded Derivatives
See Note 10 of the Notes to the Consolidated Financial Statements for
information about embedded derivatives measured at estimated fair value on a
recurring basis and their corresponding fair value hierarchy and a rollforward
of the fair value measurements for embedded derivatives measured at estimated
fair value on a recurring basis using significant unobservable (Level 3) inputs.
See Note 9 of the Notes to the Consolidated Financial Statements for information
about the nonperformance risk adjustment included in the valuation of guaranteed
minimum benefits accounted for as embedded derivatives.
See "- Summary of Critical Accounting Estimates - Derivatives" for further
information on the estimates and assumptions that affect embedded derivatives.
Off-Balance Sheet Arrangements
Credit and Committed Facilities
We maintain an unsecured revolving credit facility, as well as committed
facilities, with various financial institutions. See Note 13 of the Notes to the
Consolidated Financial Statements for descriptions of such arrangements, the
classification of expenses on such credit and committed facilities and the
nature of the associated liability for letters of credit issued and drawdowns on
these credit and committed facilities. See also "- Liquidity and Capital
Resources - The Company - Liquidity and Capital Sources - Global Funding Sources
- Credit and Committed Facilities."
Collateral for Securities Lending, Third-Party Custodian Administered Repurchase
Programs and Derivatives
We participate in a securities lending program and third-party custodian
administered repurchase programs in the normal course of business for the
purpose of enhancing the total return on our investment portfolio. See Notes 1
and 8 of the Notes to the Consolidated Financial Statements for further
discussion of our securities lending program and repurchase agreement
transactions, the classification of revenues and expenses, and the nature of the
secured financing arrangements and associated liabilities.
Securities lending: Periodically we receive non-cash collateral for securities
lending from counterparties, which cannot be sold or re-pledged, and which is
not reflected on our consolidated balance sheets. The amount of this non-cash
collateral was $0 and $78 million at estimated fair value at December 31, 2019
and 2018, respectively.
Third-party custodian administered repurchase programs: We loan certain of our
fixed maturity securities AFS to unaffiliated financial institutions and, in
exchange, non-cash collateral is put on deposit by the unaffiliated financial
institutions on our behalf with third-party custodians. The estimated fair value
of securities loaned in connection with these transactions was $85 million and
$78 million at December 31, 2019 and 2018, respectively. Non-cash collateral on
deposit with third-party custodians on our behalf was $90 million and $84
million, at estimated fair value, at December 31, 2019 and 2018, respectively,
which cannot be sold or re-pledged, and which is not reflected on our
consolidated balance sheets.
Derivatives: We enter into derivatives to manage various risks relating to our
ongoing business operations. We receive non-cash collateral from counterparties
for derivatives, which can be sold or re-pledged subject to certain constraints,
and which is not reflected on our consolidated balance sheets. The amount of
this non-cash collateral was $1.7 billion and $1.3 billion, at estimated fair
value, at December 31, 2019 and 2018, respectively. See "- Liquidity and Capital
Resources - The Company - Liquidity and Capital Uses - Pledged Collateral" and
Note 9 of the Notes to the Consolidated Financial Statements for information
regarding the earned income on and the gross notional amount, estimated fair
value of assets and liabilities and primary underlying risk exposure of our
derivatives.
Lease Commitments
As lessee, we have entered into various lease and sublease agreements for office
space and equipment. Our commitments under such lease agreements are included
within the contractual obligations table. See "- Liquidity and Capital Resources
- The Company - Contractual Obligations" and Note 11 of the Notes to the
Consolidated Financial Statements.
Guarantees
See "Guarantees" in Note 21 of the Notes to the Consolidated Financial
Statements.

                                      103

--------------------------------------------------------------------------------

Table of Contents

Other


We enter into the following additional commitments in the normal course of
business for the purpose of enhancing the total return on our investment
portfolio: mortgage loan commitments and commitments to fund partnerships, bank
credit facilities, bridge loans and private corporate bond investments. See "Net
Investment Income" and "Net Investment Gains (Losses)" in Note 8 of the Notes to
the Consolidated Financial Statements for information on the investment income,
investment expense, and gains and losses from such investments. See also "-
Investments - Fixed Maturity Securities AFS and Equity Securities" and "-
Investments - Mortgage Loans" for information on our investments in fixed
maturity securities AFS and mortgage loans. See "- Investments - Real Estate and
Real Estate Joint Ventures" and "- Investments - Other Limited Partnership
Interests" for information on our partnership investments.
Other than the commitments disclosed in Note 21 of the Notes to the Consolidated
Financial Statements, there are no other material obligations or liabilities
arising from the commitments to fund mortgage loans, partnerships, bank credit
facilities, bridge loans, and private corporate bond investments. For further
information on commitments to fund partnership investments, mortgage loans, bank
credit facilities, bridge loans and private corporate bond investments, see "-
Liquidity and Capital Resources - The Company - Contractual Obligations."
Insolvency Assessments
See Note 21 of the Notes to the Consolidated Financial Statements.
Policyholder Liabilities
We establish, and carry as liabilities, actuarially determined amounts that are
calculated to meet policy obligations or to provide for future annuity payments.
Amounts for actuarial liabilities are computed and reported on the consolidated
financial statements in conformity with GAAP. For more details on Policyholder
Liabilities, see "- Summary of Critical Accounting Estimates."
Due to the nature of the underlying risks and the uncertainty associated with
the determination of actuarial liabilities, we cannot precisely determine the
amounts that will ultimately be paid with respect to these actuarial
liabilities, and the ultimate amounts may vary from the estimated amounts,
particularly when payments may not occur until well into the future.
We periodically review our estimates of actuarial liabilities for future
benefits and compare them with our actual experience. We revise estimates, to
the extent permitted or required under GAAP, if we determine that future
expected experience differs from assumptions used in the development of
actuarial liabilities. We charge or credit changes in our liabilities to
expenses in the period the liabilities are established or re-estimated. If the
liabilities originally established for future benefit payments prove inadequate,
we must increase them. Such an increase could adversely affect our earnings and
have a material adverse effect on our business, results of operations and
financial condition.
We have experienced, and will likely in the future experience, catastrophe
losses and possibly acts of terrorism, as well as turbulent financial markets
that may have an adverse impact on our business, results of operations and
financial condition. Due to their nature, we cannot predict the incidence,
timing, severity or amount of losses from catastrophes and acts of terrorism,
but we make broad use of catastrophic and non-catastrophic reinsurance to manage
risk from these perils. We also use hedging, reinsurance and other risk
management activities to mitigate financial market volatility.
See "Business - Regulation - Insurance Regulation - Policy and Contract Reserve
Adequacy Analysis" for information regarding required analyses of the adequacy
of statutory reserves of our insurance operations.
Future Policy Benefits
We establish liabilities for amounts payable under insurance policies. See
Notes 1 and 4 of the Notes to the Consolidated Financial Statements, "- Industry
Trends - Impact of a Sustained Low Interest Rate Environment - Low Interest Rate
Scenario" and "- Variable Annuity Guarantees." A discussion of future policy
benefits by segment (as well as Corporate & Other) follows.

                                      104

--------------------------------------------------------------------------------

Table of Contents

U.S.


Amounts payable under insurance policies for this segment are comprised of group
insurance and annuities, as well as property and casualty policies. For group
insurance, future policyholder benefits are comprised mainly of liabilities for
disabled lives under disability waiver of premium policy provisions, liabilities
for survivor income benefit insurance, active life policies and premium
stabilization and other contingency liabilities held under life insurance
contracts. For group annuity contracts, future policyholder benefits are
primarily related to payout annuities, including pension risk transfers,
structured settlement annuities and institutional income annuities. There is no
interest rate crediting flexibility on these liabilities. As a result, a
sustained low interest rate environment could negatively impact earnings;
however, we mitigate our risks by applying various ALM strategies, including the
use of various interest rate derivative positions. The components of future
policy benefits related to our property and casualty policies are liabilities
for unpaid claims, estimated based upon assumptions such as rates of claim
frequencies, levels of severities, inflation, judicial trends, legislative
changes or regulatory decisions. Assumptions are based upon our historical
experience and analysis of historical development patterns of the relationship
of loss adjustment expenses to losses for each line of business, and we consider
the effects of current developments, anticipated trends and risk management
programs, reduced for anticipated salvage and subrogation.
Asia
Future policy benefits for this segment are held primarily for traditional life,
endowment, annuity and accident & health contracts. They are also held for total
return pass-through provisions included in certain universal life and savings
products. They include certain liabilities for variable annuity and variable
life guarantees of minimum death benefits, and longevity guarantees. Factors
impacting these liabilities include sustained periods of lower than expected
yields, lower than expected asset reinvestment rates, market volatility, actual
lapses resulting in lower than expected income, and actual mortality or
morbidity resulting in higher than expected benefit payments. We mitigate our
risks by applying various ALM strategies and by the use of reinsurance.
Latin America
Future policy benefits for this segment are held primarily for immediate
annuities in Chile, Mexico and Argentina and traditional life contracts mainly
in Mexico, Brazil and Colombia. There are also liabilities held for total return
pass-through provisions included in certain universal life and savings products
in Mexico. There is limited interest rate crediting flexibility on the immediate
annuity and traditional life liabilities. As a result, sustained periods of
lower than expected yields could negatively impact earnings; however, we
mitigate our risks by applying various ALM strategies. Other factors impacting
these liabilities are actual mortality resulting in higher than expected benefit
payments and actual lapses resulting in lower than expected income.
EMEA
Future policy benefits for this segment include unearned premium reserves for
group life and credit insurance contracts. Future policy benefits are also held
for traditional life, endowment and annuity contracts with significant mortality
risk and accident & health contracts. Factors impacting these liabilities
include lower than expected asset reinvestment rates, market volatility, actual
lapses resulting in lower than expected income, and actual mortality or
morbidity resulting in higher than expected benefit payments. We mitigate our
risks by having premiums which are adjustable or cancellable in some cases,
applying various ALM strategies and by the use of reinsurance.
MetLife Holdings
Future policy benefits for the life insurance business are comprised mainly of
liabilities for traditional life insurance contracts. In order to manage risk,
we have often reinsured a portion of the mortality risk on life insurance
policies. We routinely evaluate our reinsurance programs, which may result in
increases or decreases to existing coverage. We have entered into various
interest rate derivative positions to mitigate the risk that investment of
premiums received and reinvestment of maturing assets over the life of the
policy will be at rates below those assumed in the original pricing of these
contracts. For the annuities business, future policy benefits are comprised
mainly of liabilities for life-contingent income annuities and liabilities for
the variable annuity guaranteed minimum benefits that are accounted for as
insurance. Other future policyholder benefits are comprised mainly of
liabilities for disabled lives under disability waiver of premium policy
provisions, and active life policies. In addition, for our other products,
future policyholder benefits related to the reinsurance of our former Japan
joint venture are comprised of liabilities for the variable annuity guaranteed
minimum benefits that are accounted for as insurance.
Corporate & Other
Future policy benefits primarily include liabilities for other reinsurance
business.

                                      105

--------------------------------------------------------------------------------

Table of Contents



Policyholder Account Balances
Policyholder account balances are generally equal to the account value, which
includes accrued interest credited, but excludes the impact of any applicable
charge that may be incurred upon surrender. See "- Industry Trends - Impact of a
Sustained Low Interest Rate Environment - Low Interest Rate Scenario" and "-
Variable Annuity Guarantees." See also Notes 1 and 4 of the Notes to the
Consolidated Financial Statements for additional information. A discussion of
policyholder account balances by segment follows.
U.S.
Policyholder account balances in this segment are comprised of funding
agreements, retained asset accounts, universal life policies, the fixed account
of variable life insurance policies and specialized life insurance products for
benefit programs.
Group Benefits
Policyholder account balances in this business are held for retained asset
accounts, universal life policies, the fixed account of variable life insurance
policies and specialized life insurance products for benefit programs.
Policyholder account balances are credited interest at a rate we determine,
which is influenced by current market rates. A sustained low interest rate
environment could adversely impact liabilities and earnings as a result of the
minimum credited rate guarantees present in most of these policyholder account
balances. We have various interest rate derivative positions to partially
mitigate the risks associated with such a scenario.
The table below presents the breakdown of account value subject to minimum
guaranteed crediting rates for Group Benefits:
                                                    December 31, 2019
                                                                  Account
                                                 Account         Value at
Guaranteed Minimum Crediting Rate                 Value         Guarantee
                                                      (In millions)
Greater than 0% but less than 2%             $    4,728        $      4,604

Equal to or greater than 2% but less than 4% $ 1,689 $ 1,652 Equal to or greater than 4%

                  $      757        $        729


Retirement and Income Solutions
Policyholder account balances in this business are held largely for
investment-type products mainly funding agreements and also include
postretirement benefits and corporate owned life insurance to fund non-qualified
benefit programs for executives. Interest crediting rates vary by type of
contract, and can be fixed or variable. Variable interest crediting rates are
generally tied to an external index, most commonly (1-month or 3-month) LIBOR.
We are exposed to interest rate risks, as well as foreign currency exchange rate
risk, when guaranteeing payment of interest and return of principal at the
contractual maturity date. We may invest in floating rate assets or enter into
receive-floating interest rate swaps, also tied to external indices, as well as
interest rate caps, to mitigate the impact of changes in market interest rates.
We also mitigate our risks by applying various ALM strategies and seek to hedge
all foreign currency exchange rate risk through the use of foreign currency
hedges, including cross currency swaps.
The table below presents the breakdown of account value subject to minimum
guaranteed crediting rates for RIS:
                                                    December 31, 2019
                                                                  Account
                                                 Account         Value at
Guaranteed Minimum Crediting Rate                 Value         Guarantee
                                                      (In millions)
Greater than 0% but less than 2%             $      149        $          -
Equal to or greater than 2% but less than 4% $    1,070        $        102
Equal to or greater than 4%                  $    4,582        $      4,375



                                      106

--------------------------------------------------------------------------------

Table of Contents

Asia


Policyholder account balances in this segment are held largely for fixed income
retirement and savings plans, fixed deferred annuities, interest sensitive whole
life products, universal life and, to a lesser degree, liability amounts for
Unit-linked investments that do not meet the GAAP definition of separate
accounts. Also included are certain liabilities for retirement and savings
products sold in certain countries in Asia that generally are sold with minimum
credited rate guarantees. Liabilities for guarantees on certain variable
annuities in Asia are accounted for as embedded derivatives and recorded at
estimated fair value and are also included within policyholder account balances.
A sustained low interest rate environment could adversely impact liabilities and
earnings as a result of the minimum credited rate guarantees present in most of
these policyholder account balances. We mitigate our risks by applying various
ALM strategies and with reinsurance. Liabilities for Unit-linked investments are
impacted by changes in the fair value of the associated underlying investments,
as the return on assets is generally passed directly to the policyholder.
The table below presents the breakdown of account value subject to minimum
guaranteed crediting rates for Asia:
                                                 December 31, 2019
                                                             Account
                                               Account       Value at
Guaranteed Minimum Crediting Rate              Value        Guarantee
                                                   (In millions)

Annuities


Greater than 0% but less than 2%             $   29,398    $     1,578

Equal to or greater than 2% but less than 4% $ 1,131 $ 372 Equal to or greater than 4%

                  $        1    $         1
Life & Other
Greater than 0% but less than 2%             $   11,431    $    11,047

Equal to or greater than 2% but less than 4% $ 27,890 $ 9,318 Equal to or greater than 4%

                  $      276    $       276


Latin America
Policyholder account balances in this segment are held largely for
investment-type products and universal life products in Mexico and Chile, and
deferred annuities in Brazil. Some products in Chile and some of the deferred
annuities in Brazil are Unit-linked investments that do not meet the GAAP
definition of separate accounts. Liabilities for Unit-linked investments are
impacted by changes in the fair value of the associated investments, as the
return on assets is generally passed directly to the policyholder. Many of the
other liabilities have minimum credited rate guarantees, which could adversely
impact liabilities and earnings in a sustained low interest rate environment.
EMEA
Policyholder account balances in this segment are held mostly for universal
life, deferred annuities, pension products, and Unit-linked investments that do
not meet the GAAP definition of separate accounts. They are also held for
endowment products without significant mortality risk. A sustained low interest
rate environment could adversely impact liabilities and earnings as a result of
the minimum credited rate guarantees present in many of these policyholder
account balances. We mitigate our risks by applying various ALM strategies.
Liabilities for Unit-linked investments are impacted by changes in the fair
value of the associated investments, as the return on assets is generally passed
directly to the policyholder.
MetLife Holdings
Life policyholder account balances in this segment are held for retained asset
accounts, universal life policies, the fixed account of variable life insurance
policies, and funding agreements. For annuities, policyholder account balances
are held for fixed deferred annuities, the fixed account portion of variable
annuities, non-life contingent income annuities, and embedded derivatives
related to variable annuity guarantees. Interest is credited to the
policyholder's account at interest rates we determine which are influenced by
current market rates, subject to specified minimums. A sustained low interest
rate environment could adversely impact liabilities and earnings as a result of
the minimum credited rate guarantees present in most of these policyholder
account balances. We have various interest rate derivative positions to
partially mitigate the risks associated with such a scenario. Additionally, for
our other products, policyholder account balances are held for variable annuity
guarantees assumed from a former operating joint venture in Japan that are
accounted for as embedded derivatives.

                                      107

--------------------------------------------------------------------------------

Table of Contents

The table below presents the breakdown of account value subject to minimum guaranteed crediting rates for the MetLife Holdings segment:


                                                 December 31, 2019
                                                             Account
                                               Account       Value at
Guaranteed Minimum Crediting Rate               Value       Guarantee
                                                   (In millions)
Greater than 0% but less than 2%             $    1,308    $     1,174

Equal to or greater than 2% but less than 4% $ 17,896 $ 15,280 Equal to or greater than 4%

                  $    7,859    $     5,337


Variable Annuity Guarantees
We issue, directly and through assumed business, certain variable annuity
products with guaranteed minimum benefits that provide the policyholder a
minimum return based on their initial deposit (i.e., the benefit base) less
withdrawals. In some cases, the benefit base may be increased by additional
deposits, bonus amounts, accruals or optional market value resets. See Notes 1
and 4 of the Notes to the Consolidated Financial Statements for additional
information.
Certain guarantees, including portions thereof, have insurance liabilities
established that are included in future policy benefits. Guarantees accounted
for in this manner include GMDBs, the life-contingent portion of GMWBs, elective
GMIB annuitizations, and the life contingent portion of GMIBs that require
annuitization when the account balance goes to zero. These liabilities are
accrued over the life of the contract in proportion to actual and future
expected policy assessments based on the level of guaranteed minimum benefits
generated using multiple scenarios of separate account returns. The scenarios
are based on best estimate assumptions consistent with those used to amortize
DAC. When current estimates of future benefits exceed those previously projected
or when current estimates of future assessments are lower than those previously
projected, liabilities will increase, resulting in a current period charge to
net income. The opposite result occurs when the current estimates of future
benefits are lower than those previously projected or when current estimates of
future assessments exceed those previously projected. At the end of each
reporting period, we update the actual amount of business remaining in-force,
which impacts expected future assessments and the projection of estimated future
benefits resulting in a current period charge or increase to earnings.
Certain guarantees, including portions thereof, accounted for as embedded
derivatives, are recorded at estimated fair value and included in policyholder
account balances. Guarantees accounted for as embedded derivatives include
GMABs, the non-life contingent portion of GMWBs and certain non-life contingent
portions of GMIBs. The estimated fair values of guarantees accounted for as
embedded derivatives are determined based on the present value of projected
future benefits minus the present value of projected future fees. The
projections of future benefits and future fees require capital market and
actuarial assumptions including expectations concerning policyholder behavior. A
risk neutral valuation methodology is used to project the cash flows from the
guarantees under multiple capital market scenarios to determine an economic
liability. The reported estimated fair value is then determined by taking the
present value of these risk-free generated cash flows using a discount rate that
incorporates a spread over the risk-free rate to reflect our nonperformance risk
and adding a risk margin. For more information on the determination of estimated
fair value, see Note 10 of the Notes to the Consolidated Financial Statements.

                                      108

--------------------------------------------------------------------------------

Table of Contents

The table below presents the carrying value for guarantees at:


                    Future Policy           Policyholder
                      Benefits            Account Balances
                    December 31,            December 31,
                   2019       2018        2019         2018
                                (In millions)
Asia
GMDB             $     3    $     3    $      -       $   -
GMAB                   -          -          34          34
GMWB                  34         81         143         143
EMEA
GMDB                   3          7           -           -
GMAB                   -          -          25          24
GMWB                  15         70         (62 )       (82 )
MetLife Holdings
GMDB                 335        289           -           -
GMIB                 756        743         110         106
GMAB                   -          -          (1 )         5
GMWB                 125        129         375         563
Total            $ 1,271    $ 1,322    $    624       $ 793


The carrying amounts for guarantees included in policyholder account balances
above include nonperformance risk adjustments of $147 million and $263 million
at December 31, 2019 and 2018, respectively. These nonperformance risk
adjustments represent the impact of including a credit spread when discounting
the underlying risk neutral cash flows to determine the estimated fair values.
The nonperformance risk adjustment does not have an economic impact on us as it
cannot be monetized given the nature of these policyholder liabilities. The
change in valuation arising from the nonperformance risk adjustment is not
hedged.
The carrying values of these guarantees can change significantly during periods
of sizable and sustained shifts in equity market performance, equity volatility,
interest rates or foreign currency exchange rates. Carrying values are also
impacted by our assumptions around mortality, separate account returns and
policyholder behavior, including lapse rates.
As discussed below, we use a combination of product design, hedging strategies,
reinsurance, and other risk management actions to mitigate the risks related to
these benefits. Within each type of guarantee, there is a range of product
offerings reflecting the changing nature of these products over time. Changes in
product features and terms are in part driven by customer demand but, more
importantly, reflect our risk management practices of continuously evaluating
the guaranteed benefits and their associated asset-liability matching. We
continue to diversify the concentration of income benefits in our portfolio by
focusing on withdrawal benefits, variable annuities without living benefits and
index-linked annuities.
The sections below provide further detail by total account value for certain of
our most popular guarantees. Total account values include amounts not reported
on the consolidated balance sheets from assumed business, Unit-linked
investments that do not qualify for presentation as separate account assets, and
amounts included in our general account. The total account values and the net
amounts at risk include direct and assumed business, but exclude offsets from
hedging or ceded reinsurance, if any.

                                      109

--------------------------------------------------------------------------------

Table of Contents

GMDBs

We offer a range of GMDBs to our contractholders. The table below presents GMDBs, by benefit type, at December 31, 2019:


                                                               Total Account Value (1)
                                                                               MetLife
                                                            Asia & EMEA        Holdings
                                                                    (In millions)
Return of premium or five to seven year step-up            $      8,119     $     47,459
Annual step-up                                                        -     

3,159


Roll-up and step-up combination                                       -            5,756
Total                                                      $      8,119     $     56,374


__________________

(1) Total account value excludes $649 million for contracts with no GMDBs. The

Company's annuity contracts with guarantees may offer more than one type of

guarantee in each contract. Therefore, the amounts listed for GMDBs and for

living benefit guarantees are not mutually exclusive.




Based on total account value, less than 19% of our GMDBs included enhanced death
benefits such as the annual step-up or roll-up and step-up combination products
at December 31, 2019. We expect the above GMDB risk profile to be relatively
consistent for the foreseeable future.
Living Benefit Guarantees
The table below presents our living benefit guarantees based on total account
values at December 31, 2019:
                                         Total Account Value (1)
                                    Asia & EMEA          MetLife Holdings
                                              (In millions)
GMIB                           $          -             $           21,472
GMWB - non-life contingent (2)        1,168                          2,521
GMWB - life-contingent                3,737                          9,385
GMAB                                  2,009                            232
Total                          $      6,914             $           33,610


__________________

(1) Total account value excludes $24.2 billion for contracts with no living


     benefit guarantees. The Company's annuity contracts with guarantees may
     offer more than one type of guarantee in each contract. Therefore, the
     amounts listed for GMDBs and for living benefit guarantee amounts are not
     mutually exclusive.


(2)  The Asia and EMEA segments include the non-life contingent portion of the

GMWB total account value of $1.2 billion with a guarantee at annuitization.




In terms of total account value, GMIBs are our most significant living benefit
guarantee. Our primary risk management strategy for our GMIB products is our
derivatives hedging program as discussed below. Additionally, we have engaged in
certain reinsurance agreements covering some of our GMIB business. As part of
our overall risk management approach for living benefit guarantees, we
continually monitor the reinsurance markets for the right opportunity to
purchase additional coverage for our GMIB business. We stopped selling GMIBs in
February 2016.

                                      110

--------------------------------------------------------------------------------

Table of Contents

The table below presents our GMIB associated total account values, by their guaranteed payout basis, at December 31, 2019:


                                                                       Total
                                                                   Account Value
                                                                   (In millions)
7-year setback, 2.5% interest rate                                $         

5,940


7-year setback, 1.5% interest rate                                          

964


10-year setback, 1.5% interest rate                                         

4,301

10-year mortality projection, 10-year setback, 1.0% interest rate 8,666 10-year mortality projection, 10-year setback, 0.5% interest rate 1,601


                                                                  $        21,472


The annuitization interest rates on GMIBs have been decreased from 2.5% to 0.5%
over time, partially in response to the low interest rate environment,
accompanied by an increase in the setback period from seven years to 10 years
and the introduction of a 10-year mortality projection.
Additionally, 42% of the $21.5 billion of GMIB total account value has been
invested in managed volatility funds as of December 31, 2019. These funds seek
to manage volatility by adjusting the fund holdings within certain guidelines
based on capital market movements. Such activity reduces the overall risk of the
underlying funds while maintaining their growth opportunities. These risk
mitigation techniques reduce or eliminate the need for us to manage the funds'
volatility through hedging or reinsurance.
Our GMIB products typically have a waiting period of 10 years to be eligible for
annuitization. As of December 31, 2019, only 22% of our contracts with GMIBs
were eligible for annuitization. The remaining contracts are not eligible for
annuitization for an average of four years.
Once eligible for annuitization, contractholders would be expected to annuitize
only if their contracts were in-the-money. We calculate in-the-moneyness with
respect to GMIBs consistent with net amount at risk as discussed in Note 4 of
the Notes to the Consolidated Financial Statements, by comparing the
contractholders' income benefits based on total account values and current
annuity rates versus the guaranteed income benefits. The net amount at risk was
$584 million at December 31, 2019, of which $524 million was related to GMIBs.
For those contracts with GMIB, the table below presents details of contracts
that are in-the-money and out-of-the-money at December 31, 2019:
                                               Total
                    In-the-Moneyness       Account Value      % of Total
                                           (In millions)
In-the-money         30% or greater       $           512          2 %
                  20% to less than 30%                338          2 %
                  10% to less than 20%                590          3 %
                  0% to less than 10%               1,232          6 %
                                                    2,672
Out-of-the-money       -10% to 0%                   2,090         10 %
                 -20% to less than -10%             3,775         18 %
                   Greater than -20%               12,935         60 %
                                                   18,800
Total GMIBs                               $        21,472



                                      111

--------------------------------------------------------------------------------

Table of Contents



Derivatives Hedging Variable Annuity Guarantees
Our risk mitigating hedging strategy uses various OTC and exchange traded
derivatives. The table below presents the gross notional amount, estimated fair
value and primary underlying risk exposure of the derivatives hedging our
variable annuity guarantees:
                                                                                                               December 31,
                                                                                   2019                                                            2018
Primary Underlying                                     Gross Notional                Estimated Fair Value               Gross Notional               Estimated Fair Value
Risk Exposure                  Instrument Type             Amount                 Assets              Liabilities           Amount                 Assets              Liabilities
                                                                                                              (In millions)
Interest rate             Interest rate swaps         $         8,639     $        73               $           16     $         8,209     $        89               $           3
                          Interest rate futures                 1,678               3                            3               1,559               1                           3
                          Interest rate options                   838             209                            -                 838             163                           -
Foreign currency
exchange rate             Foreign currency forwards             1,644              16                           24               1,815              44                           9
                          Currency options                          1               -                            -                   -               -                           -
Equity market             Equity futures                        4,127               5                            8               2,730              11                          77
                          Equity index options                  8,775             473                          667               9,933             408                         546
                          Equity variance swaps                 1,115              23                           19               2,269              40                          87
                          Equity total return swaps               761               -                           70                 929              91                           -
                          Total                       $        27,578     $       802               $          807     $        28,282     $       847               $         725


The change in estimated fair values of our derivatives is recorded in
policyholder benefits and claims if such derivatives are hedging guarantees
included in future policy benefits, and in net derivative gains (losses) if such
derivatives are hedging guarantees included in policyholder account balances.
Our hedging strategy involves the significant use of static longer-term
derivative instruments to avoid the need to execute transactions during periods
of market disruption or higher volatility. We continually monitor the capital
markets for opportunities to adjust our liability coverage, as appropriate.
Futures are also used to dynamically adjust the daily coverage levels as markets
and liability exposures fluctuate.
We remain liable for the guaranteed benefits in the event that reinsurers or
derivative counterparties are unable or unwilling to pay. Certain of our
reinsurance agreements and all derivative positions are collateralized and
derivatives positions are subject to master netting agreements, both of which
significantly reduce the exposure to counterparty risk. In addition, we are
subject to the risk that hedging and other risk management actions prove
ineffective or that unanticipated policyholder behavior or mortality, combined
with adverse market events, produces economic losses beyond the scope of the
risk management techniques employed.
Liquidity and Capital Resources
Overview
Our business and results of operations are materially affected by conditions in
the global capital markets and the economy generally. Stressed conditions,
volatility and disruptions in global capital markets, particular markets, or
financial asset classes can have an adverse effect on us, in part because we
have a large investment portfolio and our insurance liabilities and derivatives
are sensitive to changing market factors. Changing conditions in the global
capital markets and the economy may affect our financing costs and market
interest for our debt or equity securities. For further information regarding
market factors that could affect our ability to meet liquidity and capital
needs, see "- Industry Trends" and "- Investments - Current Environment."
Liquidity Management
Based upon the strength of our franchise, diversification of our businesses,
strong financial fundamentals and the substantial funding sources available to
us as described herein, we continue to believe we have access to ample liquidity
to meet business requirements under current market conditions and reasonably
possible stress scenarios. We continuously monitor and adjust our liquidity and
capital plans for MetLife, Inc. and its subsidiaries in light of market
conditions, as well as changing needs and opportunities.

                                      112

--------------------------------------------------------------------------------

Table of Contents



Short-term Liquidity
We maintain a substantial short-term liquidity position, which was $9.8 billion
and $11.1 billion at December 31, 2019 and 2018, respectively. Short-term
liquidity includes cash and cash equivalents and short-term investments,
excluding assets that are pledged or otherwise committed, including amounts
received in connection with securities lending, repurchase agreements,
derivatives, and secured borrowings, as well as amounts held in the closed
block.
Liquid Assets
An integral part of our liquidity management includes managing our level of
liquid assets, which was $221.4 billion and $202.7 billion at December 31, 2019
and 2018, respectively. Liquid assets include cash and cash equivalents,
short-term investments and publicly-traded securities, excluding assets that are
pledged or otherwise committed. Assets pledged or otherwise committed include
amounts received in connection with securities lending, repurchase agreements,
derivatives, regulatory deposits, the collateral financing arrangement, funding
agreements and secured borrowings, as well as amounts held in the closed block.
Capital Management
We have established several senior management committees as part of our capital
management process. These committees, including the Capital Management Committee
and the Enterprise Risk Committee ("ERC"), regularly review actual and projected
capital levels (under a variety of scenarios including stress scenarios) and our
annual capital plan in accordance with our capital policy. The Capital
Management Committee is comprised of members of senior management, including
MetLife, Inc.'s Chief Financial Officer ("CFO"), Treasurer, and Chief Risk
Officer ("CRO"). The ERC is also comprised of members of senior management,
including MetLife, Inc.'s CFO, CRO and Chief Investment Officer.
Our Board of Directors and senior management are directly involved in the
development and maintenance of our capital policy. The capital policy sets
forth, among other things, minimum and target capital levels and the governance
of the capital management process. All capital actions, including proposed
changes to the annual capital plan, capital targets or capital policy, are
reviewed by the Finance and Risk Committee of the Board of Directors prior to
obtaining full Board of Directors approval. The Board of Directors approves the
capital policy and the annual capital plan and authorizes capital actions, as
required.
See "Risk Factors - Capital Risks - Legal and Regulatory Restrictions May
Prevent Us from Paying Dividends and Repurchasing Our Stock" for information
regarding restrictions on payment of dividends and stock repurchases. See also
Note 16 of the Notes to the Consolidated Financial Statements for information
regarding MetLife, Inc.'s common stock repurchase authorizations.
The Company
Liquidity
Liquidity refers to the ability to generate adequate amounts of cash to meet our
needs. We determine our liquidity needs based on a rolling 12-month forecast by
portfolio of invested assets which we monitor daily. We adjust the asset mix and
asset maturities based on this rolling 12-month forecast. To support this
forecast, we conduct cash flow and stress testing, which include various
scenarios of the potential risk of early contractholder and policyholder
withdrawal. We include provisions limiting withdrawal rights on many of our
products, including general account pension products sold to employee benefit
plan sponsors. Certain of these provisions prevent the customer from making
withdrawals prior to the maturity date of the product. In the event of
significant cash requirements beyond anticipated liquidity needs, we have
various alternatives available depending on market conditions and the amount and
timing of the liquidity need. These available alternatives include cash flows
from operations, sales of liquid assets, global funding sources including
commercial paper and various credit and committed facilities.
Under certain stressful market and economic conditions, our access to liquidity
may deteriorate, or the cost to access liquidity may increase. A downgrade in
our credit or financial strength ratings could also negatively affect our
liquidity. See "- Rating Agencies." If we require significant amounts of cash on
short notice in excess of anticipated cash requirements or if we are required to
post or return cash collateral in connection with derivatives or our securities
lending program, we may have difficulty selling investments in a timely manner,
be forced to sell them for less than we otherwise would have been able to
realize, or both. In addition, in the event of such forced sale, for securities
in an unrealized loss position, realized losses would be incurred on securities
sold and impairments would be incurred, if there is a need to sell securities
prior to recovery, which may negatively impact our financial condition. See
"Risk Factors - Investment Risks - We May Have Difficulty Selling Certain
Holdings in Our Investment Portfolio or in Our Securities Lending Program in a
Timely Manner and Realizing Full Value."

                                      113

--------------------------------------------------------------------------------

Table of Contents



All general account assets within a particular legal entity - other than those
which may have been pledged to a specific purpose - are generally available to
fund obligations of the general account of that legal entity.
Capital
We manage our capital position to maintain our financial strength and credit
ratings. See "- Rating Agencies" for information regarding such ratings. Our
capital position is supported by our ability to generate strong cash flows
within our operating companies and borrow funds at competitive rates, as well as
by our demonstrated ability to raise additional capital to meet operating and
growth needs despite adverse market and economic conditions.
Statutory Capital and Dividends
Our U.S. insurance subsidiaries have statutory surplus well above levels to meet
current regulatory requirements.
RBC requirements are used as minimum capital requirements by the NAIC and the
state insurance departments to identify companies that merit regulatory action.
RBC is based on a formula calculated by applying factors to various asset,
premium, claim, expense and statutory reserve items. The formula takes into
account the risk characteristics of the insurer, including asset risk, insurance
risk, interest rate risk, market risk and business risk and is calculated on an
annual basis. The formula is used as an early warning regulatory tool to
identify possible inadequately capitalized insurers for purposes of initiating
regulatory action, and not as a means to rank insurers generally. These rules
apply to most of our U.S. insurance subsidiaries. State insurance laws provide
insurance regulators the authority to require various actions by, or take
various actions against, insurers whose total adjusted capital does not meet or
exceed certain RBC levels. As of the date of the most recent annual statutory
financial statements filed with insurance regulators, the total adjusted capital
of each of these subsidiaries subject to these requirements was in excess of
each of those RBC levels.
As a Delaware corporation, American Life is subject to Delaware law; however,
because it does not conduct insurance business in Delaware or any other U.S.
state, it is exempt from RBC requirements under Delaware law. American Life's
operations are also regulated by applicable authorities of the jurisdictions in
which it operates and is subject to capital and solvency requirements in those
jurisdictions.
The amount of dividends that our insurance subsidiaries can pay to MetLife, Inc.
or to other parent entities is constrained by the amount of surplus we hold to
maintain our ratings and provides an additional margin for risk protection and
investment in our businesses. We proactively take actions to maintain capital
consistent with these ratings objectives, which may include adjusting dividend
amounts and deploying financial resources from internal or external sources of
capital. Certain of these activities may require regulatory approval.
Furthermore, the payment of dividends and other distributions to MetLife, Inc.
and other parent entities by their respective insurance subsidiaries is governed
by insurance laws and regulations. See "Business - Regulation - Insurance
Regulation," "- MetLife, Inc. - Liquidity and Capital Sources - Dividends from
Subsidiaries" and Note 16 of the Notes to the Consolidated Financial Statements.
Affiliated Captive Reinsurance Transactions
MLIC cedes specific policy classes, including term and universal life insurance,
participating whole life insurance, LTD insurance, group life insurance and
other business to various wholly-owned captive reinsurers. The reinsurance
activities among these affiliated companies are eliminated within our
consolidated results of operations. The statutory reserves of such affiliated
captive reinsurers are supported by a combination of funds withheld assets,
investment assets and letters of credit issued by unaffiliated financial
institutions. MetLife, Inc. has entered into various support agreements in
connection with the activities of these captive reinsurers. See Note 5 of the
Notes to the MetLife, Inc. (Parent Company Only) Condensed Financial Information
included in Schedule II of the Financial Statement Schedules for further details
on certain of these support arrangements. MLIC has entered into reinsurance
agreements with affiliated captive reinsurers for risk and capital management
purposes, as well as to manage statutory reserve requirements related to
universal life and term life insurance policies and other business.

                                      114

--------------------------------------------------------------------------------

Table of Contents



The NYDFS continues to have a moratorium on new reserve financing transactions
involving captive insurers. We are not aware of any states other than New York
and California implementing such a moratorium. While such a moratorium would not
impact our existing reinsurance agreements with captive reinsurers, a moratorium
placed on the use of captives for new reserve financing transactions could
impact our ability to write certain products and/or impact our RBC ratios and
ability to deploy excess capital in the future. This could result in our need to
increase prices, modify product features or limit the availability of those
products to our customers. While this affects insurers across the industry, it
could adversely impact our competitive position and our results of operations in
the future. We continue to evaluate product modifications, pricing structure and
alternative means of managing risks, capital and statutory reserves and we
expect the discontinued use of captive reinsurance on new reserve financing
transactions would not have a material impact on our future consolidated
financial results. See Note 6 of the Notes to the Consolidated Financial
Statements for further information on our reinsurance activities.
Rating Agencies
Rating agencies assign insurer financial strength ratings to MetLife, Inc.'s
U.S. life insurance subsidiaries and credit ratings to MetLife, Inc. and certain
of its subsidiaries. Financial strength ratings represent the opinion of rating
agencies regarding the ability of an insurance company to pay obligations under
insurance policies and contracts in accordance with their terms and are not
evaluations directed toward the protection of investors in MetLife, Inc.'s
securities. Insurer financial strength ratings are not statements of fact nor
are they recommendations to purchase, hold or sell any security, contract or
policy. Each rating should be evaluated independently of any other rating.
Rating agencies use an "outlook statement" of "positive," "stable," ''negative''
or "developing" to indicate a medium- or long-term trend in credit fundamentals
which, if continued, may lead to a rating change. A rating may have a "stable"
outlook to indicate that the rating is not expected to change; however, a
"stable" rating does not preclude a rating agency from changing a rating at any
time, without notice. Certain rating agencies assign rating modifiers such as
"CreditWatch" or "under review" to indicate their opinion regarding the
potential direction of a rating. These ratings modifiers are generally assigned
in connection with certain events such as potential mergers, acquisitions,
dispositions or material changes in a company's results, in order for the rating
agency to perform its analysis to fully determine the rating implications of the
event.
Our insurer financial strength ratings at the date of this filing are indicated
in the following table. Outlook is stable unless otherwise indicated. Additional
information about financial strength ratings can be found on the websites of the
respective rating agencies.
                               A.M. Best         Fitch          Moody's          S&P
                                                                                 "AAA
                                                                  "Aaa        (extremely
                                  "A++            "AAA          (highest     strong)" to
Ratings Structure             (superior)"    (exceptionally   quality)" to       "SD
                                 to "S       strong)" to "C    "C (lowest     (Selective
                              (suspended)"   (distressed)"      rated)"      Default)" or
                                                                                  "D
                                                                              (Default)"
American Life Insurance            NR              NR              A1            AA-
Company                                                        5th of 21      4th of 22
Metropolitan Life Insurance        A+             AA-             Aa3            AA-
Company                        2nd of 16       4th of 19       4th of 21      4th of 22
MetLife Insurance K.K.            NR              NR              NR             AA-
(MetLife Japan)                                                               4th of 22
Metropolitan Tower Life            A+             AA-             Aa3            AA-
Insurance Company              2nd of 16       4th of 19       4th of 21      4th of 22


__________________
NR = Not rated
Credit ratings indicate the rating agency's opinion regarding a debt issuer's
ability to meet the terms of debt obligations in a timely manner. They are
important factors in our overall funding profile and ability to access certain
types of liquidity. The level and composition of regulatory capital at the
subsidiary level and our equity capital are among the many factors considered in
determining our insurer financial strength ratings and credit ratings. Each
agency has its own capital adequacy evaluation methodology, and assessments are
generally based on a combination of factors. In addition to heightening the
level of scrutiny that they apply to insurance companies, rating agencies have
increased and may continue to increase the frequency and scope of their credit
reviews, may request additional information from the companies that they rate
and may adjust upward the capital and other requirements employed in the rating
agency models for maintenance of certain ratings levels.

                                      115

--------------------------------------------------------------------------------

Table of Contents



A downgrade in the credit ratings or insurer financial strength ratings of
MetLife, Inc. or its subsidiaries would likely impact us in the following ways,
including:
•      impact our ability to generate cash flows from the sale of funding

agreements and other capital market products offered by our RIS business;

• impact the cost and availability of financing for MetLife, Inc. and its

subsidiaries; and

• result in additional collateral requirements or other required payments

under certain agreements, which are eligible to be satisfied in cash or by

posting investments held by the subsidiaries subject to the agreements.

See "- Liquidity and Capital Uses - Pledged Collateral."




See also "Risk Factors - Economic Environment and Capital Markets Risks - A
Downgrade or a Potential Downgrade in Our Financial Strength or Credit Ratings
Could Result in a Loss of Business and Harm Our Financial Condition or Results
of Operations."
Summary of the Company's Primary Sources and Uses of Liquidity and Capital
Our primary sources and uses of liquidity and capital are summarized as follows:
                                                               Years Ended December 31,
                                                                 2019             2018
                                                                    (In millions)
Sources:
Operating activities, net                                   $      13,786     $   11,738
Net change in policyholder account balances                         6,524   

4,266

Net change in payables for collateral under securities loaned and other transactions

                                       2,019              -

Cash received for other transactions with tenors greater than three months

                                                     125   

200


Long-term debt issued                                               1,382   

24

Financing element on certain derivative instruments and other derivative related transactions, net

                              -   

144


Preferred stock issued, net of issuance costs                           -   

1,274


Effect of change in foreign currency exchange rates on cash
and cash equivalents                                                    9              -
Total sources                                                      23,845         17,646
Uses:
Investing activities, net                                          17,586          5,634

Net change in payables for collateral under securities loaned and other transactions

                                           -   

821

Cash paid for other transactions with tenors greater than three months

                                                          200              -
Long-term debt repaid                                                 906   

1,871


Collateral financing arrangement repaid                                67   

61

Financing element on certain derivative instruments and other derivative related transactions, net

                            126              -
Treasury stock acquired in connection with share
repurchases                                                         2,285          3,992
Dividends on preferred stock                                          178            141
Dividends on common stock                                           1,643          1,678
Other, net                                                             77            145

Effect of change in foreign currency exchange rates on cash and cash equivalents

                                                    -   

183


Total uses                                                         23,068   

14,526

Net increase (decrease) in cash and cash equivalents $ 777

$ 3,120




Cash Flows from Operations
The principal cash inflows from our insurance activities come from insurance
premiums, net investment income, annuity considerations and deposit funds. The
principal cash outflows are the result of various life insurance, property and
casualty, annuity and pension products, operating expenses and income tax, as
well as interest expense. A primary liquidity concern with respect to these cash
flows is the risk of early contractholder and policyholder withdrawal.

                                      116

--------------------------------------------------------------------------------

Table of Contents



Cash Flows from Investments
The principal cash inflows from our investment activities come from repayments
of principal, proceeds from maturities and sales of investments and settlements
of freestanding derivatives. The principal cash outflows relate to purchases of
investments, issuances of policy loans and settlements of freestanding
derivatives. Additional cash outflows relate to purchases of businesses. We
typically have a net cash outflow from investing activities because cash inflows
from insurance operations are reinvested in accordance with our ALM discipline
to fund insurance liabilities. We closely monitor and manage these risks through
our comprehensive investment risk management process. The primary liquidity
concerns with respect to these cash flows are the risk of default by debtors and
market disruption.
Cash Flows from Financing
The principal cash inflows from our financing activities come from issuances of
debt and other securities, deposits of funds associated with policyholder
account balances and lending of securities. The principal cash outflows come
from repayments of debt and the collateral financing arrangement, payments of
dividends on and repurchases of MetLife, Inc.'s securities, withdrawals
associated with policyholder account balances and the return of securities on
loan. The primary liquidity concerns with respect to these cash flows are market
disruption and the risk of early contractholder and policyholder withdrawal.
Liquidity and Capital Sources
In addition to the general description of liquidity and capital sources in "-
Summary of the Company's Primary Sources and Uses of Liquidity and Capital," the
Company's primary sources of liquidity and capital are set forth below.
Global Funding Sources
Liquidity is provided by a variety of global funding sources, including funding
agreements, credit and committed facilities and commercial paper. Capital is
provided by a variety of global funding sources, including short-term and
long-term debt, the collateral financing arrangement, junior subordinated debt
securities, preferred securities, equity securities and equity-linked
securities. MetLife, Inc. maintains a shelf registration statement with the SEC
that permits the issuance of public debt, equity and hybrid securities. As a
"Well-Known Seasoned Issuer" under SEC rules, MetLife, Inc.'s shelf registration
statement provides for automatic effectiveness upon filing and has no stated
issuance capacity. The diversity of our global funding sources enhances our
funding flexibility, limits dependence on any one market or source of funds and
generally lowers the cost of funds. Our primary global funding sources include:
Preferred Stock
See Notes 16 and 23 of the Notes to the Consolidated Financial Statements for
information on preferred stock issuances.
Common Stock
See Note 16 of the Notes to the Consolidated Financial Statements.
Commercial Paper, Reported in Short-term Debt
MetLife, Inc. and MetLife Funding each have a commercial paper program that is
supported by our unsecured revolving credit facility (see "- Credit and
Committed Facilities"). MetLife Funding raises cash from its commercial paper
program and uses the proceeds to extend loans through MetLife Credit Corp.,
another subsidiary of MLIC, to affiliates in order to enhance the financial
flexibility and liquidity of these companies.
Federal Home Loan Bank Funding Agreements, Reported in Policyholder Account
Balances
Certain of our U.S. insurance subsidiaries are members of a regional FHLB. For
the years ended December 31, 2019 and 2018, we issued $33.0 billion and
$27.3 billion, respectively, and repaid $32.8 billion and $27.5 billion,
respectively, of funding agreements with certain regional FHLBs. At December 31,
2019 and 2018, total obligations outstanding under these funding agreements were
$15.3 billion and $15.1 billion, respectively. See Note 4 of the Notes to the
Consolidated Financial Statements.

                                      117

--------------------------------------------------------------------------------

Table of Contents



Federal Home Loan Bank Advance Agreements, Reported in Payables for Collateral
Under Securities Loaned and Other Transactions
For the years ended December 31, 2019 and 2018, we borrowed $3.0 billion and
$3.1 billion, respectively, and repaid $3.0 billion and $2.6 billion,
respectively, under advance agreements with the FHLB of Boston. At both
December 31, 2019 and 2018, total obligations outstanding under these advance
agreements were $800 million. See Note 8 of the Notes to the Consolidated
Financial Statements.
Special Purpose Entity Funding Agreements, Reported in Policyholder Account
Balances
We issue fixed and floating rate funding agreements which are denominated in
either U.S. dollars or foreign currencies, to certain special purpose entities
("SPEs") that have issued either debt securities or commercial paper for which
payment of interest and principal is secured by such funding agreements. For the
years ended December 31, 2019 and 2018, we issued $37.3 billion and
$41.8 billion, respectively, and repaid $36.4 billion and $43.7 billion,
respectively, under such funding agreements. At December 31, 2019 and 2018,
total obligations outstanding under these funding agreements were $34.6 billion
and $32.3 billion, respectively. See Note 4 of the Notes to the Consolidated
Financial Statements.
Federal Agricultural Mortgage Corporation Funding Agreements, Reported in
Policyholder Account Balances
We have issued funding agreements to a subsidiary of Farmer Mac, as well as to
certain SPEs that have issued debt securities for which payment of interest and
principal is secured by such funding agreements, and such debt securities are
also guaranteed as to payment of interest and principal by Farmer Mac. The
obligations under all such funding agreements are secured by a pledge of certain
eligible agricultural mortgage loans. For the years ended December 31, 2019 and
2018, we issued $700 million and $900 million, respectively, and repaid $700
million and $900 million, respectively, under such funding agreements. At both
December 31, 2019 and 2018, total obligations outstanding under these funding
agreements were $2.6 billion. See Note 4 of the Notes to the Consolidated
Financial Statements.
Debt Issuances
In May 2019, MetLife, Inc. issued ¥151.7 billion ($1.4 billion at issuance) of
senior notes for general corporate purposes and the repayment of indebtedness,
which included the redemption of certain senior notes. See "- Liquidity and
Capital Uses - Debt Repurchases, Redemptions and Exchanges" and Note 13 of the
Notes to the Consolidated Financial Statements.
Credit and Committed Facilities
See Note 13 of the Notes to the Consolidated Financial Statements for
information on credit and committed facilities.
We have no reason to believe that our lending counterparties will be unable to
fulfill their respective contractual obligations under these facilities. As
commitments under our credit and committed facilities may expire unused, these
amounts do not necessarily reflect our actual future cash funding requirements.
Outstanding Debt Under Global Funding Sources
The following table summarizes our outstanding debt excluding long-term debt
relating to CSEs at:
                                        December 31,
                                      2019        2018
                                        (In millions)
Short-term debt (1)                 $    235    $    268
Long-term debt (2)                  $ 13,461    $ 12,824

Collateral financing arrangement $ 993 $ 1,060 Junior subordinated debt securities $ 3,150 $ 3,147

__________________


(1)  Includes $136 million and $168 million of debt that is non-recourse to
     MetLife, Inc. and MLIC, subject to customary exceptions, at December 31,
     2019 and 2018, respectively. Certain subsidiaries have pledged assets to
     secure this debt.


(2)  Includes $403 million and $422 million of debt that is non-recourse to
     MetLife, Inc. and MLIC, subject to customary exceptions, at December 31,

2019 and 2018, respectively. Certain investment subsidiaries have pledged


     assets to secure this debt.



                                      118

--------------------------------------------------------------------------------

Table of Contents



Debt and Facility Covenants
Certain of our debt instruments and committed facilities, as well as our
unsecured revolving credit facility, contain various administrative, reporting,
legal and financial covenants. We believe we were in compliance with all
applicable financial covenants at December 31, 2019.
Dispositions
For information regarding the pending disposition of MetLife Hong Kong, see
Note 3 of the Notes to the Consolidated Financial Statements.
Liquidity and Capital Uses
In addition to the general description of liquidity and capital uses in "-
Summary of the Company's Primary Sources and Uses of Liquidity and Capital" and
"- Contractual Obligations," the Company's primary uses of liquidity and capital
are set forth below.
Common Stock Repurchases
See Note 16 of the Notes to the Consolidated Financial Statements for
information relating to authorizations by the Board of Directors to repurchase
MetLife, Inc. common stock, amounts of common stock repurchased pursuant to such
authorizations for the years ended December 31, 2019 and 2018, and the amount
remaining under such authorizations at December 31, 2019. See Note 23 of the
Notes to the Consolidated Financial Statements for information regarding shares
of common stock repurchased subsequent to December 31, 2019.
Common stock repurchases are subject to the discretion of our Board of Directors
and will depend upon our capital position, liquidity, financial strength and
credit ratings, general market conditions, the market price of MetLife, Inc.'s
common stock compared to management's assessment of the stock's underlying
value, applicable regulatory approvals, and other legal and accounting factors.
Restrictions on the payment of dividends that may arise under so-called
"Dividend Stopper" provisions would also restrict MetLife, Inc.'s ability to
repurchase common stock. See "- Dividends" for information about these
restrictions. See also "Risk Factors - Capital Risks - Legal and Regulatory
Restrictions May Prevent Us from Paying Dividends and Repurchasing Our Stock."
Dividends
For the years ended December 31, 2019 and 2018, MetLife, Inc. paid dividends on
its preferred stock of $178 million and $141 million, respectively. For the
years ended December 31, 2019 and 2018, MetLife, Inc. paid dividends on its
common stock of $1.6 billion and $1.7 billion, respectively. See Note 16 of the
Notes to the Consolidated Financial Statements for information regarding the
calculation and timing of these dividend payments.
Dividends are paid quarterly on the Series A preferred stock. Dividends are paid
semi-annually on MetLife, Inc.'s 5.25% Fixed-to-Floating Rate Non-Cumulative
Preferred Stock, Series C, until June 15, 2020 and, thereafter, will be paid
quarterly. Dividends are paid semi-annually on the Series D preferred stock, in
September and March until March 15, 2028 and, thereafter, will be paid
quarterly. Dividends are paid quarterly on the Series E preferred stock.
The declaration and payment of common stock dividends are subject to the
discretion of our Board of Directors, and will depend on MetLife, Inc.'s
financial condition, results of operations, cash requirements, future prospects,
regulatory restrictions on the payment of dividends by MetLife, Inc.'s insurance
subsidiaries and other factors deemed relevant by the Board.
See Note 23 of the Notes to the Consolidated Financial Statements for
information regarding common and preferred stock dividends declared subsequent
to December 31, 2019.
"Dividend Stopper" Provisions in MetLife's Preferred Stock and Junior
Subordinated Debentures
MetLife, Inc.'s preferred stock and junior subordinated debentures contain
"dividend stopper" provisions under which MetLife, Inc. may not pay dividends on
instruments junior to those instruments if payments have not been made on those
instruments. Moreover, MetLife, Inc.'s Series A preferred stock and its junior
subordinated debentures contain provisions that would limit the payment of
dividends or interest on those instruments if MetLife, Inc. fails to meet
certain tests ("Trigger Events"), to an amount not greater than the net proceeds
from sales of common stock and other specified instruments during a period
preceding the dividend declaration date or the interest payment date, as
applicable. If such proceeds were under the circumstances insufficient to make
such payments on those instruments, the dividend stopper provisions affecting
common stock (and preferred stock, as applicable) would come into effect.

                                      119

--------------------------------------------------------------------------------

Table of Contents



A "Trigger Event" would occur if:
•      the RBC ratio of MetLife's largest U.S. insurance subsidiaries in the
       aggregate (as defined in the applicable instrument) were to be less than
       175% of the company action level based on the subsidiaries' prior year
       annual financial statements filed (generally around March 1) with state
       insurance commissioners; or

• at the end of a quarter ("Final Quarter End Test Date"), consolidated GAAP

net income for the four-quarter period ending two quarters before such

quarter-end (the "Preliminary Quarter End Test Date") is zero or a

negative amount and the consolidated GAAP stockholders' equity, minus AOCI

(the "adjusted stockholders' equity amount"), as of the Final Quarter End

Test Date and the Preliminary Quarter End Test Date, declined by 10% or

more from (A) its level 10 quarters before the Final Quarter End Test Date

(the "Benchmark Quarter End Test Date"), for Benchmark Quarter End Test

Dates after August 4, 2017 (the date of the Separation), or (B)

$49,282,000,000, the consolidated GAAP stockholders' equity, minus AOCI as

of June 30, 2017 as reported on a pro forma basis reflecting the

Separation in MetLife's Form 8-K filed with the SEC on August 9, 2017, for

Benchmark Quarter End Test Dates prior to August 4, 2017.




Once a Trigger Event occurs for a Final Quarter End Test Date, the suspension of
payments of dividends and interest (in the absence of sufficient net proceeds
from the issuance of certain securities during specified periods) would continue
until there is no Trigger Event at a subsequent Final Quarter End Test Date,
and, if the test in the second paragraph above caused the Trigger Event, the
adjusted stockholders' equity amount is no longer 10% or more below its level at
the Benchmark Quarter End Test Date that is associated with the Trigger Event.
In the case of successive Trigger Events, the suspension would continue until
MetLife satisfies these conditions for each of the Trigger Events.
The junior subordinated debentures further provide that MetLife, Inc. may, at
its option and provided that certain conditions are met, elect to defer payment
of interest. See Note 15 of the Notes to the Consolidated Financial Statements.
Any such elective deferral would trigger the dividend stopper provisions.
Further, MetLife, Inc. is a party to certain replacement capital covenants which
limit its ability to eliminate these restrictions through the repayment,
redemption or purchase of the junior subordinated debentures by requiring
MetLife, Inc., with some limitations, to receive cash proceeds during a
specified period from the sale of specified replacement securities prior to any
repayment, redemption or purchase. See Note 15 of the Notes to the Consolidated
Financial Statements for a description of such covenants.
Debt Repayments
See Notes 13 and 14 of the Notes to the Consolidated Financial Statements for
further information on long-term and short-term debt and the collateral
financing arrangement, respectively, including:
•      For the years ended December 31, 2019 and 2018, following regulatory

approval, MetLife Reinsurance Company of Charleston, a wholly-owned

subsidiary of MetLife, Inc., repurchased and canceled $67 million and

$61 million, respectively, in aggregate principal amount of its surplus


       notes, which were reported in collateral financing arrangement on the
       consolidated balance sheets;


•         In August 2018, MetLife, Inc. repaid at maturity the remaining $533
                          million of its 6.817% senior notes.


Debt Repurchases, Redemptions and Exchanges
We may from time to time seek to retire or purchase our outstanding debt through
cash purchases, redemptions and/or exchanges for other securities, in open
market purchases, privately negotiated transactions or otherwise. Any such
repurchases, redemptions, or exchanges will be dependent upon several factors,
including our liquidity requirements, contractual restrictions, general market
conditions, and applicable regulatory, legal and accounting factors. Whether or
not to repurchase or redeem any debt and the size and timing of any such
repurchases or redemptions will be determined at our discretion.
In June 2019, MetLife, Inc. redeemed for cash and canceled its £400 million
aggregate principal amount 5.250% senior notes due June 2020 and the remaining
$368 million aggregate principal amount of its 4.750% senior notes due February
2021.
See Note 13 of the Notes to the Consolidated Financial Statements for further
information on long-term and short-term debt including the FVO Brighthouse
Common Stock exchange.

                                      120

--------------------------------------------------------------------------------

Table of Contents



Support Agreements
MetLife, Inc. and several of its subsidiaries (each, an "Obligor") are parties
to various capital support commitments and guarantees with subsidiaries. Under
these arrangements, each Obligor has agreed to cause the applicable entity to
meet specified capital and surplus levels or has guaranteed certain contractual
obligations. We anticipate that in the event these arrangements place demands
upon us, there will be sufficient liquidity and capital to enable us to meet
such demands. See Note 5 of the Notes to the MetLife, Inc. (Parent Company Only)
Condensed Financial Information included in Schedule II of the Financial
Statement Schedules.
Insurance Liabilities
Liabilities arising from our insurance activities primarily relate to benefit
payments under various life insurance, property and casualty, annuity and group
pension products, as well as payments for policy surrenders, withdrawals and
loans. For annuity or deposit type products, surrender or lapse behavior differs
somewhat by segment. In the MetLife Holdings segment, which includes individual
annuities, lapses and surrenders tend to occur in the normal course of business.
For both the years ended December 31, 2019 and 2018, general account surrenders
and withdrawals from annuity products were $1.8 billion. In the RIS business
within the U.S. segment, which includes pension risk transfers, bank-owned life
insurance and other fixed annuity contracts, as well as funding agreements and
other capital market products, most of the products offered have fixed
maturities or fairly predictable surrenders or withdrawals. With regard to the
RIS business products that provide customers with limited rights to accelerate
payments, at December 31, 2019, there were funding agreements totaling
$123 million that could be put back to the Company.
Pledged Collateral
We pledge collateral to, and have collateral pledged to us by, counterparties in
connection with our derivatives. At December 31, 2019 and 2018, we had received
pledged cash collateral from counterparties of $6.3 billion and $5.0 billion,
respectively. At December 31, 2019 and 2018, we had pledged cash collateral to
counterparties of $275 million and $283 million, respectively. See Note 9 of the
Notes to the Consolidated Financial Statements for additional information about
collateral pledged to us, collateral we pledge and derivatives subject to credit
contingent provisions.
We pledge collateral and have had collateral pledged to us, and may be required
from time to time to pledge additional collateral or be entitled to have
additional collateral pledged to us, in connection with the collateral financing
arrangement related to the reinsurance of closed block liabilities. See Note 14
of the Notes to the Consolidated Financial Statements.
We pledge collateral from time to time in connection with funding agreements and
advance agreements. See Note 4 of the Notes to the Consolidated Financial
Statements.
Securities Lending and Repurchase Agreements
We participate in a securities lending program and in short-term repurchase
agreements whereby securities are loaned to unaffiliated financial institutions.
We obtain collateral, usually cash, from the borrower, which must be returned to
the borrower when the loaned securities are returned to us. Through these
arrangements, we were liable for cash collateral under our control of $19.7
billion and $19.1 billion at December 31, 2019 and 2018, respectively, including
a portion that may require the immediate return of cash collateral we hold. See
Note 8 of the Notes to the Consolidated Financial Statements.
Litigation
We establish liabilities for litigation and regulatory loss contingencies when
it is probable that a loss has been incurred and the amount of the loss can be
reasonably estimated. For material matters where a loss is believed to be
reasonably possible but not probable, no accrual is made but we disclose the
nature of the contingency and an aggregate estimate of the reasonably possible
range of loss in excess of amounts accrued, when such an estimate can be made.
It is not possible to predict the ultimate outcome of all pending investigations
and legal proceedings. In some of the matters referred to herein, very large
and/or indeterminate amounts, including punitive and treble damages, are sought.
Given the large and/or indeterminate amounts sought in certain of these matters
and the inherent unpredictability of litigation, it is possible that an adverse
outcome in certain matters could, from time to time, have a material adverse
effect on our consolidated net income or cash flows in particular quarterly or
annual periods. See Note 21 of the Notes to the Consolidated Financial
Statements.
Acquisitions
Cash outflows for acquisitions and investments in strategic partnerships for the
years ended December 31, 2019 and 2018 were $32 million and $0, respectively.

                                      121

--------------------------------------------------------------------------------

Table of Contents



Contractual Obligations
The following table summarizes our major contractual obligations at December 31,
2019:
                                                             More than          More than
                                             One Year       One Year to        Three Years         More than
                               Total         or Less        Three Years       to Five Years       Five Years
                                                               (In millions)
Insurance liabilities       $  340,290     $   21,848     $      13,752     $        13,424     $     291,266
Policyholder account
balances                       237,319         29,887            28,556              18,406           160,470
Payables for collateral
under securities loaned and
other transactions              26,745         26,745                 -                   -                 -
Debt                            31,600          1,201             2,416               4,791            23,192
Investment commitments          12,181         11,861               275                  43                 2
Operating leases                 1,902            285               495                 406               716
Other                           19,353         18,966                 -                   -               387
Total                       $  669,390     $  110,793     $      45,494     $        37,070     $     476,033


Insurance Liabilities
Insurance liabilities include future policy benefits, other policy-related
balances, policyholder dividends payable and the policyholder dividend
obligation, which are all reported on the consolidated balance sheet and are
more fully described in Notes 1 and 4 of the Notes to the Consolidated Financial
Statements. The amounts presented reflect future estimated cash payments and
(i) are based on mortality, morbidity, lapse and other assumptions comparable
with our experience and expectations of future payment patterns; and
(ii) consider future premium receipts on current policies in-force. All
estimated cash payments presented are undiscounted as to interest, net of
estimated future premiums on in-force policies and gross of any reinsurance
recoverable. Payment of amounts related to policyholder dividends left on
deposit are projected based on assumptions of policyholder withdrawal activity.
Because the exact timing and amount of the ultimate policyholder dividend
obligation is subject to significant uncertainty and the amount of the
policyholder dividend obligation is based upon a long-term projection of the
performance of the closed block, we have reflected the obligation at the amount
of the liability, if any, presented on the consolidated balance sheet in the
more than five years category. Additionally, the more than five years category
includes estimated payments due for periods extending for more than 100 years.
The sum of the estimated cash flows of $340.3 billion exceeds the liability
amounts of $214.8 billion included on the consolidated balance sheet principally
due to (i) the time value of money, which accounts for a substantial portion of
the difference; (ii) differences in assumptions, most significantly mortality,
between the date the liabilities were initially established and the current
date; and (iii) liabilities related to accounting conventions, or which are not
contractually due, which are excluded.
Actual cash payments may differ significantly from the liabilities as presented
on the consolidated balance sheet and the estimated cash payments as presented
due to differences between actual experience and the assumptions used in the
establishment of these liabilities and the estimation of these cash payments.
For the majority of our insurance operations, estimated contractual obligations
for future policy benefits and policyholder account balances, as presented, are
derived from the annual asset adequacy analysis used to develop actuarial
opinions of statutory reserve adequacy for state regulatory purposes. These cash
flows are materially representative of the cash flows under GAAP. See "-
Policyholder Account Balances."
Policyholder Account Balances
See Notes 1 and 4 of the Notes to the Consolidated Financial Statements for a
description of the components of policyholder account balances. See "- Insurance
Liabilities" regarding the source and uncertainties associated with the
estimation of the contractual obligations related to future policy benefits and
policyholder account balances.
Amounts presented represent the estimated cash payments undiscounted as to
interest and including assumptions related to the receipt of future premiums and
deposits; withdrawals, including unscheduled or partial withdrawals; policy
lapses; surrender charges; annuitization; mortality; future interest credited;
policy loans and other contingent events as appropriate for the respective
product type. Such estimated cash payments are also presented net of estimated
future premiums on policies currently in-force and gross of any reinsurance
recoverable. For obligations denominated in foreign currencies, cash payments
have been estimated using current spot foreign currency rates.

                                      122

--------------------------------------------------------------------------------

Table of Contents



The sum of the estimated cash flows of $237.3 billion exceeds the liability
amount of $192.6 billion included on the consolidated balance sheet principally
due to (i) the time value of money, which accounts for a substantial portion of
the difference; (ii) differences in assumptions, between the date the
liabilities were initially established and the current date; and
(iii) liabilities related to accounting conventions, or which are not
contractually due, which are excluded.
Payables for Collateral Under Securities Loaned and Other Transactions
We have accepted cash collateral in connection with securities lending,
repurchase agreements, FHLB of Boston short-term advance agreements and
derivatives. As these transactions expire within the next year and the timing of
the return of the derivatives collateral is uncertain, the return of the
collateral has been included in the one year or less category in the table
above. We also held non-cash collateral, which is not reflected as a liability
on the consolidated balance sheet, of $1.7 billion at December 31, 2019.
Debt
Amounts presented for debt include short-term debt, long-term debt, the
collateral financing arrangement and junior subordinated debt securities, the
total of which differs from the total of the corresponding amounts presented on
the consolidated balance sheet as the amounts presented herein (i) do not
include premiums or discounts upon issuance or purchase accounting fair value
adjustments; (ii) include future interest on such obligations for the period
from January 1, 2020 through maturity; and (iii) do not include long-term debt
relating to CSEs at December 31, 2019 as such debt does not represent our
contractual obligation. Future interest on variable rate debt was computed using
prevailing rates at December 31, 2019 and, as such, does not consider the impact
of future rate movements. Future interest on fixed rate debt was computed using
the stated rate on the obligations for the period from January 1, 2020 through
maturity, except with respect to junior subordinated debt which was computed
using the stated rates through the scheduled redemption dates as it is our
expectation that such obligations will be redeemed as scheduled. Inclusion of
interest payments on junior subordinated debt securities through the final
maturity dates would increase the contractual obligation by $7.7 billion.
Pursuant to the collateral financing arrangement, MetLife, Inc. may be required
to deliver cash or pledge collateral to the unaffiliated financial institution.
See Note 14 of the Notes to the Consolidated Financial Statements.
Investment Commitments
To enhance the return on our investment portfolio, we commit to lend funds under
mortgage loans, bank credit facilities, bridge loans and private corporate bond
investments and we commit to fund partnership investments. In the table above,
the timing of the funding of mortgage loans and private corporate bond
investments is based on the expiration dates of the corresponding commitments.
As it relates to commitments to fund partnerships and bank credit facilities, we
anticipate that these amounts could be invested any time over the next five
years; however, as the timing of the fulfillment of the obligation cannot be
predicted, such obligations are generally presented in the one year or less
category. Commitments to fund bridge loans are short-term obligations and, as a
result, are presented in the one year or less category. See Note 21 of the Notes
to the Consolidated Financial Statements and "- Off-Balance Sheet Arrangements."
Operating Leases
As a lessee, we have various operating leases, primarily for office space.
Contractual provisions exist that could increase or accelerate those lease
obligations presented, including various leases with early buyouts and/or
escalation clauses. However, the impact of any such transactions would not be
material to our financial position or results of operations. See Note 11 of the
Notes to the Consolidated Financial Statements.
Other
Other obligations presented are principally comprised of amounts due under
reinsurance agreements, payables related to securities purchased but not yet
settled, securities sold short, accrued interest on debt obligations, estimated
fair value of derivative obligations, deferred compensation arrangements,
guaranty liabilities, and accruals and accounts payable due under contractual
obligations, which are all reported in other liabilities on the consolidated
balance sheet. If the timing of any of these other obligations is sufficiently
uncertain, the amounts are included within the one year or less category. Items
reported in other liabilities on the consolidated balance sheet that were
excluded from the table represent accounting conventions or are not liabilities
due under contractual obligations. Unrecognized tax benefits and related accrued
interest totaling $295 million were excluded as the timing of payment could not
be reliably determined at December 31, 2019.
Separate account liabilities are excluded as they are fully funded by cash flows
from the corresponding separate account assets and are set equal to the
estimated fair value of separate account assets.

                                      123

--------------------------------------------------------------------------------

Table of Contents



We also enter into agreements to purchase goods and services in the normal
course of business; however, such amounts are excluded as these purchase
obligations were not material to our consolidated results of operations or
financial position at December 31, 2019.
Additionally, we have agreements in place for services we conduct, generally at
cost, between subsidiaries relating to insurance, reinsurance, loans and
capitalization. Intercompany transactions have been eliminated in consolidation.
Intercompany transactions among insurance subsidiaries and affiliates have been
approved by the appropriate insurance regulators as required.
MetLife, Inc.
Liquidity and Capital Management
Liquidity and capital are managed to preserve stable, reliable and
cost-effective sources of cash to meet all current and future financial
obligations and are provided by a variety of sources, including a portfolio of
liquid assets, a diversified mix of short- and long-term funding sources from
the wholesale financial markets and the ability to borrow through credit and
committed facilities. Liquidity is monitored through the use of internal
liquidity risk metrics, including the composition and level of the liquid asset
portfolio, timing differences in short-term cash flow obligations, access to the
financial markets for capital and debt transactions and exposure to contingent
draws on MetLife, Inc.'s liquidity. MetLife, Inc. is an active participant in
the global financial markets through which it obtains a significant amount of
funding. These markets, which serve as cost-effective sources of funds, are
critical components of MetLife, Inc.'s liquidity and capital management.
Decisions to access these markets are based upon relative costs, prospective
views of balance sheet growth and a targeted liquidity profile and capital
structure. A disruption in the financial markets could limit MetLife, Inc.'s
access to liquidity.
MetLife, Inc.'s ability to maintain regular access to competitively priced
wholesale funds is fostered by its current credit ratings from the major credit
rating agencies. We view our capital ratios, credit quality, stable and diverse
earnings streams, diversity of liquidity sources and our liquidity monitoring
procedures as critical to retaining such credit ratings. See "- The Company -
Rating Agencies."
Liquidity
For a summary of MetLife, Inc.'s liquidity, see "- The Company - Liquidity."
Capital
For a summary of MetLife, Inc.'s capital, see "- The Company - Capital." See
also "- The Company - Liquidity and Capital Uses - Common Stock Repurchases" for
information regarding MetLife, Inc.'s common stock repurchases.
Liquid Assets
At December 31, 2019 and 2018, MetLife, Inc. and other MetLife holding companies
had $4.2 billion and $3.0 billion, respectively, in liquid assets. Of these
amounts, $3.0 billion and $2.4 billion were held by MetLife, Inc. and
$1.2 billion and $607 million were held by other MetLife holding companies at
December 31, 2019 and 2018, respectively. Liquid assets include cash and cash
equivalents, short-term investments and publicly-traded securities, excluding
assets that are pledged or otherwise committed. Assets pledged or otherwise
committed include amounts received in connection with derivatives and a
collateral financing arrangement.
Liquid assets held in non-U.S. holding companies are generated in part through
dividends from non-U.S. insurance operations. Such dividends are subject to
local insurance regulatory requirements, as discussed in "- Liquidity and
Capital Sources - Dividends from Subsidiaries." The cumulative earnings of
certain active non-U.S. operations have historically been reinvested
indefinitely in such non-U.S. operations. Following a post-Separation review of
our capital needs, the Company repatriated $400 million of pre-2017 earnings in
the second quarter of 2018. As a result of U.S. Tax Reform, we expect to
repatriate future foreign earnings back to the U.S. with minimal or no
additional U.S. tax. See Note 19 of the Notes to the Consolidated Financial
Statements and "- Risk Factors - Regulatory and Legal Risks - Changes in Tax
Laws or Interpretations of Such Laws Could Reduce Our Earnings and Materially
Impact Our Operations by Increasing Our Corporate Taxes and Making Some of Our
Products Less Attractive to Consumers."
See "- Executive Summary - Consolidated Company Outlook," for the targeted level
of liquid assets at the holding companies.

                                      124

--------------------------------------------------------------------------------

Table of Contents

MetLife, Inc. and Other MetLife Holding Companies Sources and Uses of Liquid
Assets and Sources and Uses of Liquid Assets included in Free Cash Flow
MetLife, Inc.'s sources and uses of liquid assets, as well as sources and uses
of liquid assets included in free cash flow are summarized as follows.
                                               Year Ended December 31, 2019       Year Ended December 31, 2018
                                                               Sources and
                                                                 Uses of
                                                                  Liquid                              Sources and
                                                                  Assets                            Uses of Liquid
                                                Sources and    Included in                          Assets Included
                                                  Uses of       Free Cash      Sources and Uses      in Free Cash
                                               Liquid Assets       Flow        of Liquid Assets          Flow
                                                                          (In millions)
MetLife, Inc. (Parent Company Only)
Sources:
Dividends and returns of capital from
subsidiaries (1)                               $     4,800     $    4,800     $      7,454          $   7,454
Long-term debt issued (2)                            1,373            494                -                  -
Repayments on and (issuances of) loans to
subsidiaries and related interest, net (3)               -              -                -                  -
Preferred stock issued                                   -              -            1,274                  -
Other, net (4)                                         320            196                -                  -
Total sources                                        6,493          5,490            8,728              7,454
Uses:
Capital contributions to subsidiaries (5)               75             75              767                767
Long-term debt repaid - unaffiliated                   877              -            1,759                  -
Interest paid on debt and financing
arrangements - unaffiliated                            817            817              964                964
Dividends on common stock                            1,643              -            1,678                  -
Treasury stock acquired in connection with
share repurchases                                    2,285              -            3,992                  -
Dividends on preferred stock                           178            178              141                141
Issuances of and (repayments on) loans to
subsidiaries and related interest, net (3)              44             44               63                 63
Other, net (4)                                           -              -            1,029              1,083
Total uses                                           5,919          1,114           10,393              3,018
Net increase (decrease) in liquid assets,
MetLife, Inc. (Parent Company Only)                    574                          (1,665 )
Liquid assets, beginning of year                     2,430                  

4,095


Liquid assets, end of year                     $     3,004                    $      2,430
Free Cash Flow, MetLife, Inc. (Parent
Company Only)                                                       4,376                               4,436
Net cash provided by operating activities,
MetLife, Inc. (Parent Company Only)            $     4,177                  

$ 5,494



Other MetLife Holding Companies
Sources:
Dividends and returns of capital from
subsidiaries                                   $     2,199     $    2,199     $      2,836          $   2,836
Capital contributions from MetLife, Inc.                 -              -                -                  -
Total sources                                        2,199          2,199            2,836              2,836

Uses:


Capital contributions to subsidiaries                   67             67               57                 57
Repayments on and (issuance of) loans to
subsidiaries and affiliates and related
interest, net                                           16             16                6                  6
Dividends and returns of capital to MetLife,
Inc.                                                 1,100          1,100            3,200              3,200
Other, net                                             444            444              603                603
Total uses                                           1,627          1,627            3,866              3,866
Net increase (decrease) in liquid assets,
Other MetLife Holding Companies                        572                          (1,030 )
Liquid assets, beginning of year                       613                  

1,643


Liquid assets, end of year                     $     1,185                    $        613
Free Cash Flow, Other MetLife Holding
Companies                                                             572                              (1,030 )
Net increase (decrease) in liquid assets,
All Holding Companies                          $     1,146                    $     (2,695 )
Free Cash Flow, All Holding Companies (6)
(7)                                                            $    4,948                           $   3,406


__________________

                                      125

--------------------------------------------------------------------------------

Table of Contents

(1) Dividends and returns of capital to MetLife, Inc. included $3.7 billion and

$4.3 billion from operating subsidiaries and $1.1 billion and $3.2 billion

from other MetLife holding companies for the years ended December 31, 2019

and 2018, respectively.

(2) Included in free cash flow is the portion of long-term debt issued that

represents incremental debt to be at or below target leverage ratios.

(3) See MetLife, Inc. (Parent Company Only) Condensed Statements of Cash Flows

included in Schedule II of the Financial Statement Schedules for information

regarding the source of liquid assets from receipts on loans to subsidiaries

(excluding interest) and the use of liquid assets related to the issuances


     of loans to subsidiaries (excluding interest).


(4)  Other, net includes $155 million and ($877) million of net receipts

(payments) by MetLife, Inc. to and from subsidiaries under a tax sharing

agreement and tax payments to tax agencies for the years ended December 31,


     2019 and 2018, respectively.


(5)  Amounts to fund business acquisitions were $0 (included in capital
     contributions to subsidiaries) at both years ended December 31, 2019 and
     2018.

(6) In 2018, $268 million of Separation-related items (comprised of certain

Separation-related inflows primarily related to reinsurance benefit from

Brighthouse) were included in free cash flow, which increased our holding

companies' liquid assets, as well as our free cash flow ratio. Excluding


     these Separation-related items, adjusted free cash flow would be $3.1
     billion for the year ended December 31, 2018.

(7) See "- Non-GAAP and Other Financial Disclosures" for the reconciliation of

net cash provided by operating activities of MetLife, Inc. to free cash flow

of all holding companies.




Sources and Uses of Liquid Assets of MetLife, Inc.
The primary sources of MetLife, Inc.'s liquid assets are dividends and returns
of capital from subsidiaries, issuances of long-term debt, issuances of common
and preferred stock, and net receipts from subsidiaries under a tax sharing
agreement. MetLife, Inc.'s insurance subsidiaries are subject to regulatory
restrictions on the payment of dividends imposed by the regulators of their
respective domiciles. See "- Liquidity and Capital Sources - Dividends from
Subsidiaries."
The primary uses of MetLife, Inc.'s liquid assets are principal and interest
payments on long-term debt, dividends on and repurchases of common and preferred
stock, capital contributions to subsidiaries, funding of business acquisitions,
income taxes and operating expenses. MetLife, Inc. is party to various capital
support commitments and guarantees with certain of its subsidiaries. See "-
Liquidity and Capital Uses - Support Agreements."
In addition, MetLife, Inc. issues loans to subsidiaries or subsidiaries issue
loans to MetLife, Inc. Accordingly, changes in MetLife, Inc. liquid assets
include issuances of loans to subsidiaries, proceeds of loans from subsidiaries
and the related repayment of principal and payment of interest on such loans.
See "- Liquidity and Capital Sources - Affiliated Long-term Debt" and "-
Liquidity and Capital Uses - Affiliated Capital and Debt Transactions."
Sources and Uses of Liquid Assets of Other MetLife Holding Companies
The primary sources of liquid assets of other MetLife holding companies are
dividends, returns of capital and remittances from their subsidiaries and
branches, principally non-U.S. insurance companies; capital contributions
received; receipts of principal and interest on loans to subsidiaries and
affiliates and borrowings from subsidiaries and affiliates. MetLife, Inc.'s
non-U.S. operations are subject to regulatory restrictions on the payment of
dividends imposed by local regulators. See "- Liquidity and Capital Sources -
Dividends from Subsidiaries."
The primary uses of liquid assets of other MetLife holding companies are capital
contributions paid to their subsidiaries and branches, principally non-U.S.
insurance companies; loans to subsidiaries and affiliates; principal and
interest paid on loans from subsidiaries and affiliates; dividends and returns
of capital to MetLife, Inc. and the following items, which are reported within
other, net: business acquisitions; and operating expenses. There were no uses of
liquid assets of other MetLife holding companies to fund business acquisitions
during the years ended December 31, 2019 or 2018.
Liquidity and Capital Sources
In addition to the description of liquidity and capital sources in "- The
Company - Summary of the Company's Primary Sources and Uses of Liquidity and
Capital" and "- The Company - Liquidity and Capital Sources," MetLife, Inc.'s
primary sources of liquidity and capital are set forth below.

                                      126

--------------------------------------------------------------------------------

Table of Contents



Dividends from Subsidiaries
MetLife, Inc. relies, in part, on dividends from its subsidiaries to meet its
cash requirements. MetLife, Inc.'s insurance subsidiaries are subject to
regulatory restrictions on the payment of dividends imposed by the regulators of
their respective domiciles. See Note 16 of the Notes to the Consolidated
Financial Statements. The dividend limitation for U.S. insurance subsidiaries is
generally based on the surplus to policyholders at the end of the immediately
preceding calendar year and statutory net gain from operations for the
immediately preceding calendar year. Statutory accounting practices, as
prescribed by insurance regulators of various states in which we conduct
business, differ in certain respects from accounting principles used in
financial statements prepared in conformity with GAAP. The significant
differences relate to the treatment of DAC, certain deferred income tax,
required investment liabilities, statutory reserve calculation assumptions,
goodwill and surplus notes.
The table below sets forth the dividends permitted to be paid by MetLife, Inc.'s
primary U.S. insurance subsidiaries without insurance regulatory approval and
the actual dividends paid:
                                       2020                             2019                                      2018
                                Permitted Without                         Permitted Without                          Permitted Without
Company                            Approval (1)           Paid (2)           Approval (1)           Paid (2)            Approval (1)
                                                                              (In millions)
Metropolitan Life Insurance
Company                         $          3,272        $    3,065        $          3,065        $    3,736   (3)   $          3,075
American Life Insurance
Company                         $             51        $    1,100        $              -        $    3,200         $              -

Metropolitan Property and
Casualty Insurance Company      $            114        $      430        $            171        $      233         $            125
Metropolitan Tower Life
Insurance Company (4)           $            149        $        -        $            154        $      191   (4)   $             73
General American Life
Insurance Company (4)                        N/A        $        -                     N/A        $        -         $            118


__________________

(1) Reflects dividend amounts that may be paid during the relevant year without

prior regulatory approval ("ordinary dividends"). However, because dividend


     tests may be based on dividends previously paid over rolling 12-month
     periods, if paid before a specified date during such year, some or all of
     such dividends may require regulatory approval.


(2)  Reflects all amounts paid, including those where regulatory approval was
     obtained as required ("extraordinary dividends").

(3) Represents ordinary dividends of $3.0 billion and an extraordinary dividend

of $705 million. The extraordinary dividend was paid in cash with proceeds

from the sale to an affiliate of certain property, equipment, leasehold

improvements and computer software that were non-admitted by MLIC for

statutory accounting purposes. The affiliate received a capital contribution

in cash from MetLife, Inc. to fund the purchase.

(4) In April 2018, MTL merged with GALIC ("MTL Merger"). The surviving entity of

the merger was MTL, which re-domesticated from Delaware to Nebraska

immediately prior to the merger. The total dividends paid of $191 million is

equal to the sum of the individual 2018 ordinary dividends that MTL and

GALIC would each have been permitted to pay computed on a stand-alone basis

if the MTL Merger had not occurred.




In addition to the amounts presented in the table above, for the years ended
December 31, 2019 and 2018, MetLife, Inc. also received cash payments of
$195 million and $7 million, respectively, representing dividends from certain
other subsidiaries. Additionally, for the years ended December 31, 2019 and
2018, MetLife, Inc. received cash returns of capital of $10 million and $87
million.
The dividend capacity of our non-U.S. operations is subject to similar
restrictions established by the local regulators. The non-U.S. regulatory
regimes also commonly limit dividend payments to the parent company to a portion
of the subsidiary's prior year statutory income, as determined by the local
accounting principles. The regulators of our non-U.S. operations, including the
FSA, may also limit or not permit profit repatriations or other transfers of
funds to the U.S. if such transfers are deemed to be detrimental to the solvency
or financial strength of the non-U.S. operations, or for other reasons. Most of
our non-U.S. subsidiaries are second tier subsidiaries which are owned by
various non-U.S. holding companies. The capital and rating considerations
applicable to our first tier subsidiaries may also impact the dividend flow into
MetLife, Inc.
We proactively manage target and excess capital levels and dividend flows and
forecast local capital positions as part of the financial planning cycle. The
dividend capacity of certain U.S. and non-U.S. subsidiaries is also subject to
business targets in excess of the minimum capital necessary to maintain the
desired rating or level of financial strength in the relevant market. See "Risk
Factors - Capital Risks - As a Holding Company, MetLife, Inc. Depends on the
Ability of Its Subsidiaries to Pay Dividends, a Major Component of Holding
Company Free Cash Flow" and Note 16 of the Notes to the Consolidated Financial
Statements.

                                      127

--------------------------------------------------------------------------------

Table of Contents



Affiliated Long-term Debt
See "Senior Notes - Affiliated" in Note 4 of the Notes to the MetLife, Inc.
(Parent Company Only) Condensed Financial Information included in Schedule II of
the Financial Statement Schedules for information on affiliated long-term debt.
Collateral Financing Arrangement and Junior Subordinated Debt Securities
For information on MetLife, Inc.'s collateral financing arrangement and junior
subordinated debt securities, see Notes 14 and 15 of the Notes to the
Consolidated Financial Statements, respectively.
Credit and Committed Facilities
See "- The Company - Liquidity and Capital Sources - Global Funding Sources -
Credit and Committed Facilities," as well as Note 13 of the Notes to the
Consolidated Financial Statements, for further information regarding the
Company's unsecured revolving credit facility and certain committed facilities.
Long-term Debt Outstanding
The following table summarizes the outstanding long-term debt of MetLife, Inc.
at:
                                        December 31,
                                      2019        2018
                                        (In millions)

Long-term debt - unaffiliated $ 12,379 $ 11,844 Long-term debt - affiliated (1) $ 1,976 $ 1,957 Junior subordinated debt securities $ 2,458 $ 2,456

__________________

(1) In July 2019, a ¥53.3 billion 1.448% senior note issued to MLIC matured and

was refinanced with a ¥37.3 billion 1.602% senior note due July 2023 and a

¥16.0 billion 1.637% senior note due July 2026 issued to MLIC. In October

2019, a ¥26.5 billion 1.721% senior note issued to MLIC matured and was

refinanced with a ¥26.5 billion 1.81% senior note due October 2029 issued to


     MLIC.


Debt and Facility Covenants
Certain of MetLife, Inc.'s debt instruments and committed facilities, as well as
its unsecured revolving credit facility, contain various administrative,
reporting, legal and financial covenants. MetLife, Inc. believes it was in
compliance with all applicable financial covenants at December 31, 2019.
Liquidity and Capital Uses
The primary uses of liquidity of MetLife, Inc. include debt service, cash
dividends on common and preferred stock, capital contributions to subsidiaries,
common stock, preferred stock and debt repurchases, payment of general operating
expenses and acquisitions. Based on our analysis and comparison of our current
and future cash inflows from the dividends we receive from subsidiaries that are
permitted to be paid without prior insurance regulatory approval, our investment
portfolio and other cash flows and anticipated access to the capital markets, we
believe there will be sufficient liquidity and capital to enable MetLife, Inc.
to make payments on debt, pay cash dividends on its common and preferred stock,
contribute capital to its subsidiaries, repurchase its common stock and certain
of its other securities, pay all general operating expenses and meet its cash
needs under current market conditions and reasonably possible stress scenarios.
In addition to the description of liquidity and capital uses in "- The Company -
Liquidity and Capital Uses" and "- The Company - Contractual Obligations,"
MetLife, Inc.'s primary uses of liquidity and capital are set forth below.
Affiliated Capital and Debt Transactions
For the years ended December 31, 2019 and 2018, MetLife, Inc. invested a net
amount of $89 million and $778 million, respectively, in various subsidiaries.
MetLife, Inc. lends funds, as necessary, through credit agreements or otherwise
to its subsidiaries and affiliates, some of which are regulated, to meet their
capital requirements or to provide liquidity. MetLife, Inc. had loans to
subsidiaries outstanding of $100 million at both December 31, 2019 and 2018.

                                      128

--------------------------------------------------------------------------------

Table of Contents



Debt Repayments
For information on MetLife, Inc.'s debt repayments, see "- The Company -
Liquidity and Capital Uses - Debt Repayments." MetLife, Inc. intends to repay or
refinance, in whole or in part, all the debt that is due in 2020.
Maturities of Senior Notes
The following table summarizes MetLife, Inc.'s outstanding senior notes by year
of maturity, excluding any premium or discount and unamortized issuance costs,
at December 31, 2019:
Year of Maturity      Principal             Interest Rate
                    (In millions)
Unaffiliated:
2022               $           500              3.05%
2023               $         1,000              4.37%
2024               $         1,000              3.60%
2024               $           464              5.38%
2025 - 2046        $         9,496    Ranging from 0.50% - 6.50%
Affiliated:
2020               $           244              0.82%
2021               $           495              2.97%
2021               $           503              3.14%
2023               $           343              1.60%
2026-2029          $           391    Ranging from 1.64% - 1.81%


Support Agreements
MetLife, Inc. is party to various capital support commitments and guarantees
with certain of its subsidiaries. See Note 5 of the Notes to the MetLife, Inc.
(Parent Company Only) Condensed Financial Information included in Schedule II of
the Financial Statement Schedules.
Adoption of New Accounting Pronouncements
See Note 1 of the Notes to the Consolidated Financial Statements.
Future Adoption of New Accounting Pronouncements
See Note 1 of the Notes to the Consolidated Financial Statements.
Non-GAAP and Other Financial Disclosures
In this report, the Company presents certain measures of its performance on a
consolidated and segment basis that are not calculated in accordance with GAAP.
We believe that these non-GAAP financial measures enhance the understanding of
our performance by highlighting the results of operations and the underlying
profitability drivers of our business. Segment-specific financial measures are
calculated using only the portion of consolidated results attributable to that
specific segment.
The following non-GAAP financial measures should not be viewed as substitutes
for the most directly comparable financial measures calculated in accordance
with GAAP:
Non-GAAP financial measures:               Comparable GAAP financial measures:
(i)   adjusted earnings                    (i)   net income (loss)
(ii)  adjusted earnings available to       (ii)  net income (loss) available to
      common shareholders                        MetLife, Inc.'s common shareholders
(iii)                                      (iii) MetLife, Inc. (parent company only)
      free cash flow of all holding              net cash provided
      companies                                  by (used in) operating 

activities


(iv)  net investment income, as reported   (iv)  net investment income
      on an adjusted basis



                                      129

--------------------------------------------------------------------------------

Table of Contents



Any of these financial measures shown on a constant currency basis reflect the
impact of changes in foreign currency exchange rates and are calculated using
the average foreign currency exchange rates for the most recent period and
applied to the comparable prior period ("constant currency basis").
Reconciliations of these non-GAAP financial measures to the most directly
comparable historical GAAP financial measures are included in the results of
operations, see "- Results of Operations." Reconciliations of these non-GAAP
measures to the most directly comparable GAAP measures are not accessible on a
forward-looking basis because we believe it is not possible without unreasonable
effort to provide other than a range of net investment gains and losses and net
derivative gains and losses, which can fluctuate significantly within or outside
the range and from period to period and may have a material impact on net
income.
Our definitions of non-GAAP and other financial measures discussed in this
report may differ from those used by other companies.
Adjusted earnings and related measures:
• adjusted earnings;


• adjusted earnings available to common shareholders; and

• adjusted earnings available to common shareholders on a constant currency

basis.




These measures are used by management to evaluate performance and allocate
resources. Consistent with GAAP guidance for segment reporting, adjusted
earnings and components of, or other financial measures based on, adjusted
earnings are also our GAAP measures of segment performance. Adjusted earnings
and other financial measures based on adjusted earnings are also the measures by
which senior management's and many other employees' performance is evaluated for
the purposes of determining their compensation under applicable compensation
plans. Adjusted earnings and other financial measures based on adjusted earnings
allow analysis of our performance relative to our business plan and facilitate
comparisons to industry results.
Adjusted earnings is defined as adjusted revenues less adjusted expenses, net of
income tax. Adjusted loss is defined as negative adjusted earnings. Adjusted
earnings available to common shareholders is defined as adjusted earnings less
preferred stock dividends. For information relating to adjusted revenues and
adjusted expenses, see "Financial Measures and Segment Accounting Policies" in
Note 2 of the Notes to the Consolidated Financial Statements.
Return on equity, allocated equity and related measures:
•      MetLife, Inc.'s common stockholders' equity, excluding AOCI other than

FCTA, is defined as MetLife, Inc.'s common stockholders' equity, excluding


       the net unrealized investment gains (losses) and defined benefit plans
       adjustment components of AOCI, net of income tax.

• Adjusted return on MetLife, Inc.'s common stockholders' equity is defined

as adjusted earnings available to common shareholders divided by MetLife,

Inc.'s average common stockholders' equity.

• Adjusted return on MetLife, Inc.'s common stockholders' equity, excluding

AOCI other than FCTA is defined as adjusted earnings available to common


       shareholders divided by MetLife, Inc.'s average common stockholders'
       equity, excluding AOCI other than FCTA.

• Allocated equity is the portion of MetLife, Inc.'s common stockholders'

equity that management allocates to each of its segments and sub-segments

based on local capital requirements and economic capital. See "- Economic

Capital." Allocated equity excludes the impact of AOCI other than FCTA.




The above measures represent a level of equity consistent with the view that, in
the ordinary course of business, we do not plan to sell most investments for the
sole purpose of realizing gains or losses. Also, refer to the utilization of
adjusted earnings and components of, or other financial measures based on,
adjusted earnings mentioned above.
Expense ratio and direct expense ratio:
•      Expense ratio: other expenses, net of capitalization of DAC, divided by

premiums, fees and other revenues.

• Direct expense ratio: direct expenses, on an adjusted basis, divided by

adjusted premiums, fees and other revenues. Direct expenses are comprised


       of employee-related costs, third party staffing costs, and general and
       administrative expenses.



                                      130

--------------------------------------------------------------------------------

Table of Contents

• Direct expense ratio, excluding total notable items related to direct

expenses and pension risk transfers: direct expenses, on an adjusted

basis, excluding total notable items related to direct expenses, divided


       by adjusted premiums, fees and other revenues, excluding pension risk
       transfers.

The following additional information is relevant to an understanding of our performance results: • We sometimes refer to sales activity for various products. These sales

statistics do not correspond to revenues under GAAP, but are used as

relevant measures of business activity. Further, sales statistics for our

Latin America, Asia and EMEA segments are on a constant currency basis.

• Near-term represents one to three years.

• Asymmetrical and non-economic accounting refers to: (i) the portion of net

derivative gains (losses) on embedded derivatives attributable to the

inclusion of our credit spreads in the liability valuations, (ii) hedging

activity that generates net derivative gains (losses) and creates

fluctuations in net income because hedge accounting cannot be achieved and


       the item being hedged does not a have an offsetting gain or loss
       recognized in earnings, (iii) inflation-indexed benefit adjustments
       associated with contracts backed by inflation-indexed investments and
       amounts associated with periodic crediting rate adjustments based on the
       total return of a contractually referenced pool of assets and other pass
       through adjustments, and (iv) impact of changes in foreign currency
       exchange rates on the re-measurement of foreign denominated unhedged
       funding agreements and financing transactions to the U.S. dollar and the
       re-measurement of certain liabilities from non-functional currencies to
       functional currencies. We believe that excluding the impact of

asymmetrical and non-economic accounting from total GAAP results enhances


       investor understanding of our performance by disclosing how these
       accounting practices affect reported GAAP results.

• Notable items represent a positive (negative) impact to adjusted earnings

available to common shareholders. Notable items reflect the unexpected

impact of events that affect MetLife's results, but that were unknown and


       that MetLife could not anticipate when it devised its Business Plan.
       Notable items also include certain items regardless of the extent
       anticipated in the Business Plan, to help investors have a better
       understanding of MetLife's results and to evaluate and forecast those
       results.


•      The Company uses a measure of free cash flow to facilitate an
       understanding of its ability to generate cash for reinvestment into its

businesses or use in non-mandatory capital actions. The Company defines

free cash flow as the sum of cash available at MetLife's holding companies

from dividends from operating subsidiaries, expenses and other net flows

of the holding companies (including capital contributions to

subsidiaries), and net contributions from debt to be at or below target

leverage ratios. This measure of free cash flow is prior to capital

actions, such as common stock dividends and repurchases, debt reduction

and mergers and acquisitions. Free cash flow should not be viewed as a

substitute for net cash provided by (used in) operating activities

calculated in accordance with GAAP. The free cash flow ratio is typically

expressed as a percentage of annual adjusted earnings available to common

shareholders. A reconciliation of net cash provided by operating

activities of MetLife, Inc. (parent company only) to free cash flow of all


       holding companies for the years ended December 31, 2019 and 2018 is
       provided below.



                                      131

--------------------------------------------------------------------------------

Table of Contents



Reconciliation of Net Cash Provided by Operating
Activities of MetLife, Inc. to Free Cash Flow of All
Holding Companies                                             Years Ended December 31,
                                                                2019             2018
                                                                    (In millions)

MetLife, Inc. (parent company only) net cash provided by operating activities

                                       $     4,177       $     5,494
Adjustments from net cash provided by operating activities
to free cash flow:
Add: Incremental debt to be at or below target leverage
ratios                                                             494                 -
Add: Capital contributions to subsidiaries                         (75 )            (767 )
Add: Returns of capital from subsidiaries                           10      

87

Add: Investment portfolio and derivatives changes and other, net

                                                        (230 )            (378 )
MetLife, Inc. (parent company only) free cash flow               4,376      

4,436


Other MetLife, Inc. holding companies:
Add: Dividends and returns of capital from subsidiaries          2,199      

2,836


Add: Capital contributions to subsidiaries                         (67 )             (57 )
Add: Repayments on and (issuances of) loans to
subsidiaries, net                                                  (16 )              (6 )
Add: Other expenses                                               (720 )            (771 )
Add: Dividends and returns of capital to MetLife, Inc.          (1,100 )    

(3,200 ) Add: Investment portfolio and derivative changes and other, net

                                                         276      

168

Total other MetLife, Inc. holding companies free cash flow 572

       (1,030 )
Free cash flow of all holding companies (1)                $     4,948      

$ 3,406

Ratio of net cash provided by operating activities to consolidated net income (loss) available to MetLife, Inc.'s common shareholders: MetLife, Inc. (parent company only) net cash provided by operating activities

                                       $     4,177       $     5,494
Consolidated net income (loss) available to MetLife,
Inc.'s common
shareholders (1)                                           $     5,721       $     4,982
Ratio of net cash provided by operating activities (parent
company only) to
consolidated net income (loss) available to MetLife,
Inc.'s common
shareholders (1) (2)                                                73 %             110 %
Ratio of free cash flow to adjusted earnings available to
common shareholders:
Free cash flow of all holding companies (3)                $     4,948      

$ 3,406 Consolidated adjusted earnings available to common shareholders (3)

                                           $     5,767       $     5,461
Ratio of free cash flow of all holding companies to
consolidated adjusted
earnings available to common shareholders (3)                       86 %    

62 %

__________________

(1) Consolidated net income (loss) available to MetLife, Inc.'s common

shareholders for the year ended 2018 includes Separation-related costs of

$80 million, net of income tax. Excluding this amount from the denominator

of the ratio, this ratio, as adjusted, would be 109%. See "- Liquidity and


       Capital Resources - MetLife, Inc. - Liquid Assets - MetLife, Inc. and
       Other MetLife Holding Companies Sources and Uses of Liquid Assets and
       Sources and Uses of Liquid Assets included in Free Cash Flow."

(2) Including the free cash flow of other MetLife, Inc. holding companies of

$572 million and ($1.0) billion for the years ended December 31, 2019 and

2018, respectively, in the numerator of the ratio, this ratio, as

adjusted, would be 83% and 90%, respectively. Including the free cash flow

of other MetLife, Inc. holding companies in the numerator of the ratio and

excluding the Separation-related costs from the denominator of the ratio,


       this ratio, as adjusted, would be 88% for the year ended December 31,
       2018.



                                      132

--------------------------------------------------------------------------------

Table of Contents

(3) i) Consolidated adjusted earnings available to common shareholders for the

year ended December 31, 2019, was positively impacted by notable items,

primarily related to tax related adjustments, of $539 million, net of

income tax, partially offset by expense initiative costs of $332 million,

net of income tax. Excluding such notable items impacting consolidated

adjusted earnings available to common shareholders from the denominator of

the ratio, the adjusted free cash flow ratio for the year ended December

31, 2019, would be 87%.




ii) For the year ended December 31, 2018, $268 million of Separation-related
items (comprised of certain Separation-related inflows primarily related to
reinsurance benefit from Brighthouse) were included in free cash flow, which
increased our holding companies' liquid assets, as well as our free cash flow
ratio. Excluding these Separation-related items, adjusted free cash flow would
be $3.1 billion for the year ended December 31, 2018. Consolidated adjusted
earnings available to common shareholders for 2018 was negatively impacted by
notable items, primarily related to expense initiative costs of $284 million,
net of income tax, partially offset by tax adjustments of $247 million, net of
income tax. Excluding the Separation-related items, which increased free cash
flow, from the numerator of the ratio and excluding such notable items
negatively impacting consolidated adjusted earnings available to common
shareholders from the denominator of the ratio, the adjusted free cash flow
ratio for the year ended December 31, 2018, would be 56%.
Subsequent Events
See Note 23 of the Notes to the Consolidated Financial Statements.

© Edgar Online, source Glimpses